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Abstract 
 
 
Alcohol liver disease (ALD) is a major health concern throughout the world.  Currently, in the United 
States, 17 million people suffer from alcoholism, of which 1.4 million people are receiving treatment [1, 
2].  The link between ethanol metabolism, reactive oxygen species (ROS) and liver injury in ALD has been 
well characterized over the last couple decades [3-10].  Ethanol metabolism relies on the availability of 
the cofactor NAD+ for the oxidation of ethanol into acetate, consequently causing alterations in redox 
potential.  Redox dysfunction within the mitochondria can affect multiple pathways important in 
maintaining cellular homeostasis.  Chapter 1 provides an introduction to the role of ethanol metabolism 
in oxidative stress and alcohol liver injury (ALI).  During ethanol metabolism, both the cytochrome bc1 and 
NADH dehydrogenase complexes within the mitochondria have been demonstrated to be major 
contributors to ROS formation and “leak” free radicals [11-13].  As a result, the free radicals superoxide 
(O2-) and hydrogen peroxide (H2O2) is diffused into the cytoplasm where they can react with other 
molecules, proteins and DNA and cause tissue injury [4, 14].  Chapter 1 aims to introduce the link between 
ethanol metabolism and histone post-translational modifications (PTM) such as tyrosine nitration and 
lysine acetylation using proteomics techniques.   
Chapter 2 uses a global proteomic study to identify links between gender and ALI.  A 10-day chronic-
binge mouse model was employed in order to identify gender-specific proteins that may influence the 
development of ALD.  It has previously been established that females are more susceptible to developing 
ALD, however, the cause is still unknown.  This study identifies gender differences in the family of 
cytochrome P450 proteins using a mouse model for chronic-binge alcohol exposure.  The cytochrome 
P450 family of proteins are important in the metabolism of toxic compounds, such as acetaldehyde, a 
xiv 
 
byproduct of ethanol metabolism.  Interestingly, I also identified that female mice expressed naturally 
higher levels of histone acetylation prior to alcohol exposure when compared to males.  Following alcohol 
exposure, the female mice did not show much change in acetylation, whereas male acetylation levels 
were raised to similar levels of the female mice.  These acetylation changes raised the question, how does 
alcohol influence epigenetic marks on histone proteins?  Recently, new evidence has emerged that 
supports the role of epigenetics in the pathophysiology of ALD [4, 14-27]. 
Ethanol metabolism will promote shifts in redox potential and mitochondrial dysfunction, the result 
is the formation of reactive oxygen and/or nitrogen species (ROS/RNS) [4, 5, 7, 10, 14, 28].  As ethanol is 
metabolized, the accumulation of ROS/RNS species such as NO- and O2- can induce the post-translational 
modification nitrotyrosine.  Shifts in redox potential will cause the electron transport chain to “leak” the 
free radical O2-.  Another free radical known as nitric oxide (NO-) has been shown to be elevated during 
times of ethanol consumption [29, 30].  Traditionally, NO has a protective role within the cell at low 
concentrations, however, in surplus can lead to tissue damage.  Ethanol-induced increases in NO- and O2- 
can instigate to peroxynitrite (ONOO-) formation; a potent oxidant and nitrating agent of tyrosine residues 
[29, 31-34].  Chapter 3 examines the indirect effect of alcohol metabolism and ROS/RNS formation on 
histone tyrosine nitration.  This project used mass-spectrometry to identify novel targets of histone 
tyrosine nitration using a mouse-model of chronic-binge alcohol exposure.  Interestingly, histone H3 was 
found to be nitrated on the hinge-region of the N-terminal tail at tyrosine 41.  Molecular dynamics of the 
nitrated and unmodified proteoforms revealed that the DNA prefers a change in conformation upon 
H3Y41 nitration.  Further studies using an antibody synthesized against the nitrated H3y41 region of the 
protein revealed potential targets within the genome important in fatty acid synthesis and metabolism.   
Chapter 4 looks at the direct influence of alcohol metabolism and its contribution to histone 
acetylation via acetate production and acetyl-CoA.  Alcohol metabolism has traditionally been thought 
influence acetylation through the sirtuin family of deacetylase proteins.  Sirtuin deacetylases are NAD+-
xv 
 
dependent and have been shown to be a regulate protein acetylation within the mitochondria, cytoplasm, 
and nucleus during times of ethanol exposure [35-37].  Shifts in redox potential attributed to ethanol 
metabolism can inhibit sirtuin deacetylase activity by out-competing the enzymes for available NAD+, 
ultimately leading to mitochondrial and nuclear hyperacetylation [17, 28, 38-42].    Currently, there is 
evidence that ethanol increases acetylation of histone 3 lysine 9, which then targets activation of the 
alcohol dehydrogenase gene (ADH) [17, 18, 43].  Moreover, Shukla et.al. (2008) support the idea that 
ethanol can alter epigenetic transcriptional activation based on which modification is selected for a site 
during times of stress when it can be occupied by more than one modification [22].  Chapter 4 
demonstrates the use of mass-spectrometry to metabolically trace 13C2-labeled ethanol in vivo. These new 
data show clear evidence of 13C2 heavy-labeled ethanol being incorporated into known sites of acetylation 
on the N-terminal tails of histone H3 and H4.  Incorporation of heavy-label was calculated using extracted 
ion chromatograms (XIC) for the double and singly acetylated and unmodified peptides belonging to H3K9-
R17 and H3K18-R23.  Total change in acetylation was also assessed for each peptide using the ratio of 
ratios of total acetylation to unmodified peptide over the fold change in ethanol- to control-fed groups. 
An interesting observation was observed in that the incorporation of heavy-label suggests site-selectivity 
of lysine residues over time. Histone 4 contains multiple sites of acetylation on the peptide H4K5-R17, 
making it hard to quantify manually.   MaxQuant evidence files in conjunction with R were used to 
calculate the 13C2 incorporation on the multiple H4 acetyl-sites over 24-hours.  Ethanol-heavy label 
incorporation at multiple acetyl-sites occurred as a mixture suggesting a role in transcriptional regulation.  
These new data establish a link between alcohol metabolism and known epigenetic marks on histone 
proteins.  These studies have now established that alcohol metabolism is indirectly linked to histone 
tyrosine nitration through increased ROS/RNS and directly through acetate production.  Understanding 
how these epigenetic marks fluctuate as ALD progresses will provide potential targets for the 
development of new drug therapies.  The epigenetic marks identified in these studies have previously 
xvi 
 
been established to be important activators in transcription.  These data provide novel techniques using 
proteomics-based metabolic tracing in vivo.  Future studies will assess how these marks change after 
chronic ethanol exposure and whether the changes in epigenetics are heritable.  Understanding 
hereditary of alcoholism will provide insight to those predisposed to the disease.    
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Chapter 1 
 
 
Introduction 
 
Pathology of Alcohol Liver Disease  
Alcoholic liver disease (ALD) is the broad term given to encapsulate the multiple stages of liver 
damage ensued by the overconsumption of alcohol.  Although preventable, ALD is currently the major 
contributor to liver disease in Westernized civilizations.  Recently, the World Health Organization (WHO) 
reported that alcohol abuse contributed to over 3.3 million deaths globally, and was the 5th leading risk 
for premature death and disability [1, 44-46].  Alcohol consumption can be linked to over 200 diseases 
and injury-related ailments, which in turn results in the expenditure of hundreds of billions of dollars in 
healthcare-related cost annually [1].  Alone, the United States currently spends more than $249 billion 
USD annually on the misuse of alcohol; of which ¾ of the cost originates from binge-drinking [1, 2].  The 
National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines binge drinking as any pattern of 
drinking that raises the blood alcohol level to greater than 0.08 g/dL in a sitting, which translates into 
approximately 4-5 drinks in 2 hours depending on physique [2, 44, 45].  On the other hand, heavy or 
chronic alcohol consumption has been defined as drinking greater than 5 alcoholic beverages within the 
same sitting on more than 5 occasions per month (30 days) [2, 44, 45].  Alcohol dependency, whether 
chronic or binge, will eventually lead to alcoholic liver injury and if not corrected, and ultimately lead to 
steatosis, hepatitis, cirrhosis and/or cancer [2, 47-49].   
The term “alcohol liver disease” is a broad term that encompasses a range of pathological 
conditions ranging from reversible steatosis (fatty liver) to irreversible liver scarring and tumorigenesis, 
termed cirrhosis.  The first stage of ALD is called steatosis, also known as fatty liver, and is typically 
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characterized by the development of either micro- or macrovesicles of lipids within the hepatocytes 
(Figure 1.1 A & B respectively).  Although micro- and marcovesicle lipid accumulation can be observed in 
many other liver diseases by histology, it can be differentiated in ALD by the displacement of the nucleus 
to the cell membrane, which is otherwise not observed in nonalcoholic steatohepatitis (NASH) [47].  
Microvesicle accumulation observed during steatosis becomes more prominently expressed during 
periods of binge drinking with acute decomposition (Figure 1.1A) [47]. Following steatosis, a more severe 
form of injury called alcohol steatohepatitis (hepatitis) can develop, and severity can be characterized 
according to the number of histological features present within the liver tissue.  Although there is not a 
clear line of distinction between steatosis and steatohepatitis (or hepatitis) when there is evidence of 
hepatic injury in addition to the fat vesicle deposition, typically the grading system for nonalcoholic 
steatohepatitis (NASH) consisting of mild, moderate, and severe can be used [47].  Because there is no 
clear line between steatosis and hepatitis, the general term alcoholic steatohepatitis is commonly used to 
describe the development of ALD.  There are prominent features of liver injury seen in ALD that are not 
observed in NASH, which can be used to help classify the severity of alcohol steatohepatitis beyond micro- 
and macrovesicle formation.   
Mild hepatitis consists of both micro- and macrovesicle initial formation as well as increased 
hepatocyte ballooning and degeneration (Figure 1.1C). Hepatocyte ballooning, which can resemble 
Figure 1.1:  Hematoxylin-Eosin Stain of Mouse Liver 
Post 28-Day Chronic Ethanol Exposure.  The image was 
taken at 40X magnification and demonstrates mild 
alcoholic steatohepatitis.  The liver exhibits micro- (A) 
and macrovesicle formation (B), which can be seen in a 
variety of liver diseases.  Degrees of alcoholic 
steatohepatitis are characterized by a degree of factors 
including the nucleus placement to the cell membrane 
(B), the formation of Mallory-Denk bodies (C), 
neutrophilic invasion (D) and acidophil formation and 
necrosis (E).  As the disease progresses, neutrophilic 
invasion can be observed at sites of injury (F).      
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macrovesicle formation, is distinguishable by the central placement of the nuclei as well as possible 
Mallory-Denk body formation [47].  Mild hepatitis will also include one or more of the following features 
at low to moderate levels.  Swollen hepatocytes will begin to exhibit the presence of Mallory-Denk bodies 
(Figure 1.1D).  Mallory-Denk bodies are visualized as a spindle-like formation, caused by the condensation 
of denatured cytokeratin filaments within the hepatocyte cytoplasm [47].  These filaments are often 
ubiquitinated and mark the cell for apoptosis and degradation.  The liver will also begin to show signs of 
cell death and necrosis, marked by individual acidophil formation (Figure 1.1E) [47].  As the severity of 
liver damage increases, the neutrophil invasion will become elevated surrounding injured hepatocytes; 
and becomes much more prominent and concentrated in moderate to severe hepatitis than what is shown 
above (Figure 1.1F).  More moderate to severe cases of hepatitis are denoted by the drastic accumulation 
of foamy hepatocyte degenerates, which is a foam-like appearance that is formed by the lipid, bile and 
pigment accumulation in the cytoplasm [50].  Hepatocytes also accumulate glycogenated nuclei and begin 
to show signs of sclerosing hyaline cartilage development in the centrilobular dropout region[47].   
Moderate hepatitis also includes all of the aforementioned in addition to an increase in the 
number of apoptotic hepatocytes, also known as acidophils (or Councilman) bodies (Figure 1.1E) [47].  
Apoptotic hepatocytes can be recognized by their shrunken size, a dense eosinophilic cytoplasm, and 
pyknotic nucleus [47].  The last grade and most severe stage of hepatitis include all of the above in high 
densities in addition to the large deposits hyaline cartilage in the centrilobular region.  This marks the 
beginning stages of fibrosis/cirrhosis   
Fibrosis is scar tissue accumulation due to the imbalance of connective tissue formation and 
hepatocyte degradation [47].  Fibrosis results only from alcohol abuse and is not observed in the non-
alcoholic form of liver disease, making it a clear diagnostic marker.  Fibrosis is irreversible and often 
detrimental to disease outcome because of diminished liver function due to the surplus of connective 
tissue, which can restrict the blood flow into lobes causing tissue death from lack of oxygen and nutrients 
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[47].  Fibrosis typically begins near the central vein and spiderwebs down into the lobules as the disease 
progresses[47]. 
The beginning stages of cirrhosis are recognizable by fibroid tissue banding, nodule formation and 
severe bridging between the central and portal veins ensued by the decrease in blood flow [47].  Cirrhosis 
begins with the classical accumulation of micronodules and structural deformities of the liver [47].  Once 
cirrhosis progresses, the fibro-connective tissue matrix is maximized and pseudo-lobule formation occurs.  
Although micronodules are most commonly observed, during periods of prolonged alcohol abstinence, 
changes in patterns between micro- and macronodules has been observed [47].  Alcoholic patients that 
are diagnosed with cirrhosis also increase their risk of developing hepatocellular carcinoma 5-15% [47].  
Abstinence from alcohol is currently the only way to prevent cirrhosis of the liver.  
Ethanol Metabolism 
Oxidative Ethanol Metabolism 
The pathogenesis of alcoholic liver disease (ALD) depends on an array of factors, with only a 
minority of heavy drinkers actually developing fibrosis/cirrhosis of the liver [47-49, 51].   Once ethanol is 
ingested, the body begins the first-pass metabolism in the stomach.  First, pass metabolism encompasses 
gastric emptying and hepatic metabolism, and 20% of ethanol metabolism is estimated to occur in this 
phase [52-59].  Although there is much debate about the relative contribution of gastric over hepatic 
metabolism, both pathways depend on the rate of gastric emptying and the availability of their resident 
alcohol metabolite [52-60].  Gastric metabolism is said to only account for a small percentage (<20%) of 
ethanol metabolism due to the fact most of the ethanol is absorbed by the jejunum within the small 
intestine and delivered to the liver through the portal vein where hepatic metabolism is initiated [51, 57, 
58].  Hepatic metabolism is understood to be the primary mode of ethanol metabolism, largely because 
of the availability of the metabolite alcohol dehydrogenase (ADH) that is found in the liver. The liver is a 
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profound organ consisting of many metabolites, which are able to metabolize many compounds and drugs 
efficiently, such as xenobiotics and steroids, as well as regulate the oxidization of alcohol and fatty acids 
[57].  Hepatic metabolism of ethanol is an oxidative process that is catalyzed by one [or more] of the 3 
pathways within the liver.  The three separate pathways consist of the catalase pathway, alcohol 
dehydrogenase (ADH), and microsomal ethanol oxidizing system (MEOS) (Figure 1.2) [61].  The pathway 
utilized to metabolize ethanol is largely dependent on the availability of the metabolite as well as the 
quantity and duration of ethanol exposure.  Once the ethanol is absorbed and metabolized by the liver it 
enters circulation as the metabolite acetate, where it can be delivered to other organs in the body as 
energy or excreted as waste [57, 58]. 
The ADH pathway is currently the most extensively characterized pathway in hepatic metabolism, 
and it primarily takes place in the cytosol of the cell [9, 10, 51, 54-56, 59, 60, 62-66].  Two alcohol 
dehydrogenase isozymes combine in order to form a dimer with an average molecular weight of 80 kD.  
There are 5 total classes of ADH isozymes, each class results in a unique hybridization of isozymes that will 
allow for ADH optimization [58, 59].  Upon dimerization, the different combinations of subunits allow for 
activation of ADH and kinetic optimization [58, 59].  Only 4 of the 5 classes are found in the liver, they are 
class I-III and V.  Class IV or ADH7 consists of µ & σ subunits and is found in the stomach, esophagus, and 
mucosal linings [58, 59].  All Class I isozymes are all present in the liver and each possesses their own 
unique subunit; ADH1 (α),  ADH2 (β1-3) (liver and lung), and ADH3 (γ1-2) (liver and stomach).  During ethanol, 
metabolism ADH1 is thought to be the key factor in protecting a cell from acetaldehyde toxicity [57-59].  
The ADH class II of proteins consists of  ADH4 (π) and is found both in the liver and the cornea.   ADH4 
found within the liver is primarily located within mitochondria of the hepatocyte, ADH4 is the primary 
barrier to the intracellular toxic build-up of acetaldehyde [57, 58].  Class III consists of  ADH5 (χ); ADH5 is 
found in most tissues types including the brain, however, it does not take part in the oxidation of ethanol 
due to its low affinity for the substrate [57, 58].  The last class of ADH isozymes is class V and consists only 
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of the ADH6 isoform.  ADH6 is found in the liver and stomach, and currently little is known regarding its 
role in ethanol metabolism.  Ethanol metabolism of mild to moderate consumption (1-7 drinks/week) 
occurs mostly through class I ADH proteins, however, class II & IV play a significant role during times of 
greater alcohol consumption [57, 58].   
Ethanol metabolism by ADH begins by catalyzing the oxidation of ethanol to acetaldehyde while 
at the same time reducing NAD+ to NADH (Figure 1.2, center).  This reaction is initiated by the binding of 
ADH to the coenzyme NAD+ [66].  Next, the ADH and NAD+ complex binds the alcohol substrate with of 
zinc [66].  Upon forming a complex with zinc a series of deprotonation reactions occur on ADH, NAD+, and 
ethanol [66].  Finally, a hydride transfer from the alkoxide ion to NAD+ takes place, this leads to the 
formation acetaldehyde, which is released as a byproduct [66].  Acetaldehyde is toxic when it accumulates 
and therefore is almost immediately oxidized into acetate where it can be used in cellular respiration.  As 
Figure 1.2: Overview of Ethanol Metabolism.  Ethanol is metabolized by 1 more of the three 
pathways: (Center) Alcohol dehydrogenase (ADH) in the cytosol, (Bottom) Cytochrome P450 2E1 
(CYP2E1) in microsomes, (Top) Catalase in peroxisomes. ADH results in increased NADH:NAD+ ratios, 
both CYP2E1 and ADH produce increased reactive oxygen species.  Catalase is shown to have no 
contribution to ethanol metabolism in vivo.   
Adapted from Zakhari S. (2006) Overview: How is 
Alcohol Metabolized by the Body? 
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a result of the ADH pathway, there is a shortage of NAD+, which in turn induces mitochondrial dysfunction.  
In turn, the mitochondrial dysfunction leads to an increase in intracellular ROS/RNS.   
The second pathway in ethanol metabolism is the microsomal ethanol oxidizing system (MEOS) 
[9, 52, 57, 63, 65, 67].  The MEOS pathway occurs within the smooth endoplasmic reticulum (SER) and has 
been the subject of extensive research in recent years [63-65, 68, 69].  When initially discovered, MEOS 
was thought to stem from either ADH or catalase contamination, however, it is now known to work with 
the Cytochrome P450 family of isozymes [64, 65, 69, 70].  The cytochrome P450’s metabolize numerous 
types of reactions in the liver including toxic compounds, drugs, alcohol and liver byproducts [71].  
Cytochrome 2E1 (CYP2E1) is the key enzyme responsible for the metabolism of ethanol in the MEOS 
pathway [57, 58].  CYP2E1 has a higher affinity for alcohol than most of the ADH enzymes but is only 
upregulated during periods of long-term exposure to large quantities of alcohol exposure [57, 58, 63, 69].  
Although CYP2E1 levels can increase 4-10-fold during times of alcohol consumption, the increase in 
expression is transient and abstaining from alcohol greater than one-week returns CYP2E1 levels back to 
basal levels [57, 58].  It has been speculated that because only protein [not mRNA] levels of CYP2E1 are 
increased during ethanol metabolism, that degradation of CYP2E1 may somehow be inhibited [65, 72].  
CYP2E1 gene activation and mRNA stabilization have been ruled out as causes for protein upregulation 
during times of ethanol consumption [71, 73-76].  It is now being proposed that CYP2E1 accumulation can 
be attributed to protein stabilization possibly caused by changes in post-translational modifications on 
the protein itself, although no scientific evidence has been proposed to date [64].   
Because the MEOS/CYP2E1 pathway is also important in the metabolism of xenobiotics and other 
drugs, alcohol metabolism may be subjected to competition for the cofactor NADPH oxidase.  The main 
function of P450 cytochromes is to modify metabolites in order to make them easier to be excreted [71].  
Other types of compounds and metabolites such as acetaminophen [77], CCL4 [78], acetone [79, 80], and 
N-nitrosodimethylamine (NDMA) [81] may need to be cleared from the liver at the same time that alcohol 
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is being metabolized [64].  Competition in metabolism may offer insight to the stalled CYP2E1 degradation 
observed during times of prolonged alcohol consumption.   
Ethanol metabolism by CYP2E1 occurs inside a microsome.  The reaction occurs when NADPH is 
reduced to NADP+, and ethanol is reduced to acetaldehyde (Figure 1.2, bottom).  Acetaldehyde is then 
released as an intermediate and oxidized further into acetate. As ethanol is metabolized, available NADPH 
becomes depleted, and as a result, ROS/RNS are produced.  The production of superoxide (O2-) and 
hydrogen peroxide (H2O2) are prevalent and these free radicals are then free to move about the cell 
causing harm.   
The last and third oxidative pathway in alcohol metabolism is the catalase pathway (Figure 2, top).  
The catalase pathway has not been shown in vivo to significantly contribute to ethanol metabolism under 
physiological conditions and therefore will not be addressed in these studies [64].  
No matter which pathway is used to metabolize ethanol, the first step is to convert ethanol into 
acetaldehyde, which then enters the mitochondria where it is converted into the metabolite acetate.  
Acetaldehyde is the intermediate step in both pathways and is quickly converted into acetate and NADH 
to avoid toxicity.  NADH can accumulate within the mitochondria and in turn, can cause dysfunction in the 
electron transport chain as copious amounts of acetaldehyde become oxidized.  The more mitochondrial 
dysfunction, the more ROS/RNS is generated.  Acetate derived from acetaldehyde is typically transported 
through the bloodstream where it is used for energy and then converted by other organs into CO2 [82].  
Acetate may also be converted into acetyl-CoA where it can be used in lipid metabolism or as an acetyl 
donor by acetyltransferases [82].   
Ethanol Metabolism and Mitochondrial Dysfunction 
Acetaldehyde production, during ethanol metabolism, is pathway independent and as a result, 
NADH accumulates and reactive oxygen species are generated.  Ethanol is first metabolized into 
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acetaldehyde by ADH within the cytoplasm (Figure 1.3).  Acetaldehyde is toxic to the cell because of its 
ability to modify other enzymes and proteins as well as it being a carcinogenic [57, 59, 83].  Because of 
the toxicity, acetaldehyde is rapidly metabolized within the mitochondria, into acetate by acetaldehyde 
dehydrogenase (ALDH2) using the cofactor NAD+.  Decreased levels of the antioxidant glutathione (GSH) 
signify acetaldehyde adduct formation, which can lead to protein retention within the liver, hepatomegaly 
and many other many toxic manifestations [57].  GSH is a scavenger of toxic free radicals, and its depletion 
allows for acetaldehyde-induced free radical formation toxicity and lipid peroxidation [57, 64].  As a result, 
excess NADH found within the mitochondria and cytosol of the cell that is caused by the conversion of 
ethanol to acetate has been linked to hyperlactacidemia, can lead to acidosis  [64].  If not rectified acidosis 
will then lead to secondary hyperuricemia, enhanced purine degradation and even more increases in 
reactive oxygen species (ROS) [64].   Increases in NADH can also inhibit fatty acid oxidation and raise the 
concentration of α-glycerophosphate to encourage triglyceride formation in the liver (Figure 1.3).  
Moreover, increased levels of NADH may inhibit glycolysis by blocking pyruvate formation through lactic 
acid accumulation [84].  As a chain reaction, the citric acid cycle is also distressed due to the unavailability 
of NAD.  The electron transport chain is forced to use hydrogen equivalents obtained from ethanol, rather 
than from the oxidation of fatty acids, as the main energy source of the liver [64].  The disruption in the 
citric acid cycle can also promote triglyceride formation in the liver due and ultimately will promote 
hepatic lipogenesis [64, 84].   
Acetaldehyde is next converted into acetate within the mitochondria (Figure 1.3).  Ethanol 
metabolism can be assessed by quantifying the acetate levels found in the bloodstream.  Acetate is very  
important for cell metabolism, it can travel safely throughout the bloodstream to other organs and used 
in the Krebs cycle to make adenosine triphosphate (ATP).  Acetate is further metabolized into acetyl-CoA, 
where it can then enter the TCA cycle to produce energy.  Acetyl-CoA is then able to donate its acetyl 
group to other proteins and histones with the help of acetyltransferase.  In tandem, the altered redox 
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state promotes hyperacetylation throughout the cell by inhibiting deacetylase activity [85-88].  Protein 
acetylation is a reversible modification and has recently become recognized as a significant contributor to 
not only cell metabolism but also gene regulation through epigenetics [89-91].  The increased acetylation 
observed during ethanol metabolism may be due to inactivation of the sirtuin family of deacetylases or 
increased acetylation due to rising levels of acetyl-CoA (Figure 1.3).  The sirtuin proteins are NAD-
dependent deacetylase proteins that control protein expression within the cell by facilitating the removal 
of acetyl groups on proteins, their function is imperative in maintaining hepatic homeostasis [35-37].  It is 
possible that ethanol metabolism can inhibit sirtuin activity by out-competing the sirtuin enzymes for 
Figure 1.3: Overview of NADH: NAD+ Regulation during Ethanol Metabolism.  Ethanol metabolism affects 
numerous pathways within the cell.  The metabolism of ethanol relies on a large amount of NADH, which it 
uses from the available stocks required to maintain cellular homeostasis.  Ethanol causes dysfunction in 
glycolysis, as well as the Krebs cycle and electron transport chain.  Disruption in mitochondria homeostasis 
can cause dysfunction in protein regulation such as a decrease in sirtuin deacetylase.  Down regulation in 
deacetylase activity can further disrupt protein expression via hyperacetylation (i.e. CPS1 and histone 
proteins). 
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available NAD+, thus resulting in increased protein acetylation and mitochondrial dysfunction following 
long periods of alcohol consumption (Figure 1.3) [38].   
Ethanol Metabolism and Oxidative Stress  
Ethanol consumption induces substantial amounts of ROS/RNS in the liver during its metabolism, 
which primarily originates from mitochondria dysfunction induced by oxidative stress. Ethanol can 
increase redox pressure along the electron transport chain via NADH, resulting in an even larger increase 
of available ROS (Figure 1.4) [14].  Both the cytochrome bc1 and NADH dehydrogenase complexes within 
the electron transport chain have been found to be major contributors to ROS formation and “leak” free 
radicals during ethanol metabolism [11-13].  As a result, the free radicals, superoxide (O2-) and hydrogen 
peroxide (H2O2) are diffused into the cytoplasm where they can react with other molecules, proteins and 
Figure 1.4: Ethanol Metabolism Induces Oxidative Stress in the Mitochondria. As ethanol (EtOH) is 
metabolized increased levels of acetaldehyde and NADH are produced.  Acetaldehyde enters 
the mitochondria where it is converted into acetate.  Acetate is further used in cellular 
respiration for acetyl-CoA production.  As EtOH is broken down, levels of NADH also increases 
causing mitochondria dysfunction and ROS production. Increases in ROS/RNS promote the 
formation of peroxynitrite that can then nitrate tyrosine residues throughout the cell.      
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even DNA [4, 14]. Oxidative stress can have detrimental effects on homeostasis if not tightly regulated [4, 
14, 92].  Recently it has been demonstrated that at high levels of ethanol (600 mM) exposure (in 
conjunction with the resulting increased levels of ROS), initiate high levels of BCL-2-associated X protein 
(BAX) recruitment to the mitochondria, ultimately leading to cell death [93]. Traditionally, during times of 
mitochondria dysfunction, mitochondrial fission and autophagy are activated in an ethanol concentration-
dependent manner [93].  Inhibition of the autophagy pathway during ethanol-induced ROS resulted in 
increased mitochondrial fission and cell death [93].  However, upon autophagy pathway stimulation, the 
mitochondria showed signs of autophagy having a protective role in the removal of damaged 
mitochondria [93].  Furthermore, when high levels of BAX recruitment to the mitochondria was blocked 
cells treated with ethanol responded in mitochondrial fission and autophagy and not cytotoxicity [93].  
Upon ROS/RNS formation the liver can activate an inflammatory response via tumor necrosis factor alpha 
Figure 1.5: Reactive Oxygen Species, Superoxide (O2-) and Nitric Oxide (NO) Lead to the Formation of 
Nitrotyrosine (nY).  When excess superoxide and nitric oxide are formed, they can react to form the highly reactive 
peroxynitrite.  Peroxynitrite can add the post-translational modification of a nitro group to cysteine, tyrosine and 
threonine residues. 
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(TNFα).  Kupffer cells, the resident immune cells of the liver, are responsible for producing an 
inflammatory signaling molecule, and also a free radical, nitric oxide (NO-), [94].  Generally, NO- has a 
protective role at low concentrations, however, in surplus can lead to tissue damage.  Nitric oxide synthase 
(NOS) is the protein responsible for NO- formation.  Three isoforms of NOS exist, inducible (iNOS), 
neuronal (nNOS), and epithelial (eNOS) and when combined with L-arginine; NO- and L-citrulline are 
formed as a byproduct [30, 95].  NO- levels have been shown to be elevated during times of ethanol 
consumption, which has been suggested to play a role in the onset of liver injury [29, 30].  Previous 
research has demonstrated that both TNFα and endotoxin receptors are involved in the development of 
ALI through increased levels of NO, which can combine with O2- to form the powerful nitrating agent 
peroxynitrite (ONOO-)[94].  Recently a study showed that when iNOS was knocked out liver damage due 
to alcohol abuse was blunted, whereas eNOS did not have any effect on liver injury [94].  The current 
working hypothesis states that endotoxins are released or “leaked” from the gut as a result of alcohol 
consumption, activating the inflammatory response, which in turn releases ROS/RNS that can induce liver 
injury [94].  The reasoning for this is due in part by ethanol-induced increases in NO- and O2- that can lead 
to peroxynitrite (ONOO-) formation, a potent oxidant and nitrating agent of tyrosine residues (Figure 1.5) 
[29, 31-34].   
Together all of these mechanisms provide a conducive environment for framing epigenetic marks 
on histone proteins.  Altogether ethanol metabolism causes, shifts in redox potential, increased ROS/RNS,  
increased acetate, increased inflammatory response and when combined with decreased sirtuin activity 
it provides all of the components conducive to implementing changes to epigenetics [96].  It is important 
to understand how the molecular mechanisms of ethanol-induced changes can lead to the variation of 
epigenetic regulation of gene expression.   
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Alcohol and Epigenetics 
Genetics are very important in the progression of ALD and how individual genes are controlled 
during ethanol metabolism need to be tightly regulated [58].  Alcohol-induced epigenetic changes 
prompted by liver injury have become of great interest to researchers recently.  Genetics and race have 
previously been recognized to link the predisposition of alcoholism from epigenetic marks inherited at 
birth [16, 25-27].  Surprisingly, little is currently known about the mechanisms relating to alcohol-induced 
epigenetic changes.  The term epigenetics refers to phenotypic changes within the cell, without altering 
the deoxyribose nucleic acid (DNA).  Typically, these are transient marks or post-translational 
modifications (PTM) that act as activators or silencers within the genome.  When a post-translational 
modification is added to a protein it can act as a substrate, catalyst, inhibitor as well as aid in protein 
folding [97].  Alcohol consumption has been shown to induce PTM changes in protein acetylation, 
methylation, phosphorylation, DNA hypomethylation as well as induce alterations in miRNA generation 
and function [15-18, 24-26, 39, 40, 96, 98].  These modifications are thought to be influenced by the 
increase in reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated as a result of 
ethanol metabolism [96].  ROS and RNS are able to move throughout the cell and alter any proteins they 
may come into contact with, both cytoplasmic and nuclear.  When ROS and RNS enter the nucleus, they 
are able to target histone protein tails, which are known to be important modulators of transcriptional 
regulation through epigenetic marks.  Histone tails can be acetylated, methylated, phosphorylated and 
ubiquitinated just like other proteins, however, the histone tails can interplay with the DNA causing 
changes in gene regulation and transcriptional machinery recruitment.  The study of epigenetics 
investigates how the various PTM combinations added to the histone proteins or DNA effect transcription 
[99].  Histones tails are responsible for regulating many epigenetic mechanisms; altering their post-
translational modifications may result in differential gene expression and impaired recruitment of the 
necessary proteins needed for transcription [89-91].  Understanding the underlying mechanisms of how 
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alcohol metabolism influences epigenetic alterations and how those changes affect the progression of 
alcoholic liver disease has become an increasingly large interest in the Stevens lab as well as in other labs 
over the past few years.  These data presented throughout show a link between alcohol consumption and 
epigenetics, whether by an indirect mechanism of histone tyrosine nitration via increased ROS and ONOO- 
or directly to histone acetylation through acetyl-CoA.   
Ethanol-Induced Histone Tyrosine Nitration 
Protein tyrosine nitration (PTN) is a type of post-translational modification specifically induced by 
oxidative/nitrative stress.  The role of PTN in epigenetics and alcohol liver disease is currently largely 
unexplored.  PTN occurs when O2- generated from ethanol metabolism reacts with upregulated NO and 
results in the formation of peroxynitrite (ONOO-) (Figure 1.5).  Peroxynitrite is a potent oxidant and 
nitrating agent, which is able to nitrate tyrosine, cysteine and threonine residues that it comes in contact 
with.  PTN poses an interesting target in ethanol metabolism and epigenetics as there is now an emerging 
role for tyrosine phosphorylation as an epigenetic modification [100].  Specifically, tyrosine nitration may 
have a direct role in altering histone-mediated gene transcription processes, or indirectly by affecting 
histone phosphotyrosine levels that have an impact on these processes [101].  Previous work has 
demonstrated that protein tyrosine nitration can affect the phosphorylation status of tyrosine residues 
by competition (inhibition), as well as by stimulating phosphorylation events [34, 102-105].  Furthermore,  
it is interesting to note that selective nitration of histone proteins has been reported previously in another 
pathophysiological condition where Mutatect tumors showed a marked increase in tyrosine nitration on 
the low MW histone isoforms [106].  Bartesaghi et. al. (2007) describe PTN as very selective; only 1-2% 
out of all of the available tyrosine residues within the cell can be nitrated, and it largely depends on both 
the environment and the structure of the protein to be nitrated [107].  Due to the minimum amount of 
tyrosine residues available for nitration, the positively charged lysine, and arginine residues of the histone 
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N-terminal tails within the nucleosome offer promising targets for histone tyrosine nitration (HTN) during 
times of ethanol-induced oxidative stress [108].  This observation prompted us to ask whether tyrosine 
nitration on histone proteins can be an established epigenetic mark induced by ethanol, and if so, what is 
its biological relevance.  Preliminary data from our laboratory suggest that during times of increased 
oxidative stress, such as binge or chronic drinking, PTN also increases.  In vivo data presented in chapter 
3 shows an increase in pan-nitrotyrosine that was localized to the nucleus after 4-weeks chronic ethanol 
exposure. 
Definitive identification of novel nY sites in vivo has proven to be a difficult task for researchers to 
study because of the many different obstacles encountered at both the cellular and technical level.  
Currently, most of the available research on nY has been completed in vitro using synthetic peptides and 
peroxynitrite to initiate nitration [103, 104, 107, 109-112].  This method works well to give insight to 
specific tyrosine residues that can be targeted for nitration, however, there has been little to no data 
reproducibility due to the inability of peroxynitrite to mimic the physiological synthesis of nitric oxide by 
endogenous cells [31, 33, 101].  Tyrosine nitration research is also limited by the gap in knowledge 
pertaining to the mechanism underlining tyrosine nitration as well as the possibility for dinitrase activity.  
Currently, there are several reports of dinitrase activity in vitro but the underlying mechanism or the type 
of cellular environment needed for promoting dinitrase activity has yet to be elucidated [109, 113-117].  
These data presented in chapter 3 focus on how ethanol metabolism and an increase in ROS indirectly 
affects tyrosine nitration on histone proteins.  This study will identify novel sites of tyrosine nitration on 
histones and examine whether these sites are important regulators of transcription.  Moreover, the 
mechanistic detail regarding the impact of oxidative stress on other histone modifications is essentially 
unknown.  Chapter 3 investigates how ethanol-induced ROS formation influences tyrosine nitration and 
its possible role in the development of alcohol liver disease.   
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Ethanol-Induced Histone Lysine Acetylation 
Lysine acetylation is a post-translational modification that has caught the attention of many 
scientists over the last 50 years [91].  Lysine acetylation is a reversible modification that has been 
implicated in many biological processes that link metabolism and cell signaling.  More specifically, lysine 
acetylation has been shown to have roles in regulating protein interactions, as well as affecting protein 
activity and localization [89].  Lysine acetylation of histone proteins is a known activating mark of 
transcriptional regulation because of its ability to loosen the negatively charged DNA [89].  Recent studies 
show ethanol metabolism can affect the acetylation status of proteins, usually resulting in a 
hyperacetylation status of proteins.  Currently, much of the research on ethanol-induced protein 
acetylation has occurred on mitochondrial proteins [85, 88, 118, 119].  Although the mechanism 
surrounding ethanol-induced hyperacetylation is poorly understood, it is thought that the 
hyperacetylation of mitochondrial proteins is due in part to the competition of NAD+ by both ethanol and 
the deacetylase proteins, sirtuins [38].  The sirtuin proteins are NAD+-dependent deacetylase proteins that 
regulate protein expression through deacetylating target lysine residues [35-37].  Fritz et.al. (2013) now 
show that hyperacetylation of mitochondrial proteins can be induced by ethanol metabolism directly 
rather than a sirtuin deficiency [118]. 
More recently the research has shifted to understanding how ethanol-induced changes in lysine 
acetylation affect epigenetics through histone modifications.  Park et. al. (2003) discovered that 
acetylation of histone H3 lysine 9 was upregulated in hepatocytes over the course of 24 hours when 
treated with 50 and 100 mM ethanol [80].  Additionally, Kendrick et. al. (2010), showed that metabolically 
available acetyl-CoA from acetate is vital to the increased acetylation of histones that target 
proinflammatory genes and consequently the proinflammatory response in ethanol-treated macrophages 
[120].  Most recent, Shukla et.al. (2015) confirmed that ethanol and acetate exhibit different experimental 
outcomes when used to assess the metabolic effects of metabolism on hepatic gene expression [23].  The 
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study presented in chapter 4 identifies differences in histone acetylation following binge drinking.  Also, 
the study aims to understand how ethanol metabolism contributes to lysine acetylation on hepatic 
histone N-terminal tails and what effect it has on gene regulation. 
A recent link is now being established between, ethanol metabolism, oxidative stress and 
subsequent epigenetic modifications, such as acetylation within the liver (as well as other tissue types) 
triggered by ethanol exposure [20].  For example, ROS production in rat hepatocyte primary culture after 
ethanol exposure was shown to contribute to the known liver epigenetic marker, acetylation of histone 
H3 at Lys9 (H3K9Ac) [18, 43].  Histone acetylation, in particular, is regulated by the activities of various 
histone acetyltransferases (HATs) and histone deacetylases (HDACs) where the activities of these enzymes 
are altered in hepatocytes following ethanol exposure [17, 18, 23, 39, 43, 121].  Furthermore, ethanol-
induced changes in histone acetylation patterns have been shown to selectively alter gene expression in 
rat livers while not affecting global protein expression [43].  However, the molecular mechanisms 
underlying ethanol-induced oxidative stress and its relationship to histone acetylation in hepatocytes are 
still unclear.  Acetylation of the tail region of histones H3 and H4 are currently known to be transcriptional 
activators in numerous scenarios ranging from normal cellular homeostasis to disease progression.  
Chapter 4 investigates how ethanol affects histone acetylation with the help of acetyl-CoA and histone 
acetyltransferases.   
Currently, the details regarding the impact of alcohol-induced oxidative stress on histone 
modifications are essentially unknown.  The conclusion of these studies will identify how ethanol 
metabolism contributes to epigenetic modifications on histone tails.  The focus of the following chapters 
is to identify the role of ethanol metabolism and its ability to influence changes in PTM’s, more specifically 
the epigenetics of histone proteins.  Increases in ROS indirectly affects tyrosine nitration on histone 
proteins most likely by the formation of ONOO-.  The following studies will identify and validate novel sites 
of tyrosine nitration on histones and further examine whether these sites are important regulators of 
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transcription.  They will also investigate how ethanol-induced acetate formation influences histone 
acetylation through the formation of acetyl-CoA and use of histone acetyltransferase.  
Epigenetics and Proteomics  
Overview of Mass Spectrometry 
Over the past decade, liquid chromatography and mass spectrometry-based technology have 
greatly advanced.  Liquid chromatography (LC), has transitioned over the years through high-pressure 
liquid chromatography (HPLC) into ultra-high performance (UHPLC) technology by using smaller particles 
in conjunction with higher pressure [122].  This allows for better binding, separation, and elution of 
peptides as they flow through the column. Peptide separation techniques and sensitivity levels have 
reached new levels of speed and resolution to complement the increasing sensitivity and selectivity of 
mass spectrometers.  There are numerous methods of data collection that can be used in order to obtain 
good separation of complex samples and optimize results [123].  The methodology primarily used in the 
following studies applied reversed-phased UHPLC-MS in conjunction with a top-10 data-dependent 
acquisition (DDA) method.  UHPLC has two primary functions, reduce sample complexity and enhance the 
peptide concentration before entering the mass analyzer [124].  In reversed-phase liquid 
chromatography, samples are bound by hydrophobic forces and released during a mobile phase of 
increasing organic solvent.  Eluted peptides are ionized as they come off the column and enter the mass 
analyzer.  Mass spectrometers consist of 3 major parts, the ion source, the mass analyzer, and the detector 
(Figure 1.6) [124].  The ion source creates the ions, either by electrospray ionization (ESI) or matrix-
assisted laser desorption/ionization (MALDI).  Currently, the most commonly employed mass analyzers 
are the time-of-flight (TOF), quadrupole, ion trap, Orbitrap, and Fourier transform (FT) ion cyclotron 
resonance [125].  The detector, electron multipliers as an example, detect signals and then converts them 
into a spectrum and then the intensity of each peak is recorded as relative abundance.     
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The following experiments utilized UHPLC and Q-Exactive Plus mass spectrometer (Thermo Fisher 
Scientific).  The Q-Exactive Plus (QE) is a hybrid high-resolution mass spectrometer (MS) designed using 
ESI technology and 2 mass analyzers, the quadrupole, and the Orbitrap, which provides more enhanced 
peptide selectivity and tandem MS sensitivity.  The first mass analyzer in the QE Plus is the quadrupole, 
and it functions to isolate the most abundant precursor ions, as designated by the method, to send into 
the 2nd mass analyzer, an Orbitrap where the ions cycle the Orbitrap at different frequencies while 
oscillating across the horizontal axis where the current is recorded and converted into mass spectrum 
using the Fourier transform function of the recorded signal.  These studies predominantly used a top -10 
DDA methodology, which selects the 10 most abundant precursor ions within each mass spectrum to be 
selected for further fragmentation by tandem MS [or MS2].  Tandem MS is a coupled with MS1,  where 
peptides with matching precursor ions are selected, isolated and further fragmented using collision-
induced dissociation (CID) [123, 124].  CID works by the collision of a neutral gas against the peptide, 
resulting in either a b-ion or y-ion series.  The ion series is represented as specific fragment ions generated 
by cleavage of the amide bonds where charge retention occurs on N- or C-terminal side of the fragment 
ion.  When fragmented, each peptide will create a unique set of fragment ions, just like a fingerprint. 
Figure 1.6: General Overview of LC-MS Analysis.  Sample is resuspended in HPLC-H2O and 
loaded onto the LC where it will bind the separation column.  As organic solvent is increased, 
the peptides eluting off the column will be ionized into the gas phase.  The mass analyzer will 
next separate the precursor ions on mass to charge.  In tandem MS, the precursor ions can then 
be further fragmented by CID into daughter ions.  The detectors calculates the number of ions 
for each peptides and the computer records the data as relative abundance and/or intensities. 
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Tandem MS, is run in parallel to MS1 and the precursor ion is selected for further fragmentation 
that produces daughter ions.  The daughter ions can be used for de novo sequencing or validation of 
peptides by taking the difference in mass to charge (m/z) of sequential residues.  Adequate sequence 
coverage must be obtained in order to ensure complete sequencing by de novo methods.  For example, 
the N-terminal region of a peptide produces b-ions, which typically fragment into low m/z values giving 
them an easier likelihood of being deflected while traveling through the mass analyzer.  B-ion deflection 
may result in minimal coverage of peptides in low m/z regions making validating and sequencing in that 
region difficult.  Methods of validation are important to prevent misidentification of proteins.  Stevens et. 
al (2008) describe proper validation measures using de novo sequencing in order to ensure correct 
identification of peptides and PTM while lessening the chances of false-positives  [126].  True peaks should 
have greater than 20% relative abundance in the given spectra, have a run in consecutive ions within a 
series greater than 4 ions, and exhibit conventional fragmentation patterns [126].  The validation of 
spectra by tandem MS has been used recently in the identification of novel sites of post-translational 
modifications on histone proteins (epigenetics) and was used in chapter 3 in order to validate novel 
targets of histone nitration.  Histone PTM marks have a regulatory role in chromatin structure and 
functions [124].  The same DDA analysis described above can be used for histone PTM identification.  Every 
PTM has a unique elemental composition and m/z, thus it can be considered a new amino acid.  Two 
factors depend on efficient detection of a PTM, which are the stability and the abundance of the 
modification.  The mass shift observed for the newly modified residue can be compared to their 
unmodified counterpart, however, all mass shifts come with an increased error and/or false discovery 
rate (FDR) [127, 128].  Computer-based algorithms, such as MaxQuant (Andromeda), MASCOT, and 
SEQUEST are now becoming widely used to identify and quantify PTM. These applications make it easier 
to identify novel PTM on previously unidentified sites, however, there are still concerns about false 
positives and search errors [127, 128].   
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Labeling Techniques in Mass Spectrometry  
Numerous labeling strategies are currently being used in order to achieve better quantification of 
histone PTM identified by MS.  N-terminal histone tails typically contain an abundance of lysine and 
arginine residues, which are cleaved C-terminally by trypsin prior to MS.  Often this cleavage can lead to 
short hydrophilic peptides that cannot be retained on a column [124].  In turn, using a protein or peptide 
labeling system to identify relative changes in histone PTM allows for better coverage and quantitation 
by mass spectrometry.  Stable isotope labeling by amino acids in cell culture (SILAC) has become widely 
used in MS and is a useful tool for in vitro experimentation because of the ease in quantifying changes in 
protein expression [129].  SILAC is typically used in cell lines that can be cultured and passaged several 
times to ensure complete label incorporation into the proteins.  After six passages, complete label 
incorporation is accepted to occur.  The separate treatment groups of cells are then mixed as a 1:1 ratio 
of heavy to light labeled peptides so they can be analyzed as an equal mixture.  Recently this technique is 
now being applied in vivo using stable isotope labeled feeding chow. Chapter 4 uses a method similar in 
order to metabolically trace 13C2 heavy-labeled ethanol to histone acetylation.   
Although SILAC is optimal for proliferating cells, when cells are terminally differentiated such as 
primary hepatocytes, other chemical labeling techniques can be used instead.  Chemical labeling can be 
completed at the peptide level using tandem mass tags (TMT), or isobaric tags for relative and absolute 
quantification (iTRAQ) [130].  These tags are chemically attached to lysine residues and can be used for 
quantitation after proteolysis.  More recently, Andromeda has implemented a label-free quantitation 
(LFQ) option in the MaxQuant algorithm, which has both pros and cons to chemically derive labeling 
systems [131, 132].  Chapter 4 uses a labeling method called propionylation in order to detect and increase 
the hydrophobicity of N-terminal histone tails [133].  Lysine derivatization adds a propionyl group to 
unmodified lysine residues.  Upon derivatization, smaller histone peptide fragments will become more 
hydrophobic and therefore will stay on the column and provide better separation.  The following 
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experiments utilize both label-free quantitation and propionylation approaches in order to better 
understand how alcohol consumption alters the epigenetics of histone proteins. 
Project Aims and Rational 
Aim 1: Identify and characterize site-specific targets of tyrosine nitration on histone proteins regulated 
by ethanol exposure.  
Increasing evidence suggests that epigenetic regulation through DNA methylation and histone 
modifications plays a major role in numerous human diseases, including alcohol liver disease (ALD) [96].  
Alcohol through metabolism is a major contributor to the production and release of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) [4, 134-137].  Consequently, free radicals are then able 
to move freely throughout a cell and interact with an array of molecules and proteins causing destruction 
in their path [4, 5, 135-139].  Accumulation of free radicals such as nitric oxide (NO), peroxynitrite (ONOO-
) and superoxide (O2-), have the ability to oxidize the proteins they come into contact with, therefore 
modifying their function and altering signaling events [5, 92, 101, 135, 136, 139-142].  During normal 
metabolism, the antioxidant glutathione (GSH), found in the liver, acts as a reductant to keep oxidative 
stress within the cell minimal and close to physiological conditions [107].  Glutathione (GSH) levels drop 
during ethanol metabolism as a result of ROS formation, allowing ROS to accumulate even more [143-
145].  When GSH levels drop, ONOO- can form when the superoxide anion (O2-) reacts with free nitric oxide 
(NO) within the cell [29, 30, 33].  Inducible nitric oxide synthase (iNOS), a signaling protein that becomes 
upregulated during times of inflammation, is responsible for the excess production NO [94].  When iNOS 
expression is knocked out in mice or blunted by the inhibitor 1400W, tyrosine nitration is minimized and 
liver injury is blunted [94].  Mice that were void of iNOS also exhibited no clear evidence of alcohol liver 
disease formation following 4-weeks of intragastric ethanol feeding [94].  These data show a suggested 
link between ROS, NO, and pathogenesis of ALD, this aim strives to further investigate the role of ethanol-
induced tyrosine nitration on histone proteins and the role of histone nitration in the development of ALI. 
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Nitric oxide (NO) has a dual role in the body.  NO has been demonstrated to have protective 
properties when expressed at endogenous levels, and harmful effects when found at higher levels [4].  
Ethanol has been demonstrated to cause an increase in available NO within the cell upon activation of 
inflammatory modulators such as TNFα [29, 30].  Nitric oxide is found within every organ system in the 
body, and functions as a key signaling molecule and regulator of immune response, vasculature 
homeostasis and inflammation [4, 141, 146].  Furthermore, recent studies now show NO is able to 
contribute to the regulation of epigenetics by modifying methylation and acetylation sites on histone 
proteins [147-149].  However, the link between oxidative stress and subsequent epigenetic modifications 
in the liver (as well as other tissue types) triggered by ethanol exposure is only recently being investigated.  
For example, histone acetylation has become increasingly popular amongst the alcohol research 
community.  One study determined that ROS production in rat hepatocyte primary culture following 
ethanol exposure was shown to contribute to the known epigenetic marker, acetylation of histone H3 at 
Lys9 (H3K9Ac), which has also been shown to be induced by ethanol, [18, 43].  Histone acetylation is 
largely regulated by the activities of various histone acetyltransferases (HATs) and histone deacetylases 
(HDACs) where the activities of these enzymes are altered in hepatocytes after ethanol exposure due to 
shifts in redox potential and increased oxidative stress [17, 18, 23, 39, 43, 121].  Furthermore, ethanol-
induced changes in histone acetylation patterns have been shown to selectively alter gene expression in 
rat livers while not affecting global protein expression [43].  However, the molecular mechanisms 
underlying ethanol-induced oxidative stress and histone tyrosine nitration in hepatocytes are still unclear.  
Moreover, the mechanistic detail regarding the impact of histone nitration modifications is essentially 
unknown.   
Histone tyrosine residues pose as an interesting target of nitration seeing as there is now an 
emerging role for tyrosine phosphorylation as an epigenetic modification [100].  Specifically, tyrosine 
nitration may act as a transcriptional regulator, or possibly as a negative regulator of tyrosine 
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phosphorylation, in turn, impacting on phosphorylation signaling processes [101].  Previous work has 
demonstrated that protein tyrosine nitration can affect the phosphorylation status of tyrosine residues 
by competitive inhibition as well as stimulating phosphorylation events, however, the effect of alcohol on 
tyrosine nitration and phosphorylation are unknown [34, 102-105].  Recent reports found a marked 
increase in tyrosine nitration on the low MW histone in Mutatect tumors, suggesting a role for histone 
tyrosine nitration in oncogenesis  [106].  Moreover, histones pose as an interesting target of tyrosine 
nitration even though PTN as very selective, and only 1-5 tyrosine residues in 10,000 can be nitrated [107, 
108]. The nitration of tyrosine is largely dependent on the environment and structure of the protein and 
histone proteins fit the criteria [107, 108].  Seeley et.al. (2012) have previously demonstrated that tyrosine 
nitration was preferential when the tyrosine is bordered by basic residues or an adjacent uncharged polar 
residue when compared to hydrophobic and acidic residues [108].  Histones provide a positively charged 
environment that is lysine and arginine-rich suggesting the nucleosome would be promising for histone 
tyrosine nitration (HTN) during times of ethanol-induced oxidative stress [108].  This observation 
prompted the investigation to determine whether tyrosine nitration could occur as a post-translational 
modification on histone proteins and if so, whether histone tyrosine nitration is important in gene 
regulation.  It was hypothesized that ethanol metabolism encourages selective tyrosine nitration on 
histone tails, which is able to influence protein recruitment necessary for transcriptional regulation and 
gene expression. 
Aim 2: Identify ethanol-induced sites of acetylation on histone proteins and assess their effects on gene 
regulation during oxidative stress 
Protein acetylation has very important roles throughout the cell, such as metabolic regulation, 
cellular signaling, transcriptional programming and more recently, epigenetics [89-91, 150].  During times 
of ethanol exposure, lysine acetylation has been shown to be altered in a variety of cell types and 
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organelles [85, 86, 88, 119, 151, 152].  Hyperacetylation is the most prominent change observed in the 
cell after ethanol exposure, and most frequently detected within the mitochondria [85, 86, 88, 119].  The 
metabolism of ethanol within the liver is largely dependent on the ratio of NADH/NAD+, which is essential 
to metabolism and can be obtained from the mitochondria and cytoplasm within the cell [9, 82, 153].  The 
oxidation of NADH to NAD+ induces oxidative stress, which in turn causes dysfunction in numerous 
metabolic pathways [14, 154].  Ethanol-induced oxidative stress has been demonstrated to increase lysine 
acetylation and alter protein regulation within the mitochondria and throughout the cell [14, 155, 156].  
The increase in lysine acetylation has been attributed to the reduced availability of the cofactor NAD+-
and, in turn, inhibiting sirtuin activity caused by the overproduction of NADH from ethanol metabolism 
[118].  Although ethanol exposure can lead to decreases in the activity of sirtuin 1 and 3 proteins, previous 
research has shown no overall changes in sirtuin protein abundance [38, 118, 157].   
Post-translational modifications (PTMs), such as lysine acetylation, play important roles in protein 
regulation and signaling throughout the cell [158, 159].  Site-specific identification and characterization of 
PTMs are necessary for the understanding of their biological functions within the cell [158].  Lysine 
acetylation has been implicated to be one of the most important regulators of cellular processes and 
protein regulation [159-162].  Moreover, lysine acetylation has been shown to crosstalk with other PTMs 
under different environmental conditions in order to control many aspects of cellular signaling and 
maintain cellular homeostasis [162].  Recent studies have shifted their focus to understanding how 
histone lysine acetylation and their targets are affected following ethanol exposure [24, 151].  Changes in 
patterns of lysine acetylation of histone proteins have been attributed to a combination of the metabolism 
of ethanol [39], oxidative stress [163], and mitogen-activated protein kinase (MAPK) signaling pathways.  
Gene regulation can be altered by changes to acetylation patterns located on histone tails, including those 
influenced by ethanol.  The mechanism underlying how ethanol contributes to alterations in acetylation 
patterns on histone tails has yet to be established.   
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 One hypothesis is that during the metabolism of ethanol, free acetate levels rise, where it can 
then be incorporated into the acetyl-CoA pool.  Acetate levels have been recorded as high as 1.4 µMol/min 
per 108 cells or as high as 10mM in the perfusate of rat liver [23].  Once acetate levels rise it can be 
converted into acetyl-CoA.  Acetyl-CoA is then used by histone acetyltransferase to acetylate histone 
proteins [23, 120].  A recent rise in the interest of how ethanol affects epigenetics has researchers focusing 
on histone tails and transcriptional regulation.  Acetylation of histone 3 lysine 9 (H3AcK9) induced by 
ethanol has been shown to be both dose and time-dependent, with notable increases occurring between 
5 and 100 mM and highest acetylation occurring at 24 hours [23, 151].  Although 100 mM dose of ethanol 
seems high for human consumption, it is a concentration commonly observed in the serum of binge 
drinkers and chronic alcoholics [23].  In humans, a blood alcohol level (BAC) of approximately 0.20 g/dL 
would equal an approximate dose of 50mM ethanol and 100mM would be equivalent to a BAC of 0.400 
g/dL.  When acetate is used to mimic ethanol toxicity, doses of 1-10 mM showed a marked increase in 
H3K9Ac over the course of 4 hours and then plateauing until 24 hours when it begins to decrease [23].  
These data were also verified in rat hepatocytes that were treated with ethanol, showing a necessity for 
H3K9Ac in ethanol metabolism and a possible role in liver injury [151].  Chapter 4 aims to further 
investigate how lysine acetylation is altered on histone proteins during times of binge alcohol 
consumption.  It also aims to further the understanding of how alcohol metabolism regulates histone 
acetylation patterns over time on the N-terminal tails.  It is hypothesized in Chapter 4 that ethanol 
influences epigenetics marks of histone acetylation on the N-terminal tails directly through ethanol 
metabolism via acetyl-CoA and histone acetyltransferases. 
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Chapter 2 
 
 
Global Proteomic Analysis of Sex-Differences using a Chronic-Binge Mouse Model of Alcohol Liver 
Disease 
 
Abstract 
Sex differences in alcohol-induced liver injury (ALI) have previously been described in both 
humans and animal models of chronic ethanol exposure.  Females often present with ALI to a greater 
extent than males; however, the exact molecular mechanisms underlying this process are still unclear.  
The purpose of this study utilized the 10-day chronic-binge mouse model in order to evaluate gender-
specific hepatic proteome profiles in order to gain novel insight regarding protein markers and their 
related molecular pathways, which could account for the more severe liver injury observed in females.  
ALI was induced in age-matched male and female mice by administering the Lieber-DeCarli ethanol- or 
control-liquid diet for 10 days followed by a single bolus gavage of ethanol (5 g/kg body weight).  After 
the conclusion of the ethanol feeding, the female mice indeed displayed a more pronounced phenotype 
in terms of liver injury histology, although the serum levels of alanine aminotransferase and aspartate 
aminotransferase, indicators of liver injury, were comparable with their ethanol-fed male mice 
counterparts.  Liver samples were processed for mass spectrometry, and the respective analysis was 
completed using the MaxQuant application.  Over 3,000 proteins were identified at a false discovery rate 
of 1% for both the protein and peptide level.  Relative quantitation of protein expression showed gender 
differences in protein expression for ALI originating with the oxidative metabolism of ethanol.  Among the 
proteins identified in both genders was the ethanol metabolizing enzyme CYP2E1.  Interestingly, in 
addition to CYP2E1, the proteomic analysis identified 25 other cytochrome P450 enzymes, several of 
which were drastically different in fold-change expression upon a comparison between the male and 
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female experimental groups.  Moreover, functional analysis using Ingenuity Pathway Analysis revealed 
sex-specific pathway alterations which included those associated with lipid metabolism, acute phase 
response signaling, and cellular stress response pathways.  Results from this analysis have provided new 
information at the protein level for future mechanistic studies aimed towards the role of CYP P450 
enzymes in gender-specific development of ALI.  This study also suggests a role of oxidative metabolism 
and epigenetics as a potential target for the identification of therapeutic targets with consideration of 
possible sex-specific strategies for prevention or treatment of alcoholic liver disease.   
Introduction 
Alcoholism is a disease that affects a vast majority of the population worldwide.  Alcoholism was 
linked to 3.3 million deaths globally in 2012, of which were 7.6% male and 4.0% female [1].  Currently, in 
the United States, 17 million people suffer from alcoholism, of which 1.4 million people are currently 
receiving direct or indirect treatment for alcohol abuse [1].  Not only is alcohol abuse a social and 
economic burden, it can also be linked to the progression of numerous diseases, injuries, and other 
related health conditions [1].  Alcohol dependency and long-term abuse will eventually lead to alcohol 
liver injury (ALI), steatosis, cirrhosis, and possibly cancer, all which are stages in the progression of 
alcoholic liver disease (ALD) [47, 51, 83, 164].  Variables such as age, race, gender and socio-economic 
status have all been shown to play a role in a person’s susceptibility to alcohol-related health conditions 
and outcomes [165-167].  Although men drink twice as much as women on average and are two times 
more likely to die from liver disease,  women are more susceptible to cancer, gastrointestinal or 
cardiovascular diseases, when exposed to equal or lesser amounts of alcohol [166].  Currently, the 
suggested mechanism for the development of ALD begins with changes in transcriptional regulation via 
transcription factors that are mediated by cytokine secretion and inflammatory response [47, 51, 83, 
164, 165, 168-170].  Other factors that have been determined to aid in the pathogenesis of ALD include 
mitochondria dysfunction and decreased ATP production, altered levels of CYP2E1 and NADPH, and 
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increases in ROS/RNS with simultaneous decreases in antioxidants glutathione peroxidase (GPx) and 
superoxide dismutase (SOD) [47, 51, 83, 164, 165, 168-170].  Although the proposed mechanism is 
widely accepted within the scientific community, there are still major gaps in knowledge preventing a 
complete understanding of how ALD progresses and why some people and genders are more 
susceptible to liver damage than others.  It is important to understand why some persons, especially 
females, are more prone to ALI in order to develop appropriate gender-specific therapeutic approaches.   
Currently, multiple hypotheses are being pursued in the understanding of gender-specific liver 
injury markers and the pathogenesis of ALD.  Although all three proposed mechanisms are closely 
related there are gaps in knowledge between them, which are all currently under investigation.  The first 
main gap in knowledge consists of trying to find the link between sex hormones, oxidative stress, and 
metabolic pathways that are important in the development of ALD [171-177].  Another mechanism 
thought to contribute to ALD that is currently being explored examines gender differences in immune 
regulation [178, 179].  The inflammatory response is known to have a very active role in the 
pathogenesis of ALD and perhaps one gender has the advantage at regulating or suppressing the 
inflammatory response pathway [7, 170-172, 180, 181].  Lastly, the third gap in knowledge focuses on 
understanding how transcriptional regulation changes in response to alcohol metabolism and liver injury 
between genders [182-184].  Previous studies suggest that the answer may lie in differences between 
the male and female sex-hormone expression, moreover estrogen production may hold the answer to 
why females are subjected to a greater risk of ALI [165, 166, 180, 185-188].  These data presented here 
aim to contribute answers pertaining to the above gaps in knowledge.  This study uses 8-week male and 
female mice to assess differences between male and female mice receiving the Lieber-DeCarli 10-day 
chronic binge alcohol liquid diet [189]. 
The Leiber-DeCarli ethanol diet is currently the most widely used method to study alcoholic fatty 
liver development [165, 190].  Although there are multiple options for the delivery of alcohol for in vivo 
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mouse experimentation that can be used effectively in order to achieve a specific phenotype of ALD, the 
Leiber-DeCarli liquid diet is the favorite amongst researchers.  The Leiber-DeCarli liquid diet is the 
preferred method because of its affordability, ease of administration and reproducibility of inducing 
fatty liver in mice similar to what is observed in humans [165].  There are different mouse models using 
the Lieber-DeCarli ethanol feeding that have been well characterized to achieve different ALI 
phenotypes [189].  The following study used the chronic-binge ethanol diet in order to assess gender 
differences in the development of ALI.  The chronic-binge diet is a 10-day pair feeding study done 
administered in 8-week mice followed with a single gavage prior to euthanasia [189].  Following the 10-
day alcohol feeding, data should present to have marked increases in alanine aminotransferase (ALT) 
and steatosis [189].  In vivo experimentation is the preferred method over in vitro studies of ALD liver 
research due to the unavailability of current cell lines in possessing acceptable levels of protein 
expression in regards to the ALD and CYP2E1 pathways of alcohol metabolism.  
More times than not, sex differences play a role in alcohol-induced liver injury (ALI) where the 
greater liver injury is commonly observed in female animal models of chronic ethanol exposure, which is 
similar to the trends observed in humans [171, 176, 186, 191, 192].  Previous work investigating these 
differences have shown several contributing factors including direct effects of ethanol on sex hormone 
levels [165, 188, 193, 194] as well as the potential pathogenic role of estrogen in terms of gut 
permeability, endotoxin levels and inflammatory response in the liver [15, 24, 96, 169, 170, 176, 180, 
195].  Further evidence has been provided through gene expression profiling studies that showed sex 
differences in gene networks associated with hepatoprotection, oxidative stress and inflammation after 
ethanol exposure [169, 176, 180, 181, 192, 196]. These data warrant further evaluation as the efficacy of 
therapeutic intervention using hormone gender-based specific therapies seems plausible in the 
emerging era of personalized medicine.  The purpose of this study was to evaluate hepatic proteome 
profiles in both male and female mice after a chronic-binge ethanol diet in order to gain novel insight 
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into protein markers and related molecular pathways that could account for sex differences observed in 
ALI using a mouse model of ALD.   
In order to comprehensively characterize molecular pathways that are involved in ALI sex 
differences and furthermore, to gain novel mechanistic insight, mass spectrometry-based proteomics 
was used.  Mass spectrometry allowed for a global protein analysis of the livers of male and female mice 
and data was used for the identification of numerous sex-specific differentially expressed proteins and 
pathways.  One group of enzymes identified were the cytochrome P450 family or CYP enzyme class of 
proteins.  Data analysis revealed that several classes and proteins included in the CYP P450 family were 
differentially expressed following the chronic-binge and some striking differences in fold-change were 
identified after the comparison between male and female pair-fed groups. In addition to differential CYP 
expression, differences in pathway prediction showed gender differences in lipid metabolism and 
oxidative stress pathways.  Although the role of CYP2E1 has been studied extensively in the context of 
ALI [173, 174, 177, 182, 197-199], the results from this study are intriguing as the contribution of other 
CYP enzymes in ALI is largely unexplored.  Interestingly, female mice also possessed higher levels of 
basal histone acetylation observed on both Histone H3 and H4 that increased at the conclusion of the 
study to similar levels of the pair-fed male mice.  The increased acetylation of known epigenetic marks 
may offer insight into gender-based transcriptional regulation and ALI.  These data also aim to bridge 
the gap between gender, oxidative stress, inflammatory response and gene regulation.   
Materials and Methods 
Chemicals and Reagents 
 All chemicals were purchased from Fisher Scientific unless otherwise specified. 
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Chronic-Binge Mouse Model of Alcohol Liver Disease  
A mouse model of chronic plus single binge ethanol consumption (referred as a chronic-binge 
model) was used as previously described [189, 190].  The Leiber-DeCarli liquid diet was used for both 
ethanol and control-fed mice (Bio-Serv, control F1259SP, and ethanol F1258SP).  Eight-week-old male 
and female C57BL/6 mice (Jackson Laboratories) were each divided into two dietary groups with similar 
weights: Control chow (n=4 males; n=4 females) and ethanol chow (n=6 males; n=6 females). All mice 
were first acclimated, stepwise, to the liquid control diet for 5 days prior to ethanol diet containing 5% 
w/v ethanol  [189]. Ethanol and control pair-fed groups were fed isocaloric equivalents for 10 days, and 
control-fed mice received limited chow when to match ethanol-fed consumption over 10 days.  For mice 
on an ethanol-containing diet, animal cages were placed on heating pads to maintain body temperature 
and prevent ethanol-induced hypothermia. Food intake was recorded daily over the course of 10-days 
to limit over-eating of control chow. Throughout the course of the feeding period, control mice and their 
ethanol-fed counterparts were observed to consume similar volumes of their diets daily.  On day 11, 
mice in ethanol groups were gavaged a single dose of ethanol (5g/kg body weight, 20% ethanol), while 
mice in control groups were gavaged an isocaloric dose of dextrin maltose [189]. The gavage was 
performed in the early morning, and mice had access to their respective diets after the alcohol gavage.  
On the afternoon of day 11, the mice were euthanized 9-hour post-gavage and blood and tissue samples 
were collected for analysis.   
The studies were approved by the Institutional Animal Care and Use Committee of University of 
South Florida (Appendix A). 
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Histological Analysis and Liver Injury Assays. 
Histology. 
Dissected livers were allowed to fix in 10% formalin for 24 hours.  They were submitted to the 
Tissue Core Facility at the H. Lee Moffitt Cancer Center and Research Institute (an NCI-designated 
Comprehensive Cancer Center (P30-CA076292), where they were processed for histological examination 
by light microscopy.  After formalin fixation, tissues were processed in a Leica ASP 300 processer and 
embedded into paraffin blocks using a Leica EG1150C embedding station.  Once embedded, 4 μm paraffin 
sections were cut with a Leica RM2245 rotary microtome, mounted on glass slides, and stained with 
hematoxylin and eosin (Hematoxylin 2, Richard-Allan Scientific #7231 and Eosin Y Richard-Allan Scientific 
#7111) in a Leica AutoStainer XL automatic strainer.  Upon completion, the slides were mounted with a 
coverslip.   
Serum Blood Alcohol Content, ALT & AST Liver Injury Assays. 
Whole blood was separated using serum separating microtainers (BD, 365967) according to the 
manufacturer’s instructions.  Serum was then aliquoted into microplates for blood alcohol level (BAC) 
(Pointe Scientific, A7504-01-873), ALT and AST (Pointe Scientific, A7526, and A7561 respectively) analysis.  
All assays were conducted using the protocols designated by the manufacturer, read using the Powerwave 
II microplate spectrophotometer (Biotek) and quantified using Excel (Microsoft Office, 2013).  
Sample Processing 
Sample Processing for Proteomic Analysis.   
Eight-week-old C57BL6 mouse liver was homogenized in lysis buffer consisting of 4% SDS, 100 mM 
Tris-HCl, pH 7.6, 100 mM dithiothreitol.  Homogenization was followed by lysis at 95 °C for 5 minutes prior 
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to sonication at 20% amplitude for six 3 second bursts.  Samples were spun at 17,000 x g for 5 minutes at 
room temperature and pellets discarded.  Protein concentrations were determined using a 660 nm 
Protein Assay with Ionic Detergent Compatibility Reagent (Pierce).  An aliquot of, 50 µg of the sample was 
added to a spin column containing 200 µl of 8 M Urea and buffer exchanged to 8 M Urea over subsequent 
spins prior to Iodoacetamide alkylation as previously described [1-3].  Post alkylation, the samples were 
exchanged to 50 mM ammonium bicarbonate for trypsin digestion at a ratio of 50:1 with Mass Spec Grade 
Trypsin/Lys-C mix (Promega, V5073).  Digestion was carried out overnight in a humidified incubator at 37° 
C.  The following day, samples were desalted using solid phase enrichment C18 columns (Waters, 
WAT023590).  Columns were activated using 100% ACN and washed in 0.1% formic acid in H2O before 
adding the peptides.  Peptides were then washed 3 times with 0.1% formic acid in H2O and eluted using 
90% acetonitrile/10% H2O/0.1% Formic Acid.  Samples were concentrated in a vacuum concentrator 
(Thermo Fisher Scientific) and resuspended in 0.1% formic acid and HPLC-water prior to LC-MS/MS 
analysis on the Q-Exactive Plus mass spectrometer. 
Nuclear Fractionation 
Livers were thawed on ice and 50 mg of tissue was cut and placed into 2 ml PBS (Alfa Aesar, Cat. 
#A1107922, Fisher Scientific, Hampton, New Hampshire) and protease inhibitor cocktail (Roche, Cat. # 
1183617001, Sigma Aldrich, St. Louis, Missouri). Tissues were broken down into a single cell suspension 
using a Dounce homogenizer with pestle A only. The whole cell lysate suspensions were placed into 50 ml 
conical tubes (Corning, Cat. # 430291, Fisher Scientific, Hampton, New Hampshire) and spun at 1500 rpm 
for 10 minutes to form a pellet.  The homogenization buffer was discarded and the pellets were washed 
again in homogenization buffer, the spin was repeated and wash was discarded.  Nuclei were isolated 
using a nuclear extraction buffer (homogenization buffer with the addition of 0.1% NP-40 (Thermo 
Scientific, Cat. # 28324, Fisher Scientific, Hampton, New Hampshire).  Pellets were triturated 5-times using 
a wide-bore pipet tip and placed into microcentrifuge tube on ice.  Nuclei were pop-spun 10 sec in a 
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benchtop microcentrifuge and supernatant containing the cytoplasmic fractions were discarded.  Nuclei 
were again washed in nuclear isolation buffer and pop-spun two times.  Nuclei were then washed twice 
with PBS to remove excess detergent.  Nuclei were resuspended and lysed by sonication (30% amp, 5s 
on/off for 1 min) while on ice and supernatant was checked for complete DNA shearing by pipetting up 
and down.  If DNA was present then sonication was repeated until complete lysis.  Nuclear lysate was 
spun at 14,000 rpm for 10 minutes and the supernatant was placed into a clean microcentrifuge tube.  
Nuclear lysate was quantified using the BCA kit (Pierce, Cat. # 23225, Thermo Scientific, Hampton, New 
Hampshire). 
LC-MS/MS and Statistical Analysis.   
Fractions were separated on a 10 cm x 75 um I.D. reversed phase column packed with 5 um C18 
material with 300 Å pore size (Thermo Fisher Scientific) using 120-minute gradients of 2-28% ACN in 0.1% 
formic acid.  The inline mass spectrometric analysis was performed on a Q-Exactive Plus (Thermo Fisher 
Scientific). MS1 scans were performed at a resolving power of 72,000, and the top 10 most abundant peaks 
were selected for subsequent MS/MS analysis.  Raw files were processed in MaxQuant 1.4.3 employing 
the Andromeda search algorithm and Perseus version 1.2.0.13 against the UniProt KB reference database 
for Mus musculus.  The second database of known contaminants provided with the MaxQuant suite was 
also employed.  Constant modification of carbamidomethylation of cysteine and variable modifications of 
oxidized methionine and acetylated protein N-termini were used. A false discovery rate of 1% was used 
for peptides and proteins. A minimum peptide length of 7 amino acids was used. Razor and unique 
peptides were used for identification and quantification.  Ethanol-treated vs. control treated protein ratios 
were built by dividing the median normalized expression levels for all peptides across all biological 
samples for a given protein in the ethanol set by the median normalized expression levels for all peptides 
across all biological samples for a given protein in the control set separately for males and females.  
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Statistical significance of quantitation values was determined using a Welch’s t-test and a significance 
value of p < 0.05. 
Western Blots   
Samples were lysed and quantified as stated above.  Each replicate was suspended in 4X Laemmli 
buffer and loaded onto SDS-PAGE gels in accordance with sample size and molecular weight.  Precast TGX 
gels and protein standard were purchased from Bio-Rad for use with their semi-dry turbo transfer system.  
Blots were transferred to either PVDF or nitrocellulose membranes depending on the protein of interest.  
Blots were blocked in a 5% (wt/vol) powdered milk in PBS solution for 1 hour at room temp.  Next, the 
blots were washed in PBS for 1 hour prior to primary antibody incubation overnight at 4°C, shaking.  
Primary antibodies are resuspended in a 5% BSA/PBS stock solution containing 0.5% sodium azide as a 
preservative.  The next day blots are washed 1 hour in PBS at room temperature prior to the addition of 
HRP-conjugated secondary antibody.  The secondary antibody is prepared in 5% milk (wt/vol) and PBS at 
a 1:5000 dilution.  Blots were incubated in secondary antibody (cell signaling) raised against the respective 
primary for 1 hour at room temperature and then washed for 2 hours in PBS prior to developing.  Blots 
were incubated for 1 minute in Western Lighting-Plus Chemiluminescent Substrate (PerkinElmer, 
NEL104001EA) and developed using the AI06 Imager (Amersham).  Primary antibodies are as follows: all 
dilutions are 1:1000 and purchased from Cell Signaling Technologies unless otherwise stated; ADH1 
(#5295), H3AcK9 (#9649), H3AcK14 (#7627), H3 (#4499), H4AcK12 (#13944), H4AcK16 (#13534), H4 
(#2935), ACL (#13390), β-Actin (#3700), GAPDH (#5174), ACL, β-Actin, GAPDH, pan-acetyl-lysine (#9814), 
and CYP2E1 (#ab28146, Abcam).   
IPA Analysis  
 Proteins found to be significant using statistical analysis in Excel were uploaded into Perseus 
statistical software (v.1.5.5.3, http://www.perseus-framework.org) for further analysis.  Data was first 
transformed into their log 2 values for normalization.  Next, the male and female replicates were grouped 
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together for more stringent statistical analysis.  Once the replicates were grouped, data were filtered 
based on 70% valid values in at least one group and rows not meeting the criteria were discarded.  In 
order to correct for missing values, imputed values were added based on the normal distribution using 
default settings.  Data was then exported back into Excel where it was transformed back into intensities 
to be uploaded into IPA for network prediction analysis.  Calculated fold change for each group, males, 
and females, were next uploaded into Ingenuity Pathway Analysis (IPA) (Redwood City, CA) for further 
pathway analysis.   
Scaffold Protein Analysis 
 Raw data files were analyzed using MaxQuant proteomic software (Max-Planck Institute, 
http://www.biochem.mpg.de/5111795/maxquant) and then uploaded into scaffold proteomic software 
(http://www.proteomesoftware.com).  Proteins were filtered with a 1% false discovery at both the 
protein and peptide level.   
Results 
Characterization of 10-Day Chronic-Binge and Liver Injury in Male and Female Mice   
Eight-week-old male and female mice were fed the 10-day Lieber-DeCarli liquid diet according to 
the 10-day chronic-binge parameters previously described [189].  Following the completion of the 10-day 
chronic-binge feeding model, livers were extracted and visually examined for phenotypic differences 
associated with ALI in both male and female mice. Upon extraction, livers of ethanol-fed mice had 
displayed visual signs of steatosis; livers were soft, swollen, discolored and possessed white blotches when 
compared to their control-fed counterparts.  Hematoxylin and Eosin (H&E) stain revealed more 
pronounced morphological changes in the ethanol-fed mice, indicative of features associated with mild 
to moderate hepatic steatosis in both female and males when compared to their male control-fed 
counterparts (Figure 2.1).  Visually, female mice that received the ethanol diet seemed to display a greater 
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accumulation of lipids when compared to their ethanol-fed male counterparts (Figure 2.1).  Next, serum 
blood alcohol levels were measured to quantify the amount of alcohol remaining in the bloodstream after 
the 9-hour recovery window post gavage (Figure 2.2).  Average BAC levels were slightly higher in male 
mice, averaging 260 mg\dL, when compared to their female pair-fed counterparts, averaging 160 mg\dL 
(Figure 2.2).  These data suggest that females exhibited faster clearance of ethanol than their male 
counterparts.  Serum blood measurement of the liver injury markers, alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) were also measured and showed elevated levels in both male and 
female mice when compared to the control mice (Figure 2.3).  Furthermore, although male mice exhibited 
higher BAC levels female mice displayed higher levels of alanine transaminase (ALT) and aspartate 
transaminase (AST) when compared to male mice (Figure 2.3).  Liver enzymes, ALT, and AST are 
traditionally used in a clinical setting to establish hepatic injury in patients.  A 2:1 ratio of AST to ALT 
denotes that ALI has occurred.  These data show that both ALT and AST increase after the 10-day ethanol  
Figure 2.1: H&E Staining of Mouse Liver following the 10-day Chronic-Binge Ethanol 
Diet.  Following the conclusion of the Leiber-DeCarli 10-day chronic-binge ethanol 
diet, female mice displayed a more pronounced indication of ALD after pair-feeding.  
These data suggest that female mice are more susceptible to pathogenesis of ALD as 
a result of lipid accumulation when compared to their male counterparts.    
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Figure 2.3: ALT and AST Liver Injury Marker Assay Following the 10-day Chronic-Binge Alcohol 
Diet.  Serum was collected from male and female mice following the conclusion of the 10-day 
chronic binge ethanol diet.  ALT and AST are commonly found to be upregulated during times of 
liver injury.  Serum levels show an increase in ALT and AST in both males and females when 
compared to the control-fed mice.  ALT values almost doubled whereas there was only a slight 
elevation in AST. 
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Figure 2.2: Average Serum BAC Levels Following the 10-Day Chronic-Binge Ethanol Diet in 8-Week Old 
Mice.  Eight-week old, male and female C57bl\6 mice were administered either the control or 
ethanol feed over the course of 10-days followed by an isocaloric bolus gavage of either 
dextrin or ethanol 9-hours before euthanasia.  Male mice portrayed higher serum BAC levels 
then their female counterparts. 
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diet when compared to the control-fed mice.  Nevertheless, the ratio of the two enzymes does not offer 
conclusive affirmation that ALI had occurred following the finish of the 10-day chronic binge ethanol study 
in mice.  However, the histology data in conjunction with the BAC levels suggest that the chronic-binge 
ethanol diet is a good model to study gender differences in alcohol-induced liver injury (ALI). 
Sex-Specific Differences in Hepatic Protein Expression Profiles After Chronic-Binge Ethanol Feeding  
To further evaluate the ALI phenotype in male and female mouse liver through identification of 
novel pathways associated with sex differences in ALI, an innovative approach was performed using label-
free quantitation and mass spectrometry-based proteomics.  After mass spectrometry, analysis and 
database searching using MaxQuant, over 3,000 proteins were identified at a false discovery rate of 1% 
at both the protein and peptide level.  Of these, 1,835 proteins, from both genders and treatment types, 
were quantified and found to be significant.  Proteins from both male and female that were found to be 
significantly up or down regulated after ethanol exposure were uploaded into Ingenuity Pathway Analysis 
(IPA) in order to assess any network differences between genders.  Further analysis of the ALI proteomic 
Figure 2.4: Ingenuity Pathway Analysis of Male and Female Mice Predicts Liver Damage in Females and 
Liver Injury in Males.  Significant proteins identified in the male and female data sets from the primary 
analysis were uploaded into IPA for protein network interactions.  IPA predicted that following the 10-day 
chronic binge diet in mice females were more susceptible to liver damage, whereas the male mice had more 
proteins upregulated commonly found in liver injury.  The darker red the protein is pictured, the more it is 
predicted to be upregulated in the network.  IPA identified proteins important in ethanol metabolism and 
metabolite transport and excretion. 
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dataset was performed and then filtered to focus on alcohol, aldehyde and CYP metabolic enzyme 
expression level in male and female livers after chronic-binge ethanol feeding.  Interestingly, IPA pathway 
analysis predicted upregulation of proteins involved in liver damage in female mice, whereas male mice 
were only predicted to endure liver injury (Figure 2.4).  Furthermore, male mice displayed upregulated 
measurements and more proteoforms in ATP-binding proteins (ABC) when compared to female mice 
(Figure2.4).  ATP-binding proteins are important in membrane transport and the uptake or exportation of 
molecules.  Surprisingly, Apolipoprotein A2 (APOA2) was only observed in female mice and predicted to 
be drastically upregulated (Figure 2.4).  These small differences in protein expression may offer potential 
targets to furthering the understanding in regards to why females exhibit greater liver injury over men 
during times of ethanol consumption. 
In order to take a closer look at gender differences in liver injury, IPA was used to assess what 
proteins were predicted to be affected by ethanol metabolism (Figure 2.5).  Both genders expressed 
similar upstream regulator predictions, however, a few genes and proteins stood out.  For instance, the 
Figure 2.5: Predicted Upstream Activation Initiated by Ethanol Suggests that Cytochrome P450 Proteins amongst 
Others Play a Role in Liver Injury.  Upstream predicted activation was found to be similar between male and 
female mice, however a few genes stood out.  Lfi47 was predicted to be inhibited in male mice.  Male 
mice also were predicted to have more activation of genes important in the oxidative stress pathways 
such as GST and NQO1.  Female mice had similar predicted expression to males with the exception of 
ETNPPL, a protein important in the breakdown and clearance on ethanol.   
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gene lfi47 predicted to be downregulated in male mice, is an interferon-inducible/regulatory gene, 
important in innate immunity and inflammation (Figure 2.5, right).  The inflammatory response is an 
important pathway in the development of ALD and activated during times of heavy alcohol consumption 
and can be observed in both genders by the predicted increase in superoxide dismutase (SOD).  Another 
interesting gene predicted to be upregulated in male mice after ethanol exposure is NAD(P)H Quinone 
Dehydrogenase 1 (NQO1) (Figure 2.5, right).  NQO1 is a gene targeted by nuclear factor (erythroid-derived 
2)-like 2 (NRF2) during oxidative stress.  Glutathione S-transferase alpha-5 (GSTA5) is a gene important in 
Figure 2.6: Fold-Change in Cytochrome P450 Family of Proteins Post 10-day Chronic-Binge Ethanol Diet.  Cytochrome P450 
proteins were quantified by taking the average intensities for control and ethanol-fed male and female mice.  Next 
the ratio was taken for ethanol-to control-fed intensity and plotted.  A fold-change of -1 represents only observed 
in control-fed mice and a +1 fold-change was only observed in ethanol-fed mice.  If no fold-change is present for 
the cytochrome P450 isoform then no expression was observed for that gender and/or protein. 
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the metabolism of alcohol and lipid peroxidation, it is 
often depleted during times of heavy drinking.  These 
data predict upregulation in both genders, however, male 
mice are predicted to have increased upregulation of the 
GSTA5 gene over their female counterparts after the 10-
day chronic binge diet (Figure 2.5).  Furthermore, female 
mice were observed to have upregulation on the gene 
Ethanolamine-Phosphate Phospho-Lyase (ETNPPL), this 
gene is responsible for catalyzing the breakdown of 
acetaldehyde and converting phosphoethanolamine into 
ammonia (Figure 2.5, left).  Another striking observation 
was the number of cytochrome P450 proteins that were 
predicted to be activated by following ethanol 
consumption in both genders (Figure 2.6).  These data 
presented offer interesting targets of transcriptional 
regulation in regards to the relationship between CYP 
P450 proteins, metabolism, oxidative stress and gender-
specific liver injury.  Further evaluation of the entire ALI 
proteome dataset (includes proteins which are not 
differentially expressed), identified 26 different CYP enzymes all having a wide range of relative protein 
expression as shown in Table 2.1 & Figure 2.6. 
Cytochrome P450 proteins are found in almost every tissue within the body.  Cytochrome P450 
proteins function in many metabolic processes throughout the body such as hormone and cholesterol 
synthesis, as well as the metabolism of drugs and toxic compounds found in the liver. Further investigation 
Table 2.1: Gender-Specific Fold-Change in Male 
and Female Mice 
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into the gene regulation of these proteins may offer insight into the understanding of gender differences 
in the development of ALD.  As expected, CYP2E1 was found to be upregulated in both genders following 
the 10-day chronic binge.  Interestingly, CYP2E1 was observed to have almost a fold-change difference in 
males when compared to females (Table 2.1 & Figure 2.5). In addition to the increased CYP2E1 expression 
in males, several other members of the Cyp P450 family were greatly increased over their female 
counterparts. CYP2A5 and CYP4A14 were drastically increased in the male mice exhibiting approximately 
a 19.5 and 8 fold increase respectively (Table 2.1 & Figure 2.5).  Other cytochrome proteins with over a 
fold change difference between males and females included CYP2C29, CYP2C37, CYP2C50, CYP2C54, 
CYP3A13, and CYP4F15. Male mice also only exhibited expression of CYP2B10 and CYP2B9 after ethanol 
exposure and not in the control mice.  The Cyp P450 enzymes are known to be involved in lipid metabolism 
(CYP4 family), and drug metabolism (CYP2 & CYP3 families).  On the other hand, female mice lost CYP3A16 
and CYP3A44 expression after ethanol exposure and were completely absent from male mice (Table 2.1 
& Figure 2.5). Additionally, CYP2A4, CYP2C70, CYP2F2, and CYP4V2 were only expressed in female mice, 
whereas CYP1A2 and CYP4F15 were only expressed in male mice (Table 2.1 & Figure 2.5).   CYP2J5 and 
CYP4A12 were the only proteins to be identified that were upregulated in female mice when compared 
to the male mice (Table 2.1 & Figure 2.5). It has been previously been reported that CYP2J5 expression in 
the kidney is important for sex hormone regulation [194].  CYP2J5 upregulation in females was interesting 
because of its known role in oxidative stress, cardiac processes, lipid accumulation and estrogen 
regulation [200-202].  
Alcohol, Oxidative Stress, and Mitochondria Dysfunction Leads to Alterations in Post-Translational 
Modifications on Histone Proteins 
The upregulation of CYP P450, along with SOD and GST proteins observed in both genders (Figure 
2.5) prompted further investigation into alcohol, oxidative stress, and post-translational modifications.  
Both SOD and GST proteins are key players in alcohol-induced oxidative/nitrosative stress and 
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inflammation.  In addition to the gender differences in cytochrome proteins, it has been previously 
established that CYP2E1 sensitizes the liver to inflammation through elevated oxidative and nitrosative 
stress [182, 199].  Furthermore, alcohol-induced oxidative stress leads to mitochondrial dysfunction [95, 
203, 204].  As a result,  mitochondrial dysfunction has been demonstrated to induce changes in post-
translational modifications, such as acetylation, following prolonged alcohol exposure [38, 85, 87, 118, 
163, 204, 205].  In order to assess potential gender differences following ethanol exposure acetylation 
differences in males and females were observed using Scaffold for both whole cell lysate and nuclear 
fractions.  Results show 30 acetylated proteins that were identified in both genders from the whole cell 
lysate and 13 mutually expressed proteins were observed in the nuclear fractions (Figure 2.7).  Female 
mice exhibited 10 uniquely expressed proteins from their male counterparts, whereas males presented 
14 unique proteins after 10-days of ethanol exposure (Figure 2.7).  Examination of the nuclear fractions 
showed 8 differentially expressed proteins in females and only 3 in males (Figure 2.7).  Table 2.2 list the 
differentially expressed proteins respective of gender and lysate complexity.  Female mice expressed 
acetylation of proteins involved in metabolism and cellular stress, such as acetyl-CoA, ATP synthase, 
Figure 2.7: Venn-Diagram Depicting Differences in Gender-Specific Acetylated 
Proteins following the 10-day Chronic-Binge.  Male and female mouse liver was 
lysed as either whole cell or nuclear fraction.  Samples were analyzed using 
UHPLC-MS and data was processed using MaxQuant proteomic software.  
Analyzed data was uploaded into Scaffold and acetylation sites were assessed 
between male and female ethanol-fed mice. 
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isocitrate dehydrogenase, 
NDRG2, and Heat shock cognate 
71 (Table 2.2).  On the other hand, 
male mice expressed changes in 
the acetylation of the oxidative 
stress regulator protein GST 
(Table 2.2).  Other acetylated 
important in transcription, such 
as heterogeneous nuclear 
ribonucleoproteins were also 
found to have differentially 
expressed subunits in the nuclear 
fractions of both genders.  
Interestingly, both acetyl-CoA 
transferase and Histone 4 (H4) 
were identified to be uniquely 
expressed in female mice (Table 
2.2).  The identification of histone 
H4 and Acetyl-CoA prompted 
further investigation into the effects of the chronic binge ethanol diet and histone acetylation. 
Following the 10-day chronic-binge ethanol diet, Western blot analysis was used to evaluate 
gender-specific differences in proteins that are important for ethanol metabolism, as well as histones H3 
and H4 acetylation.  Results show, no comparable differences in alcohol dehydrogenase 1 (ADH1) in the 
control and ethanol-fed male and female mice (Figure 2.8A). On the other hand, CYP2E1 became 
Table 2.2: Differentially Expressed Acetylated Proteins Identified by Sex 
and Cellular Compartment following 10-Day Chronic-Binge, Corresponding 
to Figure 2.7 
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upregulated in the ethanol-fed mice in both genders following the 10-day chronic binge (Figure 2.8E).  
Both genders also displayed a decrease in ATP-citrate lyase (ACL), a protein that helps to produce acetyl-
CoA, after ethanol exposure (Figure 2.8G).  Next, acetylation on H3K9Ac, H4K12Ac and H4K16Ac was 
assessed and interestingly, male mice appear to have less acetylation at basal levels than their female 
counterparts before alcohol consumption (Figure 2.8B, 2.8C & 2.8F).  Following alcohol exposure, the 
acetylation levels in the male mice rose to comparable levels of acetylation in female mice.  Acetylation 
of H3K14Ac (data not shown) was not observed by Western blots in either control or ethanol-fed male 
Figure 2.8: (A-H): Western Blots Obtaining from Whole Cell Liver Lysate following the 10-
Day Chronic-Binge Ethanol Diet.  Control-fed females (lanes 1-4) and males (lanes 5-8) are 
compared to their ethanol-fed counterparts (female: lanes 9-14 & males: lanes 15-20).  Data 
is representative of 2 separate blots (dotted line) so that H3 lysine 9 and 14 & H4 lysine 12 
and 16 acetylation sites would not interfere with each other’s signal. 
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and female mice. These data suggest that the decrease in ACL and increase of histone acetylation in males 
may offer insight into a possible mechanism regarding the gender-specific alcohol-induced liver injury. 
Discussion 
Understanding how gender affects the development of alcohol liver disease is pivotal in finding 
novel mechanisms in the prevention and reversal of liver injury.  Current gaps in knowledge may hold 
the key to further understanding which underlining mechanisms are responsible for the onset of ALI as 
well as the heightened liver injury observed in females.  These data presented here aim to further close 
these gaps and broaden the understanding of novel mechanisms in the onset of ALD.  Following the 10-
day chronic binge ethanol diet, female mice were observed to have increased lipid accumulation over 
their male counterparts (Figure 2.1).  This was interesting since the female mice also presented with 
higher ALT & AST levels (Figure 2.3) and lower serum BAC levels (Figure 2.2) when compared to male 
mice.  ALT and AST are liver enzymes responsible for hepatocyte integrity, they break down amino acids 
and allow them to be used in the citric acid cycle [206].   The ratio of the two are typically used to 
predict liver injury, the higher the ratio translates into the more severe the liver injury [206-208].  
Elevated levels of ALT and AST have also been linked to increased oxidative stress during times of 
alcohol consumption [209, 210]. Oxidative and Nitrosative stress has been linked either directly or 
indirectly to many pathways conducive to ALI, such as inflammation, transcriptional dysregulation, 
mitochondrial dysfunction and cellular respiration [3, 5, 7, 41].  These data presented gender-specific 
targets in ALI at both the protein and gene level that can be linked to increased oxidative/nitrosative 
stress.   
Following the conclusion of the 10-day alcohol binge, CYP2E1 was found to be upregulated in 
both male and female mice (Figures 2.4, 2.5 and 2.6).  CYP2E1 is known for its alcohol metabolizing 
capabilities and tend to be upregulated over ALD during longer times of alcohol exposure [71].  
Interestingly, researchers are unclear to how CYP2E1 becomes upregulated because no increase in 
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mRNA transcript has been observed [71].  It is hypothesized that CYP2E1 accumulation stems from a 
PTM that blocks degradation, allowing the protein to accumulate and be available for alcohol oxidation 
during periods of chronic drinking.  As CYP2E1 metabolizes alcohol it generates reactive oxygen species, 
which can accumulate and cause mitochondrial dysfunction and protein modifications, in turn altering 
transcriptional regulation.  Identification of gender-specific novel transcriptional regulators will lead to 
potential targets and mechanisms responsible for gender differences in the development of ALI.  
Subsequent analysis of gender differences induced directly from ethanol metabolism revealed 
striking differences between male and female upstream activation (Figure 2.5).  Male mice exhibited gene 
activation in regards to inflammatory response and oxidative stress.  Female mice, on the other hand, 
seemed to upregulated proteins such as ETNPPL and cytochrome P450, which are responsible for ethanol 
clearance and glucose metabolism instead of injury protection (Figure 2.5).  Perhaps these upstream 
regulator predictions explain that females tend to exhibit liver damage, faster than males.  In addition to 
CYP2E1, both genders portrayed numerous CYP proteins to be upregulated after ethanol exposure (Figure 
2.6).  Both genders showed similar expression for many of the identified cytochromes, however, a few 
were deemed to be gender selective.  Both genders also displayed a marked fold-change in CYP2A5 
following the 10-day chronic-binge.  Females averaged a 4.5-fold change in CYP2A5 and male mice were 
almost five times more, averaging 19.5-fold increase.  In chronic alcohol studies using CYP2A5 knock-out 
mice, liver injury was exuberated in the CYP2A5 null mice when compared to the wild-type pair-fed mice 
[211].  Males also possessed a large increase in CYP4A14, averaging 7.8-fold, whereas females only 
possessed a 1.5-fold change.  CYP4A14 is an important regulator of fatty acid metabolism via activation 
by peroxisome proliferator-activated receptor alpha (PPARα) [212-214]. CYP4A14 has been proposed as 
a therapeutic target in the attenuation of liver injury after overexpression of CYP4A14 promotes liver 
injury [212, 213].  These data suggest a possible interplay between CYP2A5 and CYP4A14 in liver injury, 
where the ratio of CYP2A5 expression will protect the hepatocyte from CYP4A14 damage.  Many of the 
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cytochrome isoforms identified have been identified to participate in oxidative stress and lipid 
metabolism. Cytochrome P450 proteins utilize redox reactions in order to catalyze the breakdown and 
export of toxins and drugs within the liver, as a result, the byproducts cause a build-up of free radical 
formation and oxidative stress within the cell.   
Increased oxidative stress within a cell after alcohol exposure has been linked to mitochondrial 
dysfunction, hyperacetylation, inflammation and the formation of free radicals such as superoxide (O2-), 
peroxide (H2O2) and nitric oxide (NO-) [5, 7, 8, 38, 85, 87, 88].  As oxidative stress accumulates, free radicals 
are able to move throughout the cell and causing damage by lipid peroxidation, protein modifications, 
and DNA damage [4, 5, 7, 215, 216].  Following the 10-day ethanol diet, these data identified multiple 
isoforms of the antioxidant GST and the inflammatory regulator SOD to be upregulated (Figure 2.5).   
These data suggest an increase in the formation of free radicals such as O2-, H2O2, and NO.  NO, and O2- 
can combine further and form peroxynitrite (ONOO-) [31-34, 139, 217-220].  Peroxynitrite is highly 
reactive and has the capability of disrupting signaling pathways by adding a nitro-PTM to tyrosine 
residues.  Furthermore, alcohol-induced oxidative stress has been shown to induce changes in protein 
acetylation (Figure 2.7 & Figure 2.8), methylation, phosphorylation, DNA hypomethylation as well as 
induce alterations in miRNA generation and function [15, 18, 24, 39, 40, 98].    
Surprisingly, little is currently known about direct and indirect mechanisms relating to alcohol-
induced oxidative stress and epigenetic changes.  Epigenetic modifications are one or more PTM added 
to the N-terminal region of the histone tails.  These modifications can act as activators and repressors 
controlling differential gene expression and recruitment of transcriptional proteins [89-91].  Alcohol-
induced changes in epigenetic modifications can be the result of ROS/RNS generated by ethanol 
metabolism or another pathway responding to liver injury.  For instance, ONOO- is formed as a result of 
alcohol metabolism and can travel throughout the cell. Peroxynitrite can alter a wide range of proteins 
that it may encounter by adding a NO.  One such target of ONOO- is tyrosine, which forms nitrotyrosine.  
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Although having a short half-life, when ONOO- enter the nucleus, it may able to directly target histone 
protein tails, forming nitrotyrosine,  where it could act as a negative regulator of tyrosine phosphorylation 
[103].  Additionally, there are numerous reports of alcohol-induced acetylation on histone H3 lysine 9 
(H3K9Ac).  Nevertheless, it is still unclear whether the acetylation is caused directly by ethanol metabolism 
or indirectly as a response to alcohol consumption [17, 18, 43].     
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Chapter 3 
 
 
Chronic Ethanol Exposure Induces Hepatic Histone Protein Nitration in Male Mice 
 
Abstract 
Protein tyrosine nitration (PTN) is a post-translational modification that occurs as a result of 
oxidative and nitrative stress within the cell.  These data show for the first time that changes in site-specific 
histone tyrosine nitration occurs in the liver of wild-type male C57bl/6 mice after being fed the Leiber-
DeCarli chronic ethanol diet for 28 days.  The results from this study suggest that in addition to the other 
currently accepted post-translational modifications of histone proteins (ie. acetylation, methylation, 
ubiquitination, and phosphorylation); tyrosine nitration may also be an important regulator in gene 
transcription and have an active role in alcohol-induced liver injury.  Histology was completed using mouse 
livers, sectioned from both control and ethanol-fed groups.  Histology demonstrated morphological 
changes indicative of steatosis development in both the control and ethanol-fed groups following 28-days.  
The control and ethanol-fed mice were both administered with an equivalent high-fat caloric daily intake, 
however, more severe lipid accumulation occurred in the ethanol-fed mice when compared with the pair-
fed control mice.  In addition, immunohistochemical analysis was performed to assess potential changes 
in global protein tyrosine nitration (PTN) levels between the control and ethanol-fed mice.  
Immunohistochemistry revealed significant and selective nitration, localized to nuclei structures within 
the liver of the ethanol-fed mice.  Additionally, densitometry of the nitrotyrosine stained livers revealed 
nitrotyrosine immunoreactivity was significantly increased (p<0.0001) in the chronic ethanol-fed 
treatment group.  In order to confirm the immunohistochemistry results, site-specific nitration 
identification and validation were performed using mass spectrometry-based proteomic analysis.   Nuclei, 
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obtained from control and ethanol-fed mouse livers, were enriched using subcellular fractionation using 
ultra-centrifugation.  Several sites of nitration were identified within the nuclear fraction, with most 
nitration sites occurring on the histone isoforms, as well as heterogeneous nuclear ribonucleoproteins.  
Positively identified nitrotyrosine sites on histones were validated using a direct infusion of a respective 
synthetic nitro-peptide equivalent to the histone nitrotyrosine sites identified in vivo.  These are the first 
data to definitively show ethanol-induced protein nitration through site-specific identification using mass 
spectrometry.  One nitration site identified on histone 3 tyrosine 41 (H3nY41) was interesting because of 
its location in the hinge region of the histone H3 tail, which is located near the DNA interface.  Next, an 
investigation of the structural and functional consequences was conducted using molecular dynamic 
simulations of the nucleosome structure, in order to visualize the predicted DNA-H3 interface for both the 
nitrated and unmodified proteoforms of H3. The results from the simulations suggest that the nitration 
of H3Y41 causes the DNA to open, which may advocate a potential role of histone tyrosine nitration in 
chromatin remodeling and a possible role in gene regulation that are instigated in the liver after chronic 
ethanol exposure.  In order to investigate these DNA conformational changes further, ChIP-sequencing 
was performed on livers obtained from ethanol-fed mice following the 28-day ethanol study.  Further 
investigation of the H3nY41 modification using ChIP-sequencing revealed 18 novel potential targets for 
H3nY41 within the genome spanning 11 chromosomes.  Among some of the identified targets were 
proteins involved with the transport of metabolites, type-2 diabetes, and cancer, making them 
respectable targets for further validation by qPCR.  Surprisingly, 13 identified peaks were located in 
unannotated parts of the genome and, once these regions become known, they may provide insight into 
novel proteins and pathways important in the development of ALD.  The results of this study are the first 
to identify that chronic ethanol exposure induces histone tyrosine nitration within the nucleus of the 
hepatocyte.  Tyrosine nitration is able to modify histone tails, including H3Y41, which may influence 
chromatin structural changes, as well as alter transcriptional targets within genome following chronic 
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ethanol consumption.  Further analysis of histone tyrosine nitration may provide new pathways to target 
for treatment approaches in the development of alcohol liver disease. 
Introduction 
Increasing evidence suggests that epigenetic regulation through DNA methylation and histone 
modifications play a major role in numerous human diseases, including alcoholic liver disease (ALD) [96].  
Alcohol is known to be a major contributor to the production of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) during ethanol metabolism [4, 134-137].  Consequently, free radicals are then able 
to move freely throughout a cell and interact with an array of molecules and proteins causing destruction 
in their path [4, 5, 135-139].  Accumulation of free radicals such as nitric oxide (NO), and superoxide (O2-
), are free to react with each other to form the highly reactive molecule peroxynitrite (ONOO-).  ONOO- is 
more reactive then NO and O2-, but all ROS have the ability to oxidize the proteins they come into contact 
with, therefore modifying their function and altering signaling events [5, 92, 101, 135, 136, 139-142].   
During normal metabolism, glutathione (GSH) within the cell acts as a reductant to keep oxidative 
stress within the cell minimal under stressful conditions [107].  Glutathione (GSH) levels drop within the 
liver during ethanol metabolism, allowing ROS to accumulate [143-145].  When GSH levels drop, ONOO- 
can form when the superoxide anion (O2-) combines with free nitric oxide within the cell [29, 30, 33].  
Inducible nitric oxide synthase (iNOS) is the protein responsible for the synthesis of NO and found to be 
upregulated during times of inflammation [94].  When iNOS activity is decreased in mice by the inhibitor 
1400W, tyrosine nitration and liver injury are blunted following chronic ethanol exposure [94].  These data 
show a direct link between ROS, NO, and pathogenesis of ALD, however, this study aims to further 
investigate the role of ethanol-induced tyrosine nitration on histone proteins and gene regulation.  
Whereas ONOO- formation is the result of the combination of NO and O2-, NO is naturally 
synthesized within in the body.  Nitric oxide is often thought of as an injury marker that has a dual role 
within the cell and functions as a key signaling molecule and regulator of inflammation, as well as immune 
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and cardiovascular systems [4, 141, 146].  NO has been demonstrated to have protective properties when 
expressed at endogenous levels, and deleterious effects at higher levels [4].  Ethanol has previously been 
shown to increase free NO within the cell during times of prolonged drinking [29, 30].  Nitric oxide is found 
within every organ system in the body, and although its function as a key signaling molecule and regulator 
of immune response, vasculature homeostasis, and inflammation has been well established, its role in 
ethanol-induced oxidative stress and epigenetic modulation in the development of ALD is still unclear [4, 
141, 146].   
Currently, an interesting link is now being established between oxidative stress and subsequent 
epigenetic modifications in the liver (as well as other tissue types) triggered by ethanol exposure [20].  
Notably, NO signaling has previously been demonstrated to modulate histone hyperacetylation during 
cranial development as well as aid in the development of oral cancer [147, 148].  Furthermore, recent 
studies now show NO is able to contribute to the regulation of epigenetics by modifying methylation and 
acetylation sites on histone proteins [147-149].  For example, ROS production in rat hepatocyte primary 
culture after ethanol exposure was shown to contribute to the known epigenetic marker, acetylation of 
histone H3 at Lys9 (H3K9ac), which is also induced by ethanol consumption [18, 43].  Histone acetylation, 
in particular, is regulated by the activities of various histone acetyltransferases (HATs) and histone 
deacetylases (HDACs) where the activities of these enzymes are altered in hepatocytes after ethanol 
exposure [17, 18, 23, 39, 43, 121].  Furthermore, ethanol-induced changes in histone acetylation patterns 
have been shown to selectively alter gene expression in rat livers while not affecting global protein 
expression [43].  However, the molecular mechanisms underlying ethanol-induced oxidative stress linked 
to histone tyrosine nitration in hepatocytes are still unclear.  Moreover, the mechanistic detail regarding 
the impact of histone nitration modifications is essentially unknown. 
Histone tyrosine nitration poses an interesting epigenetic mark as there is now an emerging role 
for tyrosine phosphorylation as an epigenetic modification [100].  Specifically, tyrosine nitration may have 
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a direct role in altering histone-mediated gene transcription processes, or indirectly by affecting histone 
phosphotyrosine levels that have an impact on metabolic processes [101].  Previous studies have 
demonstrated that protein tyrosine nitration can compete with phosphate-groups for the binding to 
tyrosine residues as well as trigger phosphorylation events [34, 102-105].  It is interesting to note that 
selective nitration of histone proteins has been reported previously in another pathophysiological 
condition where Mutatect tumors showed a marked increase in tyrosine nitration on the different histone 
isoforms [106].  Tyrosine nitration is a very selective modification, only a few tyrosine residues in 10,000 
can be nitrated, and it largely depends on the surrounding environment and protein structure [107, 108].  
Seeley et.al. (2012) have previously demonstrated that tyrosine nitration was preferential in a basic 
uncharged polar environment when compared to hydrophobic and acidic residues [108].  Due to the 
minimum amount of tyrosine residues available for nitration, the positive charge on lysine, and arginine 
residues within the nucleosome would be a promising target for histone tyrosine nitration (HTN) during 
times of ethanol-induced oxidative stress [108].  This prompted the hypothesis of whether tyrosine 
nitration could occur as a post-translational modification of histone proteins, and what is its function.  To 
answer this question a well-established mouse model for ALD was used to induce oxidative stress in the 
liver of 8-week old mice [189, 190] in order to identify novel targets of histone tyrosine nitration.  These 
data now provide clear evidence that chronic ethanol exposure will induce histone tyrosine nitration in 
mouse liver cells after 28-days of chronic ethanol exposure and the modification promotes conformational 
changes to the DNA.  
Materials and Methods 
Chemicals and Reagents   
All chemicals and reagents were purchased from Fisher Scientific unless otherwise noted. 
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Experimental Design and Statistical Rational 
The role of ethanol-induced oxidative stress and liver damage has previously been established 
[135-138, 164, 221, 222].  The 28-day chronic ethanol diet in mice was chosen the for the induction of 
ROS because of its known similarities to the progression of ALD in humans [189].  It was determined that 
this model would be effective for studying the effects of ethanol-induced ROS/RNS on histone protein 
post-translational modifications based off of the amount of liver injury incurred.  The experiment began 
with n= 6 control mice and n=6 ethanol-treated mice with the expectation of 50% survival in the treatment 
group.  Since all mice were fed the same caloric restriction by pair feeding and were litter mates, it could 
be assumed there would be a normal distribution for the data set analysis; therefore a student t-test 
would be an acceptable statistical test (p≤.05) for the following experiments. 
Animals and 28-Day Leiber-DeCarli Ethanol Feeding 
A mouse model of chronic-ethanol consumption was used as previously described [189, 190].  The 
28-day Leiber-DeCarli liquid chronic ethanol diet was employed for both ethanol and control fed mice.  
Eight-week-old male C57BL/6J mice were each divided into two dietary groups; control (n=6 males) and 
ethanol (n=6 males).  Both the control and ethanol liquid diets provided equal caloric distributions 
between groups.  Liquid diets (Bio-Serv) were freshly prepared from powder daily, and all mice were first 
acclimated, stepwise, to a liquid control diet for 5 days. Ethanol groups were then fed a liquid diet 
containing 5% w/v ethanol for 28-days, while control mice received an equal volume of high-fat diet to 
mimic the calories obtained from alcohol.  Control mice were pair-fed to their ethanol-fed counterparts 
for 28-days and diets were measured daily.  Control diets were limited as needed as not to exceed the 
consumption volume of their pair-fed ethanol mouse.  Mice receiving the ethanol diet were housed on 
top of heating pads to maintain body temperature and prevent ethanol-induced hypothermia. On the 
morning of the 29th day, the mice were euthanized and blood and liver samples were collected. The studies 
were approved by the Institutional Animal Care and Use Committee of the University of South Florida. 
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Liver Histology, IHC and Densitometry Analysis of Nitrotyrosine Staining. 
Histology and immunohistochemistry (IHC) were completed by the H. Lee Moffitt Cancer Center 
Tissue Core Facility. Dissected livers were allowed to fix in 10% formalin for 24 hours.  They were 
submitted to the Tissue Core Facility at the H. Lee Moffitt Cancer Center and Research Institute (an NCI-
designated Comprehensive Cancer Center (P30-CA076292), where they were processed for histological 
examination by light microscopy.  After formalin fixation, tissues were processed in a Leica ASP 300 
processer and embedded into paraffin blocks using a Leica EG1150C embedding station.  Once embedded, 
4 μm paraffin sections were cut with a Leica RM2245 rotary microtome, mounted on glass slides, and 
stained with hematoxylin and eosin (H&E) (Hematoxylin 2, Richard-Allan Scientific #7231 and Eosin Y 
Richard-Allan Scientific #7111) in a Leica AutoStainer XL automatic strainer.  Upon completion, the slides 
were mounted with a coverslip.  The expression of nitrotyrosine in mouse liver was assessed by 
immunohistochemical staining (IHC) using a Ventana Discovery XT automated system (Ventana Medical 
Systems, Tucson, AZ) as per manufacturer's protocol with proprietary reagents. The slides were briefly 
deparaffinized on the automated system with EZ Prep solution (Ventana). Cell conditioning followed by 
incubation at 100°C for 24 min was conducted for antigen retrieval. The rabbit primary antibody that 
reacts to nitrotyrosine, (#A-21285, Life Technologies, Grand Island, NY) were used at a 1:200 
concentration in Dako antibody diluent (Carpenteria, CA) and incubated for 60 min. The slides were then 
incubated with the Ventana OmniMap Anti-Rabbit Secondary Antibody for 16 min for nY slides. The 
Ventana ChromoMap kit was used as a chromogen for detection followed by hematoxylin as the 
counterstain. Finally, the slides were dehydrated in 75%, 80%, 95% and 100% ethanol for 1 min each, 
cleared with xylene and cover slide were mounted on the slides.  To quantify the amount of nitrotyrosine 
staining in the IHC stained mouse livers, 25 regions of interest were selected from each image (one image 
from each of the 6 control mouse livers, n=150; two images from different regions of each of the 3 
ethanol-fed mouse livers, n=150) and the mean, minimum, and maximum pixel intensity was measured 
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using ImageJ.  The resulting mean pixel intensities were converted into reciprocal mean pixel intensities 
[223] and a two-tailed Student’s t-test was used to compare the reciprocal mean pixel intensities from 
the control and ethanol-fed groups assuming a normal distribution. 
Sample Processing, Mass Spectrometry, and Data Analysis.   
Nuclear Fractionation.   
Individual liver samples were sectioned (~750mg) to be separated into whole cell and nuclear fractions. 
Livers used for whole cell lysate were homogenized in lysis buffer consisting of 4% SDS, 100 mM Tris-HCl, 
pH 7.6, and 100 mM dithiothreitol.  Homogenization was followed by lysis at 95 °C for 5 minutes prior to 
sonication at 20% amplitude for six 3 second bursts.  Samples were spun at 17,000xg for 5 minutes at 
room temperature and pellets discarded.  Livers sectioned for nuclear enrichment were homogenized in 
3 ml homogenization buffer (10 mM Hepes, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.74 mM Spermidine, 1 
mM DTT, 0.3 M sucrose, protease and phosphatase inhibitor cocktail (Pierce) at 9000rpm for 1.5 min. 
Homogenate was resuspended in 6 ml cushion buffer (10 mM Hepes, pH 7.9, 0.1 mM EDTA, 0.74 mM 
Spermidine, 1 mM DTT, 2.2 M sucrose, 2 µg/ml aprotinin, 2 µg/ml leupeptin) and then overlaid on 2 ml 
cushion buffer. Nuclei were pelleted by 1 hr centrifugation at 25000g for 1 hr at 4°C as previously 
described [224, 225].  The pellet was collected and lysed in lysis buffer consisting of 4% SDS, 100 mM Tris-
HCl, pH 7.6, 100 mM dithiothreitol, followed by lysis at 95 °C for 5 minutes prior to sonication at 20% 
amplitude for six 3 second bursts.  Samples were spun at 17,000xg for 5 minutes at room temperature 
and pellets discarded.  
 Protein concentrations from both groups were determined using a 660 nm Protein Assay (Pierce) 
supplemented with Ionic Detergent Compatibility Reagent (Pierce).  Next, 30 µl of the sample was added 
to a Microcon-30kD spin column (Millipore) containing 200 µl of 8 M urea and buffer exchanged to 8 M 
urea over subsequent spins prior to iodoacetamide alkylation.  Samples were allowed to alkylate for 20 
min in the dark.  Post alkylation, the samples were exchanged to 50 mM ammonium bicarbonate for 
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digestion at a ratio of 50:1 with Trypsin/Lys-C mix Mass Spec Grade (Promega).  Digestion was carried out 
overnight in a humidified incubator at 37 ° C.  The next day samples were desalted by being loaded onto 
a hypersep reversed phase C18 column (Thermo), washed with 0.1% formic acid in H2O and then eluted 
using 90% acetonitrile/10% H2O/0.1% formic acid.  Samples were dried using a vacuum concentrator 
(Thermo) and resuspended in 0.1% formic acid and water prior to LC-MS/MS analysis.   
LC-MS/MS 
Individual samples were placed into the Easy nanoLC-1000 for separation on a NanoViper 50 cm 
x 75 µm I.D. reversed phase column packed with 3 µm C18 material with 100 Å pore size (Thermo) using 
a 120 min gradient of 2-28% ACN in 0.1% formic acid.  The inline mass spectrometric analysis was 
performed on a Q Exactive Plus mass spectrometer (Thermo).  A precursor MS scan of 350-1550 m/z was 
performed at a resolution of 70,000 and the top 10 most abundant peaks were selected for subsequent 
MS/MS analysis.   
Mass spectra were first analyzed using Mascot Distiller (version 2.2.06).  Parameters included a 
parent and fragment tolerance of 10 and 5 ppm respectively.  The reference database was obtained from 
SwissProt, (UniProtKB, ftp://ftp.uniprot.org/pub/databases/uniprot/previous_releases/, January 2012) 
for Mus musculus containing 16428 protein entries.  Mass spectra were then processed using the 
MaxQuant software package (version 1.5.0.30 (http://maxquant.org)) employing the Andromeda search 
algorithm against the SwissProt reference database (UniprotKB, July 2013) for Mus musculus containing 
16615 protein entries and then repeated using reference database UP000000589 (UniprotKB, August 
2015) containing 16717 protein entries.  The second database of known contaminants provided with the 
MaxQuant suite was also employed.  A minimum peptide length of 7 amino acids was used in conjunction 
with a maximum of 2 missed cleavages and a mass tolerance of 20 ppm.  A 1% false discovery rate was 
used for both peptides and proteins, and nY identifications were accepted based on a localization score 
of >0.80 and mass error of <1 ppm.  Carbamidomethylation of cysteine was applied as a constant 
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modification and oxidized methionine and nitrotyrosine were set as variable modifications.  Upon 
completion, analyzed datasets were placed into Scaffold software (version 4.4.5) for retention of protein 
and peptide coverage and statistics. 
Extracted Chromatogram Analysis 
XIC analysis was completed using the precursor MS obtained from the raw data files 
corresponding to each animal.  The area under the curve was calculated by identifying the change in 
retention time corresponding to the beginning of the peptide elution until no more eluted peptide was 
observed.  The change in relative abundance between the nitrated and unmodified forms of the peptide 
was calculated and reported as a percent fold change in expression.   
Western Blots 
Samples were processed as stated above and loaded into SDS-PAGE gels in accordance with 
sample size and molecular weight.  Precast TGX gels and protein standard were purchased from Bio-Rad 
(Hercules, CA) for use with their semi-dry turbo transfer machine.  Blots were transferred to methanol 
activated PVDF membranes for Western blot analysis.  Western blots were blocked in a 5% (wt/vol) 
powdered milk in PBS solution for 1 hour at room temp.  Next, the blots were washed in PBS for 1 hour 
prior to primary antibody incubation overnight at 4°C, shaking.  Primary antibodies are resuspended in a 
5% BSA/PBS solution containing 0.05% sodium azide as a preservative.  The next day blots were washed 
1 hour in PBST at room temperature prior to the addition of the respective species HRP-conjugated 
secondary antibody (Cell Signaling, Denver, MA).  The secondary antibody is prepared in 5% milk (wt/vol) 
and PBST at a 1:5000 dilution.  Blots were incubated in secondary antibody for 1 hour at room 
temperature and then washed for 2 hours in PBST prior to developing (nitrotyrosine blots are washed for 
24 hours in PBST prior to developing).  Blots were incubated for 1 minute in Western Lighting-Plus 
Chemiluminescent Substrate (PerkinElmer, NEL104001EA) and developed using the AI06 Imager 
(Amersham).  Primary antibodies are as follows: all dilutions are 1:1000; ADH1 (#5295), H3 (#4499), H4 
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(#2935), ACL (#13390), β-Actin (#3700), GAPDH (#5174), nitrotyrosine (#9691), pan-NOS (#2977), Cell 
Signaling Technologies; CYP2E1 (#ab28146, Abcam); nitrotyrosine (#6B2-3G2, Bio-Rad).  
Dot Blots 
PVDF membrane was activated in 100% methanol for 10 minutes.  After activation the membrane 
was washed for 5 minutes, shaking, in DI water and then placed into PBS for acclimation.  A piece of 
Whatman filter paper is soaked in PBS and placed on top of a dry piece of filter paper that is sitting on a 
stack of paper towel.  The membrane is placed on top of the stack and allowed to dry until damp.  
Previously synthesized nitro-peptides against H1nY70, H1nY27, H2BnY50, H3nY41, H4nY51, H4nY72, 
H3Y41 (Covance), H3nY41 (Covance) were dotted in 1µg, 500ng, 250ng, 50ng, 1ng, and 500pg.  The 
peptide was allowed to bind at room temp for 1.5 hours.  The membranes were then placed into PBS 
before beginning the previously stated Western blot protocol for testing of the H3nY41 (Covance) 
antibody.     
Nitro-peptide synthesis, Mass Spectrometric Analysis, and Validation of Histone Nitrotyrosine 
Identification     
In order to validate our findings, nitrotyrosine peptides were synthesized corresponding to the 6 
nitrotyrosine sites identified on the histone proteins (H1, H2B, H3, and H4).  Peptides were synthesized by 
Fmoc solid phase chemistry using the activator 5-chloro-1-[bis(dimethylamino)methylene]-1H-
benzotriazolium 3-oxide (HCTU).  The synthesis was completed using the 25 µmole synthesis scale by the 
Protein Technologies Symphony Peptide Synthesizer at the University of South Florida Peptide Synthesis 
and Mass Spectrometry Facility.  Each coupling step required 5 equivalents of Fmoc-amino acid and 7.5 
equivalents of HCTU to be dissolved in 0.4M N-methylmophorine in dimethylformamide (DMF).  Fmoc 
deprotection was done using 20% piperidine, 2% 1, 8-diazobiclo[5, 4, 0]undec-7-ene (DBU).  After 
synthesis, the resin was washed with N-methylpyrrolidone (NMP) followed by dichloromethane (DCM) 
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and cleaved using a cocktail mixture (94% TFA, 2.5% water, 2.5% ethanedithiol, 1% triisopropyl silane) 
prior to precipitation in cold ether.   
 The nitropeptides were resuspended in a 50:50 methanol and 0.1% FA in H2O at a concentration 
of 1µg/ml.  The peptides were directly infused into the Q-Exactive Plus Mass Spectrometer using the same 
normalized collision energy (NCE) and mass range as their respective experimental identified nitrotyrosine 
modified histone proteins from each individual sample. The synthetic peptide data was then used to 
validate the presence of the nitrotyrosine observed on the experimental histone residues.  Spectra from 
both the experimental samples and the synthetic peptides were annotated using protein prospector MS-
Product (version 5.14.1, http://prospector.ucsf.edu).  Positive nitrotyrosine sites were validated according 
to specifications previously described [126]. 
Molecular Dynamic Simulations 
The initial conformation for the wild-type nucleosome system was constructed from the X-ray 
structure of a nucleoprotein complex formed by recombinant variants of Xenopus laevis histones and 
modified human α-satellite DNA (PDB ID 1kx5) [226]. The crystal structure contains a 147 base pair DNA 
stretch wrapped around the octameric histone core resolved at 1.9 Å. [227].  Experiments were carried 
out over several all-atom MD simulations of the nucleosome complex with various modifications, one of 
which had truncated histone tails (H3 was truncated at K36, H4 at K16, H2A at A12, and H2B at K21).  In 
the latter system, RMSD of the core histone region remained within 1.5 Å of the crystallographic positions, 
and the RMSD of the DNA was slightly larger (5 Å) when compared to the nucleosome without truncated 
histone tails (4 Å), indicating that the nucleosome with the clipped tails maintains an average 
conformation close to that of the crystal structure.  As such, in order to expedite the acquisition of longer 
time scales, the histone tails were truncated at the same locations (Figure 3.8).  The nucleosome complex 
was co-crystallized with 14 manganese (Mn) ions. Manganese is a divalent ion and a transition metal that 
enforces an octahedral geometry on the ligands coordinating with it in the inner shell.  There are currently 
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no force fields that can accomplish this, therefore, Mn was switched out for magnesium (Mg), which has 
the same charge and a similar radii.  Coordinates for missing atoms were obtained through the pdb2gmx 
GROMACS utility. The nucleosome, along with the crystallographically resolved water molecules, were 
placed in a 14 nm3 unit cell and was then solvated with the SPC/E model water [228].  After energy 
minimization, non-crystallographic water molecules were randomly replaced by potassium (K+) and 
chloride (Cl-) ions in order to achieve a 100 mM ion concentration. K+ and Cl- ions were added in a 
proportion such that the unit cell has a zero net charge. After the introduction of ions, the unit cell was 
energy minimized once more.  To construct the H3nY41 system, the confirmation at t=500 ns from the 
wild-type ensemble was modified by substituting the CE2 hydrogen of H3Y41 with a nitrate group, whose 
bond parameters were obtained from Myung and Han [229].  Energy minimization was again performed 
on the H3nY41 system prior to starting the MD simulation.  
All simulations were carried out with the Gromacs 4.5.3 package [230] with an integration step of 
2 fs.  Protein, ions, and DNA parameters are described by the AMBER99SB-ILDN force field [231].  The 
simulations are carried out under isobaric conditions using the Parrinello-Rahman extended ensemble 
approach [232], with a reference pressure of 1.01325 bar. The coupling time constant for the barostat is 
1.0 ps and the compressibility factor is set to 4.5 e-5. The simulations are carried out at a temperature of 
310 K and are coupled every 0.1 ps to a velocity-rescale thermostat [233], which uses a stochastic term 
for the generation of a proper canonical ensemble.  Periodic boundary conditions are set in all directions 
and neighbor lists are constructed through a grid search that is updated every 10 fs. van der Waals 
interactions are computed explicitly for interatomic distances of up to 10 Å. Electrostatic interactions are 
computed using the particle mesh Ewald scheme with a Fourier grid spacing of 0.1 nm, a fourth-order 
interpolation, and a direct space cutoff of 10 Å [234].  Convergence is monitored by tracking the time 
evolution of histone and DNA RMSDs as well as H3Y41 and H3nY41-DNA distances (Figures 3.9-3.11). 
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H3nY41 Antibody Synthesis, Chromatin Immunoprecipitation, and qPCR 
A ChIP-grade antibody was raised in 2 rabbits, at Covance antibody facilities (Denver, PA).  The 
rabbits were immunized using synthetic peptides generated to recognize either H3Y41 (Ac-
PHRYRPGTVALC-amide) or H3nY41 (Ac-PHR(NO2Y)RPGTVALC-amide) over 77 days.  Serum was tested 3-
times, over 77 days using Dot-Blots probed with the previously made nitro-peptides [synthesized for the 
verification of MS data] and Western blots of whole cell lysate obtained from the 28-day mouse chronic-
ethanol study.  Rabbit FL111 was designated for affinity purification to be used for ChIP-sequencing.   
ChIP-Seq service was performed by Zymo Research Corporation (Irvine, CA). Briefly, mouse liver 
tissue was crosslinked with 1% (v/v) formaldehyde for 10 min and quenched with final 125 mM glycine 
for 5 min at room temperature. Chromatin was prepared using the Zymo-SpinTM ChIP kit (Zymo Research 
Corp., Irvine, CA). Sonication was performed at high power setting for 40 cycles (30 s on, 30 s off) using a 
Bioruptor PlusTM (Diagenode Inc., Denville, NJ), yielding fragment size range of 200-700 bp. The ChIP 
assay was performed in triplicate (N=3) using 20 μg of chromatin and 10 μg of anti-H3nY41 polyclonal 
antibody. Anti-IgG (Diagneode C15410206; Lot RIG001L) at a concentration of 10 μg was included as a 
negative control. A non-precipitated DNA sample was included as an input control. ChIP DNA was purified 
using the ChIP DNA Clean and ConcentratorTM (Zymo Research, Irvine, CA). ChIP-Seq libraries were 
prepared and sequenced on a HiSeq sequencer (Illumina, San Diego, CA). ChIP-Seq reads were aligned to 
the mouse genome version mm10 Bowtie with at most 2 mismatches. Reads that appeared more than 
twice at the same position on the same strand were discarded to remove PCR duplication. BIGWIG files 
were generated from the coverage for visualization purposes. MACS2 was used to identify peaks at q-
value cutoff 0.05 and a broad cutoff of 0.1.Following ChIP-sequencing, validation of Ano2 and Dpp9 were 
tested for validation using ChIP-qPCR.  ChIP-qPCR analysis was performed by Zymo Research Corporation. 
Briefly, unique primer sets were designed for Dpp9 and Ano2 introns using H3nY41 sequencing data. 
H3nY41 ChIP and IgG negative control DNA enriched from 3 independent ChIP assays were pooled and 1 
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µl DNA/reaction was amplified using ZymoTaq™ qPCR Premix (Zymo Research Corp., Irvine, CA). ChIP DNA 
enrichment was determined as % of input (i.e. the relative amount of immunoprecipitated DNA compared 
to 100% input DNA after qPCR analysis). 
Results 
28-Day Chronic Ethanol Diet in 8-Week Male Mice Promotes Liver Injury & Nitrotyrosine Formation  
 Eight week old male C57bl/6 mice were administered either the control or ethanol Leiber-DeCarli 
liquid diet for the course of 28 days.  Mice were sacrificed on day 29 and the blood and livers were 
harvested for further analysis.  Upon extraction, livers of ethanol-fed mice had displayed visual signs of 
hepatitis; livers were soft, swollen, discolored and possessed white blotches when compared to their 
control mice counterparts.  Livers were then next sectioned and fixed in 10% formalin, for 24 hours, prior 
to being embedded in paraffin for IHC analysis.  Hematoxylin and Eosin (H&E) stain were first performed 
on each liver to ensure alcohol-induced fatty liver has occurred in the ethanol-fed mice.  H&E staining of 
the ethanol-fed mice revealed signs of lipid accumulation commonly seen in the development of steatosis 
when compared to the control-fed mice (Figure 3.1A).  Upon confirmation that the mice had alcohol-
induced fatty-liver, global nitrotyrosine expression in the liver was assessed by IHC.  An IHC grade antibody 
against pan-nitrotyrosine (Invitrogen, A-21285) was used to stain each liver sample.  Interestingly, 
nitrotyrosine staining revealed increased levels of nitrotyrosine that was localized to the vascular and 
nuclear regions of the livers in the ethanol-fed mice (Figure 3.1B).  Next densitometry was performed on 
the resulting IHC data, to assess if the increase in nY after ethanol exposure was significant when 
compared the pair-fed control mice.  One hundred and fifty individual regions were randomly selected 
from the IHC livers of both the control and ethanol-fed mice, the resulting mean pixel intensities.   The 
resulting mean pixel intensities were then converted into reciprocal means and compared using a 2-tailed 
student t-test.  Statistical analysis of nY abundance between control and ethanol-fed mice yielded a 
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significant increase of nY (p=1.65E-38) in both the individual reciprocal means, as well as their averages 
(Figure 3.1C).  
 
Figure 3.1: Histological Analysis of Mouse Liver following the 28-Day Leiber-DeCarli Chronic Ethanol 
Diet. A) H&E staining shows increased lipid accumulation in the liver observed in ethanol-fed (A. Right) 
mice when compared to control-fed (A. Left) mice, indicative by the “hole”-like appearance.  B)  IHC pan-
nitrotyrosine staining of the control-fed (B. Left) and ethanol-fed (C. Right) mouse livers displays increased 
nitrotyrosine localized to the nuclear regions in the ethanol-fed mice.  C) Densitometry and Statistical 
analysis was completed on 150 random regions from the IHC images obtained from both the control and 
ethanol-fed livers.  C) (Left) Densitometry analysis was performed to quantify the fold change observed 
in the PTN between the control and ethanol fed mice depicted in part B above.  C) (Right) Statistical 
analysis of densitometry data revealed significant increases in PTN (** p<0.0001) after ethanol exposure.     
** 
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Functional Analysis of Nuclear Enrichment and Protein Tyrosine Nitration 
Next, the number of nuclear proteins that were identified by mass spectrometry were quantified 
in order to assess the purity of the nuclear enrichment.  To do this, the raw files were first analyzed using 
MaxQuant (Max Plank) and then added to Scaffold (Proteome Software Inc., Portland OR) for quantitation 
analysis [109, 235].  The gene-ontology (GO) function in Scaffold was used in order to determine which 
cellular compartment the protein identified is traditionally located in.  Scaffold-GO identified that 
approximately 50% of the total identified proteins were found within the cellular nuclear compartment 
(Figure 3.2A).  In order to ensure that a similar amount of protein was being utilized for XIC comparison 
analysis, the non-normalized total ion current (TIC) was used to establish a loading control.  The TIC was 
extracted from the nuclear proteins, Lamin B, Histone H3 (H3), and histone deacetylase 1 (HDAC1) from 
both the control and ethanol-fed mice and it was concluded that no significant changes in TIC occurred 
between experimental groups (Figure 3.2B).  These data suggest that any further data analysis of protein 
up or down-regulation could be completed with the confidence of equal loading of lysate onto the mass 
spectrometer.  The MaxQuant dataset was used to extract intensities and conducted a student’s t-test to 
calculate significant fold-change in expression between control and ethanol-fed mice.  Once proteins were 
found to have a significantly different (p<0.05) fold change, they were uploaded into Ingenuity Pathway 
Analysis (IPA) for further pathway analysis to detect differences in protein networks due to ethanol 
exposure.  Results show that ethanol upregulated numerous enzymes, such as GSTA5, CBR1, and HTATIP2 
that are important in pathways responsible for the reduction of free radicals and alleviating oxidative 
stress (Figure 3.2C).  The transcription factor, CCAAT/Enhancer Binding Protein Alpha (CEBPA) was 
identified to be downregulated, which is most notable for its role in cell cycle and proliferation arrest.  IPA 
analysis further confirmed that the expression changes being observed were commonly linked to enzymes 
necessary for ethanol metabolism and the reduction of oxidative stress within the cell.     
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Identification of Nitrotyrosine Modifications on Histone Proteins 
Utilizing both MaxQuant and Mascot proteomic software algorithms, 51 proteins were identified 
to undergo tyrosine nitration (Table 3.1). Excitingly, the search identified 7 novel sites of tyrosine nitration 
Figure 3.2: Quantitative analysis of Mass Spectrometrically Derived Nuclear Fractionation and Changes in 
Protein Upregulation.  A) Total ion current was quantified from the non-normalized data obtained from the 
MaxQuant data analyzed by Scaffold Q/S.  Scaffold’s Gene ontology function was used to quantify all proteins 
isolated and identified within the nuclear compartment.  No significant changes were observed between the 
control and ethanol-fed mice.  B) Comparison of nuclear loading control proteins Histone H3, Lamin B1 and 
HDAC1.  No significant changes were observed across the nuclear loading controls tested, relaying that all 
samples were equally loaded onto the column and mass spectrometer.  C)  Fold-change in significantly different 
proteins between control and ethanol-fed groups were uploaded into Ingenuity Pathway Analysis for analysis of 
protein expression.  IPA results yielded upregulation of proteins and enzymes important in the metabolism of 
ethanol.   
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(nY) on histone proteins.  The histone nY sites that were identified included 3 novel sites of tyrosine 
nitration in Histone H4 (Y51, Y72, and Y98), two nY sites in Histone H1 (Y27 and Y70), and one nY site on 
each, Histone H3 (Y41) and Histone H2B (Y37) (Table 3.2).  All of the prospective nY sites identified on the 
histone proteins received a localization score of 100% as well as a Scaffold PTM A-score of 1000, except 
Assession # Protein names Gene names Peptide Sequence and nY Probabilities Charge
Mass 
error 
[ppm] PEP
MaxQuant 
Score
P63038 60 kDa heat shock protein, mitochondrial Hspd1 SIDLKDKY(1)K 3 -0.360 1.10E-02 57.267
P20029 78 kDa glucose-regulated protein Hspa5 VY(1)EGERPLTK 3 -0.526 2.96E-02 55.467
P59511 A disintegrin and metalloproteinase w ith thrombospondin motifs 20 Adamts20 LEEKY(1)CSHLHK 2 1.839 4.97E-02 55.314
P68134 Actin, alpha skeletal muscle Acta1 LCY(1)VALDFENEMATAASSSSLEK 2 -1.539 4.51E-08 79.177
P68134 Actin, cytoplasmic 2 Actg1 DSY(1)VGDEAQSK 2 0.186 2.76E-05 115.33
Q9JME5 AP-3 complex subunit beta-2 Ap3b2 EAASDMSPY(1)VRK 2 1.776 5.71E-02 43.604
Q61285 ATP-binding cassette sub-family D member 2 Abcd2 PY(1)MSLGSLR 3 0.220 2.57E-02 50.04
Q9Z1N7 AT-rich interactive domain-containing protein 3B Arid3b QILDLY(1)MLY(1)KLVTEK 2 1.581 5.84E-03 42.314
Q9Z1N7 AT-rich interactive domain-containing protein 3B Arid3b QILDLY(1)MLY(1)KLVTEK 2 1.581 5.84E-03 42.314
Q99PF4-2 Cadherin-23 Cdh23 LDY(1)ELIQR 3 -0.649 3.88E-02 47.082
Q8C196 Carbamoyl-phosphate synthase [ammonia], mitochondrial Cps1 LY(1)FEELSLER 2 3.688 7.76E-05 123.79
Q8C196 Carbamoyl-phosphate synthase [ammonia], mitochondrial Cps1 EIEY(1)EVVR 2 -0.402 4.08E-02 67.897
P16015 Carbonic anhydrase 3 Ca3 HDPSLQPWSASY(1)DPGSAK 3 -2.344 7.59E-03 43.383
Q3ULW6-4 Coiled-coil domain-containing protein 33 Ccdc33 Y(1)LRIFHPYQFKLEK 3 -1.730 3.62E-03 55.196
Q8R3L8-3 Cyclin-dependent kinase 8 Cdk8 VGRGTY(1)GHVYK 2 0.416 6.36E-02 64.374
Q9DBT9 Dimethylglycine dehydrogenase, mitochondrial Dmgdh DLEGSY(0.5)Y(0.5)LR 2 0.334 2.45E-02 63.076
Q9DBT9 Dimethylglycine dehydrogenase, mitochondrial Dmgdh DLEGSY(0.5)Y(0.5)LR 2 0.334 2.45E-02 63.076
P06802-2 Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 Enpp1 KY(1)VY(1)LNK 2 -4.361 8.33E-03 100.74
P06802-2 Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 Enpp1 KY(1)VY(1)LNK 2 -4.361 8.33E-03 100.74
P10126 Elongation factor 1-alpha 1 Eef1a1 MDSTEPPY(1)SQK 2 -0.096 1.83E-03 82.437
P10126 Elongation factor 1-alpha 1 Eef1a1 RY(1)EEIVK 2 0.778 3.26E-02 53.968
P26443 Glutamate dehydrogenase 1, mitochondrial Glud1 NY(1)TDNELEK 2 -0.485 1.87E-03 98.048
P16858 Glyceraldehyde-3-phosphate dehydrogenase Gapdh LISWY(0.999)DNEY(0.001)GYSNR 2 0.215 3.87E-04 113.25
P01942 Hemoglobin subunit alpha Hba IGGHGAEY(1)GAEALER 3 -2.323 6.21E-04 79.337
Q8R3H7 Heparan sulfate 2-O-sulfotransferase 1 Hs2st1 PIY(1)INVIR 1 -0.520 4.72E-03 79.939
Q8BG05 Heterogeneous nuclear ribonucleoprotein A3 Hnrnpa3 SSGSPY(0.001)GGGY(0.992)GSGGGSGGY(0.007)GSR 2 -0.210 2.35E-17 144.95
Q8BG05 Heterogeneous nuclear ribonucleoprotein A3 Hnrnpa3 EDTEEY(1)NLR 2 -0.629 1.25E-03 103.55
P15864 Histone H1.2 Hist1h1c ALAAAGY(1)DVEK 2 0.635 3.12E-03 84.479
Q6ZWY9 Histone H2B type 1-P Hist1h2bp KESY(0.08)SVY(0.348)VY(0.572)K 2 0.565 1.61E-02 63.397
Q6ZWY9 Histone H2B type 1-P Hist1h2bp ESY(0.071)SVY(0.465)VY(0.465)K 2 -0.432 2.40E-02 63.397
Q6ZWY9 Histone H2B type 1-P Hist1h2bp ESY(0.808)SVY(0.191)VY(0.001)K 2 -0.482 2.71E-02 66.962
P84244 Histone H3.3, Histone H3.1, Histone H3.2 H3f3a Y(1)RPGTVALR 2 -0.462 4.44E-03 117.02
P62806 Histone H4 Hist1h4a RISGLIY(1)EETRGVLK 3 -3.551 1.81E-07 133.16
P62806 Histone H4 Hist1h4a DAVTY(1)TEHAK 2 -0.025 4.68E-05 110.38
P62806 Histone H4 Hist1h4a TLY(1)GFGG 1 0.464 4.15E-03 92.723
Q62240-3 Lysine-specif ic demethylase 5D Kdm5d LNY(1)LDQIAK 2 -0.063 1.76E-02 67.414
P45952 Medium-chain specif ic acyl-CoA dehydrogenase, mitochondrial Acadm KGDEY(1)VINGQK 2 0.252 8.20E-68 259.18
Q62425 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 Ndufa4 LGPNEQY(1)K 2 -0.598 3.99E-02 68.224
P51660 Peroxisomal multifunctional enzyme type 2 Hsd17b4 SGSGEVY(1)QGPAK 2 -0.294 1.46E-07 137.01
Q9R0E2 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 Plod1 FLGSGGFIGY(1)APSLSK 2 1.953 2.95E-03 65.219
O55125 Protein NipSnap homolog 1 Nipsnap1 GWDENVY(0.5)Y(0.5)TVPLVR 2 1.606 1.51E-03 79.614
O55125 Protein NipSnap homolog 1 Nipsnap1 GWDENVY(0.5)Y(0.5)TVPLVR 2 1.606 1.51E-03 79.614
Q9JKF1 Ras GTPase-activating-like protein IQGAP1 Iqgap1 Y(1)QELINDIAK 2 -0.117 4.81E-02 52.49
F6SEU4 Ras/Rap GTPase-activating protein SynGAP Syngap1 YQTMSILPMELY(1)K 2 0.791 7.44E-03 54.023
Q6ZQ82 Rho GTPase-activating protein 26 Arhgap26 GINEQGLY(1)RIVGVNSR 2 1.356 1.95E-02 63.29
P38647 Stress-70 protein, mitochondrial Hspa9 RY(1)DDPEVQK 2 0.750 6.85E-03 73.887
P09671 Superoxide dismutase [Mn], mitochondrial Sod2 HHAAY(1)VNNLNATEEK 3 0.879 1.11E-04 101.43
O08710 Thyroglobulin Tg FLGVPY(1)AAPPLADNR 2 -0.635 1.58E-02 53.377
Q99JY0 Trifunctional enzyme subunit beta, mitochondrial Hadhb MEQDEY(1)ALR 2 -0.371 1.71E-02 67.704
P25688 Uricase Uox GEY(1)SPSVQK 2 0.891 8.86E-03 75.571
Q5DU09-2 Zinc f inger protein 652 Znf652 VFNTRWY(1)LEK 2 -2.145 1.64E-02 67.334
Table 3.1: MaxQuant Nitrotyrosine Identification in Mouse Liver following the 28-Day Chronic Ethanol Diet 
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for H2B.  H2B has 3 tyrosine residues with similar neighboring amino acids, making it difficult for the 
software to localize which tyrosine was nitrated.  Furthermore, all of the nY sites identified fell within the 
allowable range of acceptable mass error (<5ppm) as determined by the performance of the Q-Exactive 
Plus mass spectrometer lowering the probability of a falsely identified PTM.  Because these nitration sites 
are novel, synthetic peptides were used in order to validate the histone nY modifications identified by the 
software.  Multiple parameters were used for the nY PTM to be considered valid, each of the nitrated 
histones must pass the following 4 criteria’s in conjunction with their respective synthetic peptide.  First 
the peptide must be >7 amino acids long, second the majority of peaks must have a relative abundance 
of >20%, third the peptide must have ≥4 consecutive ions identified (b or y), and lastly, the spectrum must 
redundant across samples.  Identified nY sites that did not fully pass the criteria listed above were 
considered invalid until further validation can prove otherwise.  Four positive sites of tyrosine nitration 
on histones were able to be validated, H3 (Y41), H1 (Y70), and H4 (Y51) and (Y72).  The b and y ion series 
identified from MS/MS spectra of the experimental samples (Figure 3.3) were compared to the 
corresponding MS/MS generated from direct infusion of the respective nitrated synthetic peptide (Figure 
3.4).  The remaining experimental peptides originally identified to be nitrated on histone H1 (Y27), H2B 
(Y37) and H4 (Y98) (Figure 3.5), were unable to pass the validation criteria when compared to their 
synthetic counterparts (Figure 3.6).  In regards to peptides that did not pass the validation, the analysis 
Table 3.2: XIC Analysis of Nitrotyrosine on Histone Proteins following the 28-day Chronic Ethanol Diet in Mice 
*Denotes nitrated tyrosine residue 
†Peptide identified by Mascot 
‡Peptide identified by MaxQuant 
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Figure 3.3: Identification and Validation of Histone Tyrosine Nitration that Passed Validation.  (A-D) Annotated 
spectra obtained from histone proteins containing nitrotyrosine residues.  Representative MS/MS that were 
found to have nitrated tyrosine were annotated using Protein Prospector.  Spectra obtained from the synthetic 
peptides were compared to the best scans of histone tyrosine nitration identified from the livers of their 
respective experimental samples obtained from the 28 day chronic ethanol diet.  Validation was dependent on 
the amount and consecutively placed ions that matched between experimental ions and ions obtained from 
the synthetic peptides.  A) Histone H3 tyrosine 41 was identified to be nitrated after ethanol exposure.  B & C) 
Histone H4 was identified to be nitrated at tyrosine residues 51 and 72, respectively after ethanol exposure. 
D) Histone H1 isoforms H1.2, H1.3, H1.4 and H1.5 were identified to be nitrated at tyrosine 70 after ethanol 
exposure.  
 
74 
 
Figure 3.4:  Annotation of Synthetic Peptides H3nY41, H4nY51, H4nY72, and H1nY70.  Synthetic peptides were 
synthesized to mirror the experimental histone nitrotyrosine peptides identified by MaxQuant.  The synthetic 
peptides were infused directly into the Q Exactive Plus mass spectrometer and parameters were adjusted to mirror 
experimental settings.  Synthetic peptides MS/MS were annotated using Protein Prospector and the respective 
MS/MS generated were compared to their respective experimental peptides for validation.  Spectra obtained from 
the synthetic peptides were compared to the best scans of histone tyrosine nitration identified from the livers of 
their respective experimental samples obtained from the 28 day chronic ethanol diet.  A) Histone H3 nY41. B & C) 
Histone H4 nY51 and nY72, respectively. D) Histone H1 isoforms H1.2, H1.3, H1.4 and H1.5 nY70.   
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Figure 3.5: Potential sites of Histone Tyrosine Nitration That Did Not Pass Validation. (A-C) Annotated spectra 
obtained from histone proteins containing nitrotyrosine residues.  Representative MS/MS that were found to have 
nitrated tyrosine were annotated and compared to nitropeptides as previously described.  All experimental settings 
were configured as previously described in Fig.3.  Spectra obtained from the synthetic peptides were compared to 
the best MS/MS of histone tyrosine nitration identified by MaxQuant software.  Figures A-C did not pass validation 
as previously described; A) Histone H1.0 nitration was suggested to be found on tyrosine 27, the coelution of an 
isobaric peptide is shown on the inset.  B) Histone H2B nitration of tyrosine 50 was unable to be fully validated due 
to the sequence similarity between tyrosine residues.  C) Histone H4 tyrosine 98 was unable to be validated due to 
the lack of positively identified consecutive ions. 
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Figure 3.6:  Annotation of Synthetic Peptides Pertaining to H1nY27, H2BnY50, & H4nY98.  Synthetic peptides were 
synthesized to mirror the experimental histone nitrotyrosine peptides identified by MaxQuant.  The synthetic 
peptides were infused directly into the Q Exactive Plus mass spectrometer and parameters were adjusted to mirror 
experimental settings.  Synthetic peptides MS/MS were annotated using Protein Prospector and the respective 
MS/MS generated were compared to their respective experimental peptides for validation.  Spectra obtained from 
the synthetic peptides were compared to the best scans of histone tyrosine nitration identified from the livers of 
their respective experimental samples obtained from the 28 day chronic ethanol diet.  A) Histone H1.0 nY27 B) 
Histone H2B nY50 C) Histone H4 nY98. 
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suggests that the inability to validate may have been due to the low nitrotyrosine abundance, and/or 
possible MS signal interference, most likely due to the coelution of an isobaric peptide. Next, individual 
spectra were used to assess the average percent nitration observed across both the control and ethanol-
fed mice.   
Nitrotyrosine modifications were observed to be present in both the control and ethanol-fed 
mice, however, the quantity of nY detected was minimal in the control-fed mice when compared to their 
pair-fed ethanol-matched mice (Table 3.2).  Analysis of the overall percent nitration showed >2 fold 
change between control and ethanol-fed mice for 3 nitrotyrosine sites; H3nY41 showed a 3.22 fold 
change, H4nY72 revealed a 2.51 fold change, and H1nY27 exhibited a 2.81 fold change (Table 3.2).  
Interestingly, the H3nY41 site is located in the hinge region of the H3-tail, whereas other identified histone 
nitration sites were located towards the center of the nucleosome.  The nitration of H3 in the tail region 
suggests the modification may be important for DNA interactions and gene regulation due to its 
positioning near both DNA and histone H1, this discovery prompted further investigation into H3nY41. 
Implications of Tyrosine Nitration Influences and Gene Regulation 
Protein Tyrosine Nitration Targets Proteins Involved in Gene Regulation 
Next, the addition of the nitrotyrosine modification was assessed on proteins involved in gene 
regulation and transcription.  Notably, heterogeneous nuclear ribonucleoprotein A3 (Hnrnpa3) was 
identified to be nitrated following chronic ethanol exposure.  Hnrnpa3 is often associated with the 
cytoplasmic trafficking of RNA, and may also have a possible role in pre-mRNA splicing.  Mass 
spectrometry identified two novel tyrosine nitration modifications on Hnrnpa3, Y139, and Y303 (Figure 
3.7A & 3.7B).  Moreover, the Y139 nitration site on Hnrnpa 3 is located in the RNA recognition motif 
domain (RRM) (IPR000504), suggesting a role in protein regulation or nucleotide binding.  Also, elongation 
factor 1-alpha 1 (Eef1a1) was found to contain two novel nitrotyrosine modifications at Y61 and Y82 
(Figure 3.7C & 3.7D).  Eef1a1 is important in helping GTP-dependent binding of aminoacyl-tRNA to the A-
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Figure 3.7:  Site-Specific Identification of Nitrotyrosine on Heterogeneous Nuclear Ribonucleoproteins & Eef1a1.  
Heterogeneous nuclear ribonucleoprotein A3 (Hnrnpa3) (A & B) and Elongation factor 1-alpha 1 (Eef1a1) (C & D) 
were both identified to be nitrated after ethanol exposure.  Hnrnpa3 was annotated using protein prospector and a 
positive identification of nitration on Y139 (A) and Y303 (B) was determined after ethanol exposure.  Annotation of 
the protein Eef1a1 also revealed that ethanol exposure induced nitration on Y166 (C) and Y161 (D).  All peptides and 
nitration sites were identified by MaxQuant analysis software. 
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site of the ribosome during elongation, further 
strengthening a plausible role for nY modifications 
in protein and gene regulation during times of cell 
stress.  
Molecular Dynamics Predict H3nY41 Induces a 
Conformational Change in the DNA 
The wild-type and H3nY41 nucleosome 
systems were each simulated for 500 ns. Histone 
and DNA RMSDs suggest that both systems begin 
to converge at t=100 ns (Figure 3.8 A-C).  A 
qualitative analysis was first completed by visually 
comparing ensembles sampled from t=100 ns to 
t=500 ns of the two systems, H3Y41 and H3nY41, 
by superimposing them onto each other.  This 
comparison suggests that when the H3Y41 is 
nitrated, the DNA bulges near its entry/exit sites at 
the nucleosome (Figure 3.9).  To obtain a 
quantitative evaluation of this observation, the 
distance from H3Y41 to the phosphorus atoms of 
those nucleotides that are within 5 Å of H3 in the 
crystallographic conformation was tracked (Figure 3.10).  The distance reported was calculated between 
the center of mass of these P atoms and that of H3Y41. The two histone 3 peptides within the nucleosome 
are considered independently in this analysis and are termed H3A and H3B.  Their respective time-
dependent DNA-P to H3Y41 distances are shown in (Figure 3.10).  The distance reported 
Figure 3.8: Tracking the Time Evolution of Histones 
and DNA RMSDs.  (A-B) The individual histones that 
comprise the nucleosome were placed into the 
simulated environment and tested for equilibrium 
using RMSD over time for both the wild-type (WT) 
H3Y41 (A) and the nitrated H3nY41 (B). (C) DNA 
stability was also assessed for convergence by RMSD 
over time.  Both the nucleosome containing the 
nitrated and unmodified H3Y41 and the DNA 
achieved equilibrium after 100ns.  
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was calculated between the center of mass of 
these P atoms and that of H3Y41. The histone 3 
dimer within the nucleosome is considered 
independently in this experiment and are termed 
H3A and H3B.  Their respective time-dependent 
DNA-P to H3Y41 distances are shown in (Figure 
3.10). This analysis indicates that the DNA P-
H3Y41 distance starts to converge at t=200ns, 
hence, the equilibrated portion is now taken to be 
from t=200 ns to t=500 ns.  Figure 3.10 also shows 
that when H3Y41 is nitrated, the DNA-P to H3Y41 
distance increases by 2 Å on average.  However, 
the average alone does not capture the full effect 
of the nitrated tyrosine because the fluctuation 
about the mean of the H3nY4I to DNA-P is twice 
Figure 3.9: Molecular Dynamic 
Simulations Predict the DNA Prefers 
a Different Conformation upon 
Histone Tyrosine Nitration.  
Computational modeling of the 
nucleosome containing the H3 
dimer with truncated tails.  The 
location of H3Y41 is depicted 
relative to the DNA (Right).  (Left) 
Magnified region of the H3Y41 and 
DNA interface showing the 
predicted DNA conformation in the 
presence of H3nY41 (Pink) and 
H3Y41 (blue).  The algorithm 
predicted the DNA to prefer a 
different conformation upon the 
nitration of H3Y41. 
Figure 3.10: Distance from H3Y41 to a Set of the DNA 
Phosphorus (P) Atoms.  The distance calculated between 
the center of mass of these P atoms and that of H3Y41.  
The H3 dimer were analyzed independent of each other 
(A and B). The DNA P-H3Y41 distance starts to converge 
at t=200ns, thus shifting the equilibrium starting point 
to t=200 ns to t=500 ns. 
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the distance of the wild-type.  While the H3nY41 
system consistently assumes conformations where the 
DNA-P and H3Y41 distance is >67 Å, it occasionally 
samples the conformational space of the wild-type 
system, yielding a lower average. In contrast, the 
maximum DNA-P to H3Y41 distance observed in the 
wild-type system is <64 Å. Although this difference may 
seem small relative to the scale of the entire 
nucleosome, an increase of just 3-4 Å is enough to 
accommodate the entry of a K+ ion, whose ionic 
diameter is 2.8 Å. To check how closely various moieties 
are to H3Y41, a RDF analysis was performed on DNA P, 
K+, Cl-, and water with respect to the carbon at position 
ε2 of H3Y41, which is the site of nitration introduction 
(Cl- not shown) (Figure 3.11A).  These data show that 
compared to the wild-type system, the K+ ions in the H3nY41 system are found much closer to the carbon 
that gets nitrated, while the RDFs for water and DNA-P are shifted further away. These data also show 
that potassium ion presence is indeed increased in the cavity formed by DNA and the H3 tail bearing 
H3nY41, thereby displacing the DNA further away from the histone core (Figure 3.11B). This phenomenon 
is shown visually in Figure 3.12, which juxtaposes the cavities formed by the H3 tail and DNA in the two 
model systems. The RMSD plot shows that the DNA of both systems undergoes large fluctuations. Hence 
there are instances where potassium ions may enter the H3 tail-DNA cavity in the wild-type system.  
However, it is apparent that this occurs at a much higher rate for the H3nY41 system (Figures 3.11-3.12).  
At time t=0, the DNA P-H3Y41 distance is about 6.1 nm. In order for a K+ ion to potentially be 
Figure 3.11: RDF analysis was performed on DNA 
P, K+, Cl-, and water with respect to the carbon at 
position ε2 of H3Y41.  (A) The K+ ions in the H3nY41 
system are found much closer than the non-nitrated H3, 
while the RDFs for water and DNA-P are shifted further 
away.  (B) DNA-P magnified to show the shift away from 
H3nY41. 
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accommodated in the H3 tail-DNA cavity, this distance must be increased by at least 2.8 Å (Figure 3.10). 
In conformational ensembles consisting of 300 snapshots sampled every nanosecond from t=200 to t=500, 
this threshold is met in 100 of the frames for the H3nY41 system, but it is observed in only two of the 
frames for the wild-type system. Based on these MD results, it can be postulated that the large 
fluctuations in the conformation of the DNA around the histone core, as evidenced by the large DNA RMSD 
in both systems, allow for the entry of ions into cavities formed by DNA and histones. However, in the 
case of the H3nY41 system, the residence time of the potassium ion in this cavity is increased through 
stabilized interactions with the electronegative oxygens of the nitrate group on one side, and the DNA 
phosphorus atoms on the other (Figures 3.11-3.12). Such a series of events could lead to an increased 
likelihood of DNA to be pulled away from the histone core. 
H3(nitro)Y41 and Antibody Validation by ChIP-Seq and qPCR 
Following molecular dynamic simulations, a ChIP-sequencing grade antibody pertaining to the 
peptide sequence surrounding H3nY41 was generated by Covance.  The antibody was tested using the dot 
blot method as previously described in the methods section.  Following the affinity purification, the 
Figure 3.12:  Potassium Ion Presence is in the Cavity Formed by DNA and the H3 Tail Bearing     H3nY41, thereby 
Displacing the DNA Further Away.  (A-C) Different point of views representing the H3nY41 (pink) and H3Y41 (blue) 
proteoforms.  Potassium ions (black spheres) are shown closer to the nY41 site whereas the DNA-P and water (blue 
spheres) are moving further away from the nY41 site.  
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H3nY41 antibody was tested against the previously synthesized nitropeptides used in the validation of the 
nY in the experimental samples.  Dots were placed in rows respective to each nitropeptide and diluted to 
1 µg, 500 ng, 50 ng, 1ng, and 1pg and the antibody tested at 1:1000, 1:5000, and 1:10,000 dilutions (Figure 
3.13).  The H3nY41 antibody was found to be highly specific at low concentrations (1:10,000) and was 
Figure 3.13:  Dot Blots Used to Test the Specificity of the H3nY41 Antibody.  Anti-
H3nY41 stock 0.279 µg/mL was diluted in order to identify optimal binding efficiency 
needed for ChIP-seq (Left) 1:1000 antibody dilution, (Middle) 1:5000 dilution, and 
(Right) 1:10,000 antibody dilution.  Each blots was dotted from left to right 1cµg, 500cng, 
50 ng, 1 ng, & 500 pg.  Nitropeptide order from top to bottom: H1nY70, H1nY27, 
H2BnY50, H3nY41 (USF), H4nY51, H4nY72, H3Y41 (Covance), and H3nY41 (Covance).   
 
 
Table 3.3: Novel Targets of H3nY41 Nitration  
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determined to be suitable for ChIP-sequencing validation.  Livers (~400mg) were taken from three 
different ethanol-fed mice, each having similar consumption levels and weights throughout the 28-day 
chronic ethanol feeding experiment.  The livers were snap frozen for ChIP-seq antibody validation.  Prior 
to ChIP-seq, the ethanol-fed livers were pooled together in order to maximize H3nY41 abundance and 
maximize DNA interactions.  Greater than 10,000,000 reads were obtained for both the input and the pull-
down experimental sample.  ChIP-seq of the H3nY41 pull-down identified 18 novel DNA interacting sites 
for H3nY41 (Table 3.3).  The 18 sites identified were all significantly enriched, having between 10 and 50 
fold enrichment, when compared to the input.  Surprisingly, only five reads were located within the 
annotated region of the genome.  Furthermore, all five known targets were located within the intron 
region of the gene and the peaks were all well-defined (Figure 3.14).  The remaining thirteen identified 
Figure 3.14: ChIP-Seq Peak Identification in the H3nY41 Pull-Down Shows 5 Peaks Found within the Intron Region of Genes 
Important in Metabolism and Liver Disease.  Each of the 5 genes identified are pictured above.  The top read in each 
plot is the input and below is the H3nY41 pull-down.  The red boxes are the peaks identified to be unique found in 
the experimental sample after the H3nY41 pull-down and sequencing.  The genes are in order of chromosome 
starting at the top left to right and in descending order.  The top left is Plxdc2, middle is Ano2, bottom is Myo7; top 
right is Dpp9 and bottom right is Bbx.     
 
85 
 
sites were all located within unannotated 
portions of the genome.  Two potential 
targets identified in ChIP sequencing, 
Ano2, and Dpp9, were further tested for 
validity by quantitative PCR (qPCR) 
because of their functional roles in glucose 
transport, type-2 diabetes, obesity, and 
cancer.  Quantitative PCR was performed 
for Dpp9 and Ano2, primer sets were used 
to assess the ChIP specificity by qPCR. The results indicate that these 2 regions were not significantly 
enriched in the ChIP samples compared to IgG negative control (Table 3.4 and Figure 3.15). 
Discussion 
Tyrosine makes up approximately 1-2% of all amino acids, making it an unlikely target for post-
translational modifications [141].  Here I demonstrate that tyrosine nitration occurs under normal 
physiological conditions, and also increases during times of oxidative stress.  Alcohol consumption seems 
to increase nY abundance within the cell, most likely attributed to the increases in ROS/RNS stemming 
from ethanol metabolism [31-33, 108, 141].  Tyrosine nitration is thought to be a highly selective 
modification and occurs approximately 100-fold times less than tyrosine phosphorylation [106, 236].  It 
Figure 3.15:  qPCR Validation of Ano2 and Dpp9.  Two primer sets 
were designed for each genomic region. Optimal annealing 
temperature for each primer set was determined using end point PCR 
with input genomic DNA. Based on the results both Ano2 and Dpp9 
failed validation. 
Table 3.4: qPCR of Ano2 and Dpp9 following ChIP-Seq 
Figure  
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has previously been reported that nY levels are found elevated in numerous pathological conditions such 
as inflammation, cardiovascular disease, and neurodegenerative disorders, and is thought to contribute 
to disease progression [101, 237-240].  Alcohol consumption and metabolism have been linked to high 
increases of oxidative stress and free radical formation within the liver [4, 20, 134, 135, 137, 142, 222].  
These data further support the notion that nY has an important role in disease progression due to the 
increase of nY abundance for histone proteins after ethanol exposure (Table 3.2).   
Previously, it has also been established that alcohol metabolism has a role in gene regulation by 
altering histone modifications such as acetylation and methylation [17, 18, 43, 96, 204, 241].  These new 
data now demonstrate that histone tyrosine nitration is a novel post-translational modification that is 
expressed endogenously at low levels and alcohol can cause increased expression after exposure (Figure 
3.1 & Table 3.2 respectively).  It has also been speculated that tyrosine nitration may compete with 
tyrosine phosphorylation in order to inhibit signaling pathways and therefore alter transcriptional 
regulation [34, 103-105].  One example of competition between nitration and phosphorylation is the H3 
(Y41) phosphorylation.  H3pY41 signals the activation of Janus kinase 2 (JAK2)-regulated genes, including 
the hematopoietic oncogene Imo2, by inhibiting the binding of heterochromatin binding protein 1 (HBP1) 
[109, 235, 242].  These data show for the first time, the nitration of H3Y41, as well as a conformational 
change in the DNA upon H3Y41 nitration (Figure 3.11 and 3.12).  H3Y41 nitration may have a role in 
repressing the JAK2-regulated genes during times of oxidative stress, offering a protective role against 
oncogenesis.  Furthermore, these data also identified H3 (Y41) nitration was present on all 3 isoforms of 
H3 (3.1, 3.2, 3.3) (Table 3.1), which suggests a possible role in for histone nitration in all stages of DNA 
replication [242].   
The importance of tyrosine nitration in gene regulation if further supported by the identified sites 
of nitration on heterogeneous nuclear ribonucleoproteins (hnRNP-A3) and Elongation factor 1-alpha 1 
(Eef1a1).  Heterogeneous nuclear ribonucleoproteins and enhancer binding proteins are important in the 
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regulation of transcription.  Heterogeneous nuclear ribonucleoproteins are traditionally found in the 
nuclear compartment during transcription.  The hnRNPs function to bind to the intron region of preRNA 
and mark it as not ready for transport into the cytoplasm [243-245].  Once the RNA is mature and ready 
for transport, the hnRNP is spliced out and then acts to mark the intron for degradation within the nucleus 
[243-245].  Eef1a1 is commonly known for its role in delivering transfer RNA (tRNA) to the ribosome during 
protein synthesis [246-249].  Eef1a1 also functions in nuclear export and has involvement in processes 
such as cell growth, cytoskeleton organization, signal transduction, and proliferation [246, 247, 250, 251].  
Upon upregulation, Eef1a1 has also been demonstrated to have a role in the metastasis of different types 
of solid tumors [247, 250].  Nitration on Eef1a1 may act as a regulator for tumor suppression just as it is 
hypothesized to do upon H3nY41 nitration.  When H3nY41 becomes nitrated it inhibits phosphorylation 
of that site, therefore, blocking the JAK2 signaling cascade [235].  Tyrosine nitration on hnRNPs and 
Eef1a1, along with the molecular dynamic evidence presented here, further support the hypothesis that 
tyrosine nitration is important in gene regulation, translation and also potentially tumorigenesis (Figure 
3.7).   
Identifying the mechanism for tyrosine nitration has proven to be difficult due to many different 
obstacles, both at the cellular and technical level.  During times of ethanol consumption, the working 
hypothesis is that the increase in nitration is the result of peroxynitrite formation stemming from 
increased ROS/RNS.  To date, most of the research on nY has been completed in vitro using synthetic 
peptides and peroxynitrite to initiate nitration [103, 104, 107, 109-112].  This method works well to give 
insight to specific tyrosine residues that are targeted for nitration, however, there has been little to no 
reproducibility in vivo because of the inability to mimic the physiological synthesis of peroxynitrite by the 
cell [31, 33, 101].  Tyrosine nitration research is also limited by the gap in knowledge pertaining to the 
possibility of dinitrase activity, which is able to reverse the nitro modification on tyrosine residues.  There 
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have been several reports of dinitrase activity but currently little is known regarding the underlying 
mechanism or cellular environment important for promoting dinitrase activity [109, 113-117].   
 Another large hurdle of in vivo tyrosine nitration is the ability to isolate the nitrated peptide by 
mass spectrometry in complex mixtures.  Nitrotyrosine is a very lowly expressed modification, and often, 
this modification goes undetected in cell lysate by using a traditional mass spectrometry methods.  Recent 
research has suggested that using a pull-down method such as an IP in order to isolate nY from a whole 
cell lysate, works well to detect the nY modification on tryptic peptides [101].  However, using a pull-down 
method limits data analysis of a complex mixture by excluding any changes in protein abundance or 
pathway regulation in the cell.  SILAC has also shown to be a useful resource in identifying nitrotyrosine 
but is limited by the cost of in vivo analysis [252].  Cellular fraction by ultra-centrifugation in combination 
with HPLC & high-resolution MS was sufficient to identify 51 potentially nitrated tryptic peptides after 
MaxQuant analysis.  Even though only 4 out of the 7 histone nitrotyrosine sites (Figure 3.3 & Figure 3.4), 
the remaining 3 histone nitrotyrosine sites are pending further validation of H1 (Y27), H2B (Y37), and H4 
(Y98) (Figure 3.5 & Figure 3.6) based on signal interference. Following the previously described validation 
methods by Stevens et al (2008) [126], the identified peptides failed validation because not enough 
consecutive b or y ions could be referenced at acceptable abundance levels.  Another reason these 
nitrotyrosine sites were not able to be fully annotated was due to the coelution of an isobaric peptide.  
Coelution of an isobaric peptide would cause signal interference, and hinder the mass spectrometers 
ability to differentiate between the 2 peptides fragmentation patterns.  Furthermore, Haqqani et al (2002) 
have previously identified both, H2B (Y37) and H4 (Y98) to be nitrated in the Mutatect tumor mouse 
model, which additionally strengthens the legitimacy of these nY sites to be true [106].  However, 
validation of H2B may prove to be more difficult than expected due to 3 tyrosine residues within close 
proximity to each other (Y37, Y40, and Y42).  Future testing of the validity H2B (Y37) should incorporate 
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nitration at Y40 and Y42 since MaxQuant software identified the likelihood that both H2B (Y37) and (Y40) 
could potentially become nitrated.  
 Nitrotyrosine modifications and their role in gene and protein regulation are only beginning to be 
understood.  The abundance of nY histone proteins and ribonuclear proteins further strengthens the 
probability that nY modifications are important for gene and protein regulation (Figure 3.7).  These data 
now show that by the use of synthetic peptides, four out of seven nY sites identified on histone proteins 
were able to be validated.  Furthermore, molecular dynamic simulations strengthen the hypothesis by 
showing the DNA prefers a different conformation upon histone nitration (Figure 3.8).  Interestingly, ChIP-
seq identified 5 novel targets and 13 unannotated targets in the genome that H3nY41 interacts with 
following ethanol exposure.  All five of the identified chromosome sites were located within the intron 
region, suggesting a potential role in splicing (Figure 3.10).  However, Ano2 and Dpp9 were unable to be 
validated by qPCR following ChIP-seq experiment.  The low abundance of nitrotyrosine may have played 
a role in the binding efficiency, or possibly H3nY41 does not target the genome and instead is a negative 
regulator of phosphorylation.  Molecular dynamics suggest that the DNA prefers a different confirmation 
upon the nitration of H3Y41, however, the mechanism for tyrosine nitration and its functional role with 
the liver are still unknown.  Nevertheless when taken in conjunction with the multiple nitrotyrosine sites 
on hnRNP-A3 as well as Eef1a1, further suggest the importance of nitrotyrosine modifications in RNA 
synthesis and RNA maturity, perhaps through mediating splicing machinery.  
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Chapter 4 
 
 
Metabolic tracing of 13C2 in the livers of 8-week male mice demonstrates the contribution of acetyl- 
CoA derived from ethanol metabolism to histone acetylation 
 
Abstract 
Epigenetic dysregulation through ethanol-induced changes in DNA methylation and histone 
modifications has been implicated in several alcohol-related disorders such as alcoholic liver disease 
(ALD).  It has previously been shown that ethanol induces hyperacetylation in the liver following periods 
of heavy drinking.  Currently, there are two proposed methods of alcohol-induced hyperacetylation.  The 
first hypothesis encompasses ethanol metabolism and the formation of acetate, a metabolite that can be 
further converted to acetyl-CoA.  Acetyl-CoA can then be used by histone acetyltransferases to acetylate 
lysine residues on histone proteins.  This mechanism results in a direct use of ethanol for acetylation of n-
terminal histone proteins, therefore hyperacetylation is a direct result of ethanol consumption.  The 
second hypothesis involves the sirtuin family of deacetylase proteins.  Sirtuin proteins regulate protein 
and histone acetylation throughout the cell because of their ability to remove the acetyl group from a 
protein when it is no longer needed.  Like ethanol metabolism, the sirtuin family of proteins are also 
NAD+/NADH-dependent.  Ethanol metabolism has been linked to the inhibition of sirtuin activity by out-
competing the deacetylases for the available cofactor NAD+.  As a result ethanol metabolism will indirectly 
influence lysine acetylation due to inhibition of sirtuin proteins by increasing the amount of NADH, in turn, 
acetylation is upregulated from the inhibition of sirtuin proteins.   
Alcohol-induced hyperacetylation has been well characterized although the underlying 
mechanism is still unclear.  This study aims to use known targets for histone acetylation in order to identify 
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a mechanistic approach in order to bridge the gap between the two proposed hypotheses.  By 
understanding how ethanol influences lysine acetylation potential targets of transcriptional regulation 
through epigenetic modifications that may influence the pathogenesis of ALD can be established.  In order 
to determine how ethanol metabolism influences histone acetylation heavy-labeled ethanol (13C2) in 
conjunction with UHPLC-mass spectrometry in order to site-specifically quantify lysine acetylation on 
histone proteins after binge drinking.  Using a single binge of ethanol (5g/kg) in 8-week-old male mice, 
ethanol was metabolically traced using the label incorporation derived from acetyl-CoA generated during 
ethanol metabolism.  Blood alcohol levels were observed to be raised 4 hours the gavage, which correlates 
to an increase in 13C2-label incorporation seen on the N-terminal lysine residues of histones H3 and H4.  
Total acetylation quantified from the N-terminal lysine acetylation sites identified on H3 and H4 were also 
observed to be significantly increased after 24 hours.  However, rapid turnover of histone acetylation sites 
was observed, and the heavy label was cleared following 24 h post-gavage.  Moreover, the site-specific 
selectivity of label incorporation was observed to occur preferentially at one lysine acetylation site over 
another as determined by tandem mass spectrometry and when compared to projected isotope 
simulations.  These data provide further evidence that hepatic ethanol metabolism directly impacts 
histone lysine acetylation in a site-specific manner and may also influence ethanol-induced gene 
expression through these transcriptionally activating chromatin marks. 
Introduction  
Chronic liver disease is consistently in the top 15 leading causes of death, of which 50% of those 
deaths are due to ALD [1].  Alcohol liver disease (ALD) is 100% preventable, however, in recent years binge 
drinking has been on the rise, especially in young adults between the ages of 18-34 [253].  Currently, 
alcohol-related expenditures cost the United States healthcare industry over $250 billion dollars each 
year, of which $119 billion stems from binge drinking alone [253].  The National Institute on Alcohol Abuse 
and Alcoholism (NIAAA) define binge drinking as any pattern of drinking that raises a person’s BAC to 
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above 0.08 g/dL in one sitting [253].  Although most binge-drinkers do not exhibit alcohol dependency, 
the health risks are just as dangerous as chronic or heavy drinking [253-257].  Even though there is no 
distinct line in regards to when binge-drinking stops and chronic drinking begins, both are equally as 
dangerous to the consumer.  Surprisingly, much is still unclear regarding the effects of binge drinking and 
ALI, when compared to the current literature regarding chronic ethanol exposure [4, 8].   
Once alcohol is consumed, the liver begins to metabolize it using either ADH or CYP2E1.  Alcohol 
metabolism disrupts normal cellular metabolic pathways by causing shifts redox potential and large 
increases in reactive oxygen species (ROS).  Disruption in redox homeostasis can ultimately lead to 
disruption in pathways such as lipid peroxidation, cellular signaling, inflammation, and most recently 
transcriptional reprogramming and epigenetics, all of which lead to liver injury [89-91, 150].  Recently, the 
role of alcohol-induced epigenetic changes and their role in liver injury have become of great interest to 
scientist [15, 17-19, 25, 43, 96, 258-260].  Currently, little is known about the underlying mechanisms 
relating to alcohol-induced epigenetic changes and liver injury.  This chapter aims to investigate how the 
metabolism of ethanol influences the acetylation of histone proteins.  
Protein acetylation has very important roles throughout the cell, such as metabolic regulation, 
cellular signaling, transcriptional programming and more recently, epigenetics [89-91, 150].  During times 
of ethanol exposure, lysine acetylation has been shown to be altered in a variety of cell types and 
organelles [85, 86, 88, 119, 151, 152].  Hyperacetylation is the most prominent change observed in the 
cell after ethanol exposure, most frequently detected within the mitochondria [85, 86, 88, 119].  These 
changes in acetylation can be attributed to two separate mechanisms since protein acetylation is 
reversible.  The first potential mechanism of hyperacetylation may be caused by the increasing levels of 
acetate that are produced as a byproduct of ethanol metabolism.  Acetate levels have been recorded as 
high as 1.4 µMol/min per 108 cells or as high as 10mM in the perfusate of rat liver [23].  Acetate travels 
 
93 
 
throughout the bloodstream where it can be converted into acetyl-CoA and donate its acetyl group for 
metabolic processes such as lipid metabolism and cellular respiration. The acetyl group is removed from 
coenzyme-A by histone acetyltransferase, and then can be used to acetylate proteins [23, 120].  The 
second mode of action relies heavily on the inhibition of deacetylase proteins, most commonly known as 
the sirtuin family of deacetylase.   Sirtuin activity can be inhibited by the competition for available NAD+ 
that is being used for ethanol metabolism [118].  The metabolism of ethanol within the liver is largely 
dependent on the cofactor NAD+, which is obtained from the mitochondria and cytoplasm within the cell 
[9, 82, 153].  As ethanol is metabolized, it competes with sirtuin deacetylase for available cofactor, in turn, 
promoting hyperacetylation [14, 155, 156].  Although ethanol exposure can lead to decreases in the 
activity of sirtuin 1 and 3 proteins, previous research has shown no changes in sirtuin protein abundance 
[38, 118, 157].   
Post-translational modifications (PTMs), such as lysine acetylation, play important roles in protein 
regulation throughout the cell [158, 159].   Site-specific identification and characterization of PTMs are 
necessary for understanding their biological functions within the cell and their role in the pathogenesis of 
ALD [158].  Lysine acetylation has been implicated to be one of the most important regulators of cellular 
processes and protein regulation [159-162].  Moreover, lysine acetylation has been shown to crosstalk 
with other PTM’s under different environmental conditions in order to control many aspects of cellular 
homeostasis [162].   Recent studies have shifted their focus to understanding how known sites of lysine 
acetylation are affected on histone protein tails following ethanol exposure [24, 151].  Changes in lysine 
acetylation of histone proteins have been attributed to a combination of the metabolism of ethanol [39], 
oxidative stress [163], and mitogen-activated protein kinase (MAPK) signaling pathways.  These epigenetic 
changes in acetylation on histone tails are able to alter gene regulation and transcription to accommodate 
times of cellular stress.   
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Recently interest has developed in understanding how ethanol affects gene regulation through 
targeting known epigenetic marks on histone tails.  For instance, acetylation of histone 3 lysine 9 (H3AcK9) 
induced by ethanol has been shown to be both dose and time-dependent, with notable increases 
occurring between 5 and 100 mM, which peak around 24 hours [23, 151].  Although 100 mM dose of 
ethanol seems high for human consumption (~0.450 g/dl), it is a concentration commonly observed in the 
serum of binge drinkers and chronic alcoholics [23].  In humans, a blood alcohol level (BAC) of 
approximately 0.200 g/dL would equal an approximate dose of 50mM ethanol and 100mM would be 
equivalent to a BAC of 0.400 g/dL.  When acetate is used to mimic ethanol toxicity, doses of 1-10 mM 
showed a marked increase in H3K9Ac over the course of 4 hours and then plateauing until 24 hours when 
it begins to decrease [23].  These data were also verified in rat hepatocytes that were treated with ethanol, 
showing a necessity for H3K9Ac in ethanol metabolism and a possible role in liver injury [151].  For 
example, epigenetic marks of DNA methylation that are inherited, have been implicated in various 
diseases, such as the predisposition to alcoholism and ALD [16, 25-27].  These modifications are thought 
to be influenced by the increase in reactive oxygen species (ROS) and reactive nitrogen species (RNS) 
generated as a result of ethanol metabolism.  
A recent shift in research has focused understanding on how ethanol-induced changes in lysine 
acetylation effect epigenetics by site-specific histone modifications.  An interesting link is now being 
established between oxidative stress and subsequent epigenetic modifications in the liver (as well as other 
tissue types) triggered by ethanol exposure [20].  For example, ROS production in rat hepatocyte primary 
culture after chronic ethanol exposure was shown to contribute to the known liver epigenetic marker 
induced by ethanol, acetylation of histone H3 at Lys9 (H3K9Ac) [18, 43].  Histone acetylation is regulated 
by the activities of various histone acetyltransferases (HATs) and histone deacetylases (HDACs) where the 
activities of these enzymes are altered in hepatocytes after ethanol exposure [17, 18, 23, 39, 43, 121].  
These changes may be explained by deacetylase inhibition,  as well as rising acetate levels in the 
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bloodstream, which can become more than 20 times greater than fasting or consuming foods rich in fat 
[261]. 
Furthermore, ethanol-induced changes in histone acetylation patterns have been shown to 
selectively alter gene expression in rat livers while not affecting global protein expression [43].  Park et. 
al. (2003) discovered that acetylation of histone H3 lysine 9 was upregulated in hepatocytes over the 
course of 24 hours when treated with 50 and 100 mM ethanol [151].  Additionally, Kendrick et. al. (2010), 
showed that metabolically available acetyl-CoA from acetate is vital to the increased acetylation of 
proinflammatory gene histones and consequently the proinflammatory response in ethanol-treated 
macrophages [120].  Shukla et.al. (2015) established that ethanol and acetate exhibit differential 
outcomes of their metabolic effects on hepatic gene expression [23].  Current work by Kori et. al., 2017 
uses stable isotope labeling in cell culture (SILAC) and proteomic analysis to assess histone protein lysine 
acetylation, turnover and their potential targets on the genome [262].  The molecular mechanisms 
underlying how ethanol metabolism is be linked to histone acetylation is still unclear. Moreover, the 
mechanistic detail regarding the impact of oxidative stress on other histone modifications is essentially 
unknown.  These data now demonstrate that ethanol metabolism contributes to the Acetyl-CoA pool, 
where in conjunction with HAT’s can be used to acetylate histone proteins at known epigenetic marks of 
gene activation.    
Materials and Methods 
Acute-Binge Mouse Model using 13C2-Labeled Alcohol or Maltose-Dextrin 
C57bl\6J mice (Jackson Laboratory, Sacramento, California) were maintained at the University of 
South Florida animal facility following the guidelines provided by the Institutional Animal Care and Use 
Committee (Appendix B).   
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Eight-week male C57bl/6 mice (n=3/group) weighing approximately 25 g, were administered an 
acute bolus dose of either 13C2-labeled ethanol (5g/kg) (Cambridge Isotope, Cat. # CLM-551-1, 
Tewksbury Massachusetts) or an isocaloric equivalent dose of maltose dextrin (BioServ , Cat. # 3653, 
Flemington, New Jersey) as previously described by Bertola et. al. [189].  Mice gavaged with 13C2-labeled 
ethanol were placed in their respective cages on top of heating pads to prevent hypothermia. At 0, 4, 
and 24 hours, mice were sedated using isoflurane, and a cardiac puncture were performed prior to 
euthanasia.  Blood was collected and placed in a BD Microtainer (Cat. # 365967, Franklin Lakes, New 
Jersey) and a cervical dislocation was performed according to IACUC standards of humane euthanasia.  
Livers were collected and snap frozen in liquid nitrogen for later processing. 
Blood Alcohol Test 
Microtainers containing whole blood were allowed to clot at room temperature for 30 minutes 
and then spun at 10,000g for 10 minutes using a benchtop centrifuge.  Serum was collected and stored 
in 1.7 µl microcentrifuge tubes (Axygen, Cat. # MCT-175-A, Fisher Scientific, Hampton, New Hampshire). 
Blood alcohol serum levels were measured in a 96-well plate, using Pointe Scientific diagnostic test (Cat. 
# A7504, Fisher Scientific, Hampton, New Hampshire) as per the manufacturer's instructions.  Quality 
control was measured using Pointe Scientific standard (Cat. # A7504-STD, Fisher Scientific, Hampton, 
New Hampshire), and alcohol controls (Cat. #A7504-CTL, Fisher Scientific, Hampton, New Hampshire). 
Samples were read at 340nm using a Powerwave SX2 (BioTek, Winooski, Vermont) microplate 
spectrophotometer and exported to Excel for analysis. Serum collect from the first day was stored at 
-20°C and analyzed a second time with the 24 hr collections.     
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Sample Processing and LC-MS 
Tissue Lysis, Histone Extraction, and Derivatization 
Livers were thawed on ice and 50 mg of tissue was cut and placed into 2 ml homogenization 
buffer containing 10 mM sodium butyrate (Alfa Aesar, Cat. #A1107922, Fisher Scientific, Hampton, New 
Hampshire) and protease inhibitor cocktail (Roche, Cat. # 1183617001, Sigma Aldrich, St. Louis, 
Missouri). Tissues were broken down into a single cell suspension using a Dounce homogenizer with 
pestle A only. The whole cell lysate suspensions were placed into 50 ml conical tubes (Corning, Cat. # 
430291, Fisher Scientific, Hampton, New Hampshire) and spun at 1500 rpm for 10 minutes to form a 
pellet.  The homogenization buffer was discarded and the pellets were washed again in homogenization 
buffer, the spin was repeated and wash was discarded.  Nuclei were isolated using a nuclear extraction 
buffer (homogenization buffer with the addition of 0.1% NP-40 (Thermo Scientific, Cat. # 28324, Fisher 
Scientific, Hampton, New Hampshire).  Pellets were triturated 5-times using a wide-bore pipet tip and 
placed into microcentrifuge tube on ice.  Nuclei were pop-spun 10 sec in a benchtop microcentrifuge 
and supernatant containing the cytoplasmic fractions were discarded.  Nuclei were again washed in 
nuclear isolation buffer and pop-spun two times.  Nuclei were then washed twice in homogenization 
buffer to remove excess detergent before histone isolation.  Histone extraction buffer was prepared by 
adding 0.4N HCl (Fisher Chemical, Cat # A144-500, Fisher Scientific, Hampton, New Hampshire) to the 
homogenization buffer.  Nuclei were resuspended and lysed by sonication (30% amp, 5s on/off for 1 
min) while on ice and supernatant was checked for complete DNA shearing by pipetting up and down.  If 
DNA was present then sonication was repeated until complete lysis.  Histone lysate was placed at 4°C 
over-night, rocking to ensure complete protein precipitation.  The following day the histone lysate was 
spun max rpm and the supernatant, containing the histones, was placed into a clean microcentrifuge 
tube.  Histone lysate was quantified using the BCA kit (Pierce, Cat. # 23225, Thermo Scientific, Hampton, 
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New Hampshire). Histones were placed into 5 µg aliquots and dried in a SpeedVac (Thermo Fisher 
Scientific, Hampton, New Hampshire) for derivitization.  Histones were next subjected to propionylation 
as previously described by the Garcia Lab, except a 3:1 ratio of ACN (Fisher Chemical, Cat. # A998SK-4, 
Fisher Scientific, Hampton, New Hampshire)  to propionic anhydride (Sigma Aldrich, Cat. # 240311, St. 
Louis Missouri) was substituted in lieu of 2-propanol [263].   
LC-MS and Data Analysis  
Lypholyzed samples were resuspended in 0.1% formic acid (Fisher Chemical, Cat. # A117-50, 
Hampton, New Hampshire) and HPLC-grade water (Fisher Chemical, Cat. # W5-4, Hampton, New 
Hampshire).  Samples were next analyzed using tandem mass spectrometry on a UHPLC-MS Q-Exactive 
Plus Mass Spectrometer (Thermo Fisher Scientific, Hampton, New Hampshire) and eluted over 1 hr 
gradient.  Samples were eluted over a NanoViper 50 cm x 75 µm I.D. reversed phase column packed with 
3 µm C18 material with 100 Å pore size (Thermo Fisher Scientific, Hampton, New Hampshire) using a 
stepped normalized collision energy (NCE) of 29 and 32 and a gradient of 2-98% ACN in 0.05% TFA.  A 
precursor MS scan of 350-1550 m/z was performed at a resolution of 70,000 using a larger isolation 
window (2.5 m/z) and the top 10 most abundant peaks were selected for subsequent MS/MS analysis.  
Mass spectra were then processed using the MaxQuant software package (version 1.5.0.30, 
http://maxquant.org) employing the Andromeda search algorithm against the SwissProt reference 
database for Mus musculus (UniprotKB, April 2017), a second database of known contaminants provided 
by the MaxQuant suite was also employed.  Parameters include a minimum peptide length of 7 amino 
acids, a maximum of 2 missed cleavages and a mass tolerance of 20 ppm.  A 0.01% false discovery rate 
was used for both peptides and proteins with a mass error of less than 1.  Protein quantification was 
calculated using N-terminal lysine acetylation and methionine oxidation.   Variable modifications included 
in the search consisted of lysine acetylation, heavy lysine acetylation (13C2), lysine propionylation, and 
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mono- and tri-methylation of lysine and arginine.  Manual data analysis by extracted ion chromatogram 
(XIC) and relative abundance (RA) analysis were completed using Xcalibur software package (version 3.0, 
Thermo Fisher Scientific, Hampton, New Hampshire).  Base peaks were analyzed using a 5 ppm cutoff and 
precision to the 5th decimal for each 12C and 13C2 peak containing a lysine acetylation or propionylation 
site that was identified by MS and verified by tandem mass spectrum.  
Isotopic Precursor Intensity Extraction Using R 
Raw files were converted to .mzML format using Proteowizard [264, 265].  MaxQuant 
“Evidence.txt” search results were used to identify modified Histone H4 peptide-spectrum-matches 
(PSMs) for intensity extraction.  Precursor intensity values were extracted using the Bioconductor package 
“mzR” [264].  MaxQuant results were filtered for modified histone PSMs containing values for ‘Raw file’, 
‘MS/MS Scan Number’, and ‘MS/MS m/z’ value.  These values were compared to the scan header 
information for each raw file to obtain precursor scan numbers.  Intensity values for monoisotopic m/z 
peaks were extracted from the corresponding precursor scan number, using m/z values within 0.01 m/z 
units of the ‘MS/MS m/z’ value.  The maximum intensity value within the given m/z window was used for 
each measurement.  Intensity values for M + 1, M + 2, and M + 3, and M + 4 peak were extracted using 
the ‘MS/MS m/z’ value plus the mass difference of 13C and 12C divided by the charge state (1.003355 / z * 
isotope peak ).  Incorporation of 13C-labeled ethanol was calculated using the ratio of [M + 2] peak to [M] 
peak.  Incorporation values were plotted using ggplot2 from the Tidyverse package [266]. 
Results 
Blood Alcohol Levels after an Acute Alcohol Binge Correlate with 13C2 Incorporation over 24 Hours 
Eight-week-old male mice (n=3) were separated into control or experimental groups based on 
equal weight.  The mice were gavaged in the early morning with an acute dose of either 5g/kg 13C2-labeled 
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ethanol or an isocaloric control of maltose dextrin.  Mice were sedated prior to euthanasia, and blood was 
collected via a cardiac puncture in order to determine the serum blood alcohol content (BAC).  Mice that 
were gavaged with 13C2-heavy labeled ethanol were observed to have average BAC levels of 305 mg/dL 
(n=3) 4-hours after the gavage; following 24-hours serum BAC levels returned to levels comparable to the 
control mice (Figure 4.1A).  Peptides were subjected to propionylation prior to MS analysis, this technique 
adds a propionyl group to all the unmodified lysine residues.  Propionylation makes the N-terminal regions 
of the histone tails more hydrophobic and increases coverage and separation of the column (Figure 4.1F). 
Respectively, each proteoform was next analyzed for relative abundance in 13C2 using mass spectrum 
analysis (Figure 4.1B-E).  Data shown in Figure 4.1B-E corresponds to peptide H3(K18-R26) and is 
representative of the H3(K9-16) peptide (data not shown).  The top two spectra are taken from the 4-hour 
time point pertaining to the control and heavy-labeled ethanol gavaged mice (Figure 4.1B-C).  The [M+2] 
peak labeled in the top spectrum is the naturally occurring 13C2 peak, and the difference in relative 
abundance calculated for the 13C2 peaks in the control and ethanol mice can be used to quantify the 
amount of ethanol was incorporated into the acetylation site.  Heavy label incorporation was found to 
have a similar increasing trend as the BAC results and was maximized at the 4-hr time point.   The ethanol 
mice gavaged with the 13C2-heavy label showed marked increase of the [M+2 peak] after 4-hours (Figure 
4.1C) when compared to the time-matched control mice (Figure 4.1B).  Following 24-hours 13C2 expression 
returned to basal levels in the ethanol gavaged mice and matched both the 4 and 24-hour control mice 
(Figure 4.1 B, D, & E).   
Next, histone peptide coverage was evaluated using MS in regards to the unmodified, single 
acetyl, and double acetyl H3 peptides containing lysine K9, K14, K18, and K23.  Both H3 peptides identified 
by MS contained two potential acetyl sites, H3 (K9 & K14) and H3(K18 & K23).  Chromatographic 
separation was used in order to isolate the double propionylated, propionylated/ acetylated, and the 
double acetylated peptide for quantitation (Figure 4.1F).  Because of the fragmentation pattern of the b 
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Figure 4.1: Site-Specific Incorporation of Heavy-Labeled Ethanol Peaks Around 4-Hours following the Same Trend as Serum 
BAC Level.  (A) Blood was collected from 8-week-old mice (n=3) and serum was used for BAC analysis at 0, 4, and 
24-hours.  Data was plotted using the average BAC within each group with the standard deviation.  (B-D) 
Representative mass spectrum of the H3K9/K14 peptide demonstrating 13C2-heavy label incorporation at the [M+2] 
peak. (B-C) Mass spectrum taken from the 4 h mice gavaged with either maltose dextrin (C) or 13C2-labeled ethanol 
(D). (E-F) Mass spectrum taken from the 24 h mice gavaged with either maltose dextrin (D) or 13C2-labeled ethanol 
(E).  Endogenous 12C is represented by the monoisotopic peak [M+2H]2+ and either endogenous 13C2 or increased 
13C2 expression from label incorporation is depicted by the [M+2] peak (dashed ovals). (F) Chromatographic 
separation of the peptide coverage representative of Histone 3 K9-R17.  Left peak (black) represents the doubly 
acetylated H3K9Ac and H3K14Ac, middle peaks (grey) include H3K9Ac(left) and H3K14Ac (right), and the dashed 
peak on far right (grey dashed) denotes the doubly propionylated H3K9(prop) and H3K14(prop) peak. 
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and y-ions, H3K9Ac was able to be isolated from H3K14Ac allowing for site-specific quantitation of heavy-
label at each site.  Each modified and unmodified peptide was quantified for heavy-label incorporation 
using extracted ion chromatogram analysis (XIC) of relative abundance (Figure 4.1F).  Relative abundance 
of acetylation at each H3 site was quantified independently for both the 12C [M] and 13C2 [M+2] peaks in 
regards to the individual proteoform (doubly acetylated, singly acetylated (acetyl/propionyl), and doubly 
propionylated) for the identified H3 peptides (Figure 4.1F).  XIC analysis was performed on the two 
consecutive histone H3 peptides, the first is H3 (K9-R17) containing lysine’s K9 and K14, and the second 
peptide covers H3(K18-R26) and contains lysine’s K18 and K23.  The average ratio of 13C2 to 12C was then 
calculated in order to determine the fold-change 13C2 incorporation for each potentially modified site.   
Characterization of 13C2-label incorporation on Histone Proteins after an Acute Ethanol Gavage 
Histone H3K9 and H3K14 proteoforms were analyzed and graphed to show fold change in 13C2 
incorporation (Figure 4.2A). Graphs depict both with (H3K9-R16) and without (H3K17-R26) site specificity 
regarding the singly acetylated proteoform (acetyl/prop) (Figure 4.2A).  Significant incorporation of 13C2 
was established using a 2-tailed Welch’s t-test where p≤0.05) and plotted with standard error of the mean 
(SEM).  Significant incorporation of 13C2 was observed site specifically for H3K14Ac (p=0.004 and p=0.01) 
as well as the non-site specific singly acetylated peptide (p=0.01 and p=0.02) at 4-hours post gavage when 
compared to the 0 (baseline) and 4-hour control, respectively (Figure 4.2A).  The H3K14Ac peptide was 
also found to have a significant increase in 13C2 incorporation (p=0.002) following 24 h ethanol gavage 
when compared to the baseline (0 h control) mice (Fig. 2A).  Fold change of 13C2 incorporation pertaining 
to the peptide containing H3K18/K23 were also calculated as previously described above, and ratios were 
graphed for each proteoform, however without site-specificity (Figure 4.2B).  Significant 13C2 
incorporation was observed on the singly acetylated proteoform at 4 hours (p=0.01) and 24-hours 
(p=0.02) when compared to both the baseline (0 h) and their respective time-matched controls (Figure 
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4.2B).  No significant incorporation of heavy label was observed for either doubly acetylated peptide, 
H3K9Ac/K14Ac or H3K18Ac/K23Ac at any time point (Figure 4.2A-B). 
Next, total acetylation was quantified as a ratio of ratios; equal to the ratio of the acetylated (13C2 
+ 12C) peptide to non-acetylated peptide, divided by the ratios of the ratio of the acetylated (13C2 + 12C) 
peptide to non-acetylated peptide for each time-matched control and the ratio of the acetylated (13C2 + 
12C) peptide to non-acetylated peptide for the ethanol-treated mice (Figure 4.3 A-B).  The ratio of ratios 
was calculated for both the H3K9/K14 (Figure 4.3A) and H3K18/K23 (Figure 4.3B) peptides.  Propagation 
Figure 4.2: Label Incorporation for each H3 Peptide were Quantified by Extracted Ion   Chromatogram Analysis. 
(A-B) Fold change in 13C2 incorporation was calculated by taking the average of the XIC ratios of 13C2:12C 
(n=3) for peptides containing H3K9/K14 (A) and H3K18/K23 (B).  Individual standard deviations were used 
to calculate were the samples fell in regards to the mean. Significant 13C2 incorporation is denoted by * 
p≤0.05 or ** p≤0.01, and calculated using a Welch’s t-test.  (A) Fold change of 13C2 incorporation pertaining 
to the peptide containing H3K9/K14.  Ratios were graphed for 0, 4 and 24 hours for the doubly acetylated 
H3K9 and K14, either H3K9 or K14 single acetylation, the sum of both singly acetylated peptides or total 
peptide single acetylation and the doubly propionylated peptide.  (B)  Fold change of 13C2 incorporation 
for the peptide containing H3K18/K23 was calculated as stated above.  Ratios were graphed for the doubly 
acetylated, singly acetylated, and doubly propionylated peptide containing H3K18/K23.   
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of error was used to calculate the random error within the sample distribution.  Increases in overall 
acetylation of the H3K9/K14 peptide, show a significant increase (p=0.04) in acetylation over the 24-hour 
time-course when compared to the baseline (0 h) (Figure 4.3A, left).  Total change in acetylation was also 
calculated site-specifically to include H3K9 (Figure 4.3, middle) and H3K14 independently from each other 
(Figure 4.3A, right).  Interestingly, total acetylation excluding H3K14 acetylation (Figure 4.3A, middle) was 
not found significant, whereas the total acetylation excluding H3K9 was found to be significant (p= 0.02) 
Figure 4.3: Overall Changes in Total Acetylation on H3 were quantified by Extracted Ion Chromatogram 
Analysis.  (A-B)  Total acetylation was expressed as the average of the sum of 13C2 and 12C for each mouse 
and then taking the ratio of total acetylation to unacetylated over the ratio of ethanol-treated to their 
time matched controls for the H3K9/K14 (A) and H3K18/K23 (B).  Propagation of error was used to 
calculate the random error within the sample distribution for each peptide.  Significance was determined 
using a 2-tailed paired students t-test and denoted by denoted by * p≤0.05 or ** p≤0.01.  (A) Overall 
acetylation was calculated for the peptide corresponding to H3K9/K14 as well as site-specifically for K9 
and K14 acetylation and the doubly acetylated peptide. (B) Overall total acetylation was calculated for 
the peptide pertaining to H3K18/K23 in its entirety. 
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after 24 h when compared to the 0-hr control mice and not to their time-matched control (Figure 4.3A, 
middle).  Next, the overall changes in acetylation were calculated as described above in regards to the 
peptide containing H3K18 and H3K23.  Total acetylation on the H3K18 and H3K23 peptide was found to 
be significantly increased (p= 0.02) in ethanol-treated mice after 24-hr when compared to the 0-hr control 
mice, however, no changes in overall acetylation were observed between the ethanol- and control-
treated mice at 4 hours (Figure 4.3B).   
Isotope Simulation Suggests a Mixture of 13C2 Incorporation on the Double Acetylated Peptide after 4-
hours Ethanol Exposure  
H3K9-R17 Analysis of 13C2 Incorporation on the Doubly Acetylated Peptide After 4-hours Ethanol 
Gavage 
Mass spectrum obtained from the doubly acetylated H3K9/K14 and H3K18/K23 peptides were 
compared to predicted isotope simulations generated in X-Caliber Software.  The simulation is based on 
the naturally occurring 12C isotopic peak distribution for the peptide of interest.  Figure 4A depicts the 
predicted isotope simulation of the naturally occurring doubly acetylated peptide containing H3K9Ac and 
H3K14Ac (H3K9-R16). Below the isotope, simulation is the mass spectrum pertaining to a representative 
spectrum obtained from a control mouse 4-hours after being gavaged with maltose dextrin (Figure 4.4B).  
The isotope distribution was found to be comparable between the simulation and experimental sample, 
with no detectable increases in the 13C2 ([M+2]) peak.  However, when the [M+4] peaks are compared 
between the simulation and the control mouse, the signal was lost in the experimental sample due to 
coelution of an isobaric peptide (Figure 4.4A and 4.4B).  Below the control sample, is spectra obtained 
from a mouse gavaged with heavy-labeled ethanol, and data indicates a marked increase in relative 
abundance of 13C2 [M+2] and 13C4 [M+4] when compared to the control mouse (Figure 4.4C and 4.4B).  
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Figure 4.4: Mass Spectra of the H3 Doubly Acetylated Peptide Representative of H3K9/K14     Suggests Site-Specific and Time-
Dependent Incorporation of the Heavy-Label Ethanol.  (A-D) Mass spectrum comparison of the isotopic distribution of 
the doubly acetylated peptide covering H3K9/K14 by simulation (A) Isotope 12C simulation predicting the expected 
isotopic distribution of the doubly acetylated peptide H3K9/K14 (m/z=521.28801). (B-C) 8-week mice gavaged with 
either 13C2-labeled ethanol (C) or maltose dextrin (B).  Increases in heavy-label incorporation can be determined by 
peak comparison of the 13C2 [M+2], and 13C4 [M+4] peaks (dashed ovals).  (D) Mass spectra simulation depicting a 
ratio of no label incorporation [M+2H]2+, 13C2 incorporated at a single acetyl site [M+2], or incorporation at both 
acetylation sites [M+4].  
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Also, the 13C2 [M+2] peak was found to exceed 13C2 peak at the 4-hour time point in the ethanol gavaged 
mice (Figure 4.4C).  The 13C4 [M+4] peak obtained from the ethanol mouse had to be compared to the 
isotope simulation because of the isobaric interference of the coeluted peptide in the control mouse 
spectra (Figure 4.4A-C).  Finally, in order to assess the incorporation of the heavy-label, a mixture of 
isotopes containing 12C, 13C2, and 13C4 was used to simulate the ratio of isotopes observed the ethanol-
treated mice after 4-hours (Figure 4.4D).  The simulation predicted a mixture of isotopes arising from 
different incorporation rates on the separate acetylation sites (Figure 4.4D).  Simulation analysis showed 
that 41% of 13C2 incorporation occurred at a single acetyl site, whereas 19% of incorporation occurred at 
both sites, leaving 40% of the acetyl groups unlabeled (Figure 4.4D). 
H3K18-R26 Analysis of 13C2 Incorporation on the Doubly Acetylated Peptide 4-hours After Ethanol 
Gavage 
The same analysis of isotopic distribution was completed for the doubly acetylated peptide 
containing H3K18Ac/K23Ac (Figure 4.5A-D).  Figure 4.5A shows the 12C simulation for the H3K18-R26 
peptide.  A mixture of label incorporation was again observed when comparing the 12C simulation to the 
control gavage mouse 4-hours post maltose dextrin (Figure 4.5A-B).  Results were similar for the control 
and the 12C simulation, except the 4-hour control mouse, did not display the 13C2 peak due to coelution 
of an isobaric peptide (Figure 4.5A-B).  Because both the 4-hour control mice and simulated isotopic 
distributions closely resembled each other, they were considered equal to the heavy-label ethanol 
comparison (Figure 4.5A and C).  Furthermore, the mice receiving the heavy-label gavage also 
demonstrated a mixture of label incorporation when comparing the 12C, 13C2, and 13C4 peaks (Figure 4.5C).  
Simulation of the doubly acetylated peptide, H3K18Ac/K23Ac, indicated that 44% of label incorporation 
only occurred at a single acetylation site and, 23% of peptides show incorporation at both acetyl sites,  
leaving 33% of the remaining peptides unlabeled when compared to the 4-hr ethanol-treated mice (Figure 
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Figure 4.5:  Four-Hour Comparison of Simulated Mass Spectra to the Experimental MS of the H3 Doubly Acetylated 
Peptide H3K18/K23 Suggests Site-Specific and Time-Dependent Incorporation of the Heavy-Label Ethanol.  (A-D) 
Isotopic distribution of the doubly acetylated peptide corresponding to the peptide containing H3K18/K23.  (A) 
Simulated mass spectra portraying the expected 12C isotope distribution for peptide H3K18-R26. (m/z=521.28801) 
(C-D) Isotopic distribution taken from the 8-week –old mice gavaged with either 13C2-labeled ethanol (C) or maltose 
dextrin (D).  Increases in heavy-label incorporation can be determined by peak comparison of the 13C2 [M+2], and 
13C4 [M+4] peaks (dashed ovals).   
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4.5C-D).  These data suggest that following an acute ethanol binge, label incorporation is preferential at a 
single acetylation site before being incorporated at both sites (Figure 4.5C). 
Incorporation of 13C2 on Multiple N-Terminal Acetylation Sites on H4 (K5-R17)  
The N-terminal region of histone H4 consists of 4 lysine residues, H4K5, K8, K12, and K16, all of 
which are free to become acetylated and/or methylated (data not shown).  XIC analysis proved to be an 
impractical method of quantification on H4 due to the numerous different configurations of lysine 
modifications that could be detected at any given time.  The software R was used to extract the acetylated 
H4 intensities identified by MaxQuant.  Nine separate acetylation configurations were identified on 
H4(G4-R17) (Figure 4.6)  Box plots were used to illustrate each of the identified H4 proteoforms identified 
Figure 4.6:  R Facilitates Quantitation of 13C2 Incorporation for the Multiple Acetylation Sites              on Histone 
4 (G4-R17).  Precursor intensity values for 13C2 and 12C isotopic peaks were extracted using the Bioconductor 
package “mzR”.  Plot values represent the ratio of 13C2 / 12C peak intensities for each identified Histone H4 
proteoform after 4-hours and 24-hours post 13C2-labeled ethanol gavage or dextrin gavage.  The points represent 
average incorporation for each mouse, and line ranges represent 0.5 standard deviations above and below the 
average. 
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by MaxQuant from both the control and heavy-label gavaged mice.  The average intensities for each 
proteoform were calculated from both the control and ethanol gavaged mice and used to find the ratio 
of 13C2 to 12C.  Surprisingly, each singly acetylated H4 proteoform was identified as a single modification, 
and 13C2 was incorporated within 4-hours post gavage (Figure 4.6).  Histone H4K12Ac was found in each 
mouse to have the greatest fold-change, and the smallest standard deviations (Figure 4.6).  All 
proteoforms identified followed the same metabolic trend of the greatest heavy-label incorporation 
occurring within 4-hours (Figure 4.6).  Interestingly, the monoacetylated (H4K16Ac), and triacetylated 
(H4K5Ac, H4K8Ac, H4K12Ac and H4K5Ac, H4K12Ac, H4K16Ac) peptides showed 13C2-label incorporation 
remaining after 24 hours (Figure 4.6).  These data show that once multiple acetylation sites are 
incorporating the heavy-label at different rates, combined with acetylation turnover rates, quantification 
gets more difficult to assess.  In cases like H4, where the sequence is lysine and glycine-rich, tandem mass 
spectrometry and de novo sequencing can be used as a way to cross-reference heavy-label incorporation 
at a specific site (Figure 4.7, top).  Annotating a respective spectra displays a mass shift of 2+ Da when an 
acetylated residue contains the heavy-label (Figure 4.7, top).  When the peaks are magnified, the peak 
distribution contains the y7 monoisotopic peak, as well as peaks pertaining to the 13C2 and 13C4 peaks 
(Figure 4.7, bottom).  These data present challenges for the software to decipher if the peak profile 
contains label incorporation at one site as a 12C monoisotopic peak, a true monoisotopic peak with 13C2 
heavy label or as a mixture of label incorporation (Figure 4.7, bottom). 
Discussion 
Chronic ethanol exposure has been shown to induce hyperacetylation of proteins within the 
mitochondria and cytoplasm [85, 87, 88, 118, 119].  Dysregulation of lysine acetylation has been linked to 
having numerous implications in diseases such as oncogenesis, DNA damage, inflammation, and 
neurogenesis, however, its role in alcoholic liver disease is still largely unexplored [120, 262, 267-269].  
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Figure 4.7:  Tandem Mass Spectrometry in Conjunction with De Novo Sequencing Offers Potential Insight in 
Quantifying 13C2-Label Incorporation on Peptides with Multiple Acetylation Sites such as Histone 4 G4-R17.  
(Top) Tandem mass spectrometry was used to annotate the H4 peptide, in which all 4 lysine (5, 8, 12, and 14) are acetylated.  
Sequencing was completed on the MS2 using MS-Product, (UCSF, Protein Prospector v. 5.20.0, http://prospector.ucsf.edu) 
and a mass shift of +2 Da on either the b or y ion series inferred incorporation of the 13C2.on the respective lysine residues.   
(Bottom) Magnification of the MS2 (Top) showing the y7 12C monoisotopic peak (m/z= 757.4315) as well as increased 13C2 
[m+2] and a 2+ Da mass shift 
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Recently, a link has been established between alcohol use and changes to histone acetylation [15, 18, 21, 
25, 39].  Moreover, mass spectrometry-based identification and metabolic tracing techniques are 
becoming more prominently used in the identification of histone epigenetic changes induced by external 
sources, such as alcohol abuse [3, 15-17, 21, 23, 25, 39, 262, 270-274].  These data show the first in vivo 
experiment using a heavy-labeled ethanol to metabolically trace ethanol metabolism to histone 
acetylation thought the metabolite acetyl-CoA.  These data now show a correlation between serum BAC 
levels and 13C2-label incorporation on histone proteins over the course of 24-hours (Figure 4.1A-B).  Lysine 
acetylation sites on histones have a relatively fast turnover, typically between 53 – 87 minutes, which is 
faster than methylation, however, still slower than phosphorylation [262].  The fast turnover rate 
observed in these data suggests that acetylation stemming from alcohol may be transient and work as a 
mechanism to alleviate cellular stress during ethanol metabolism.   
Traditional methods of SILAC ensure that complete label incorporation is achieved through many 
cell passages and supplemented media in order to minimize variability and assess differences in control 
and experimental groups.  These experiments used one bolus dose of heavy-labeled alcohol, which was 
then metabolically traced throughout the Acetyl-CoA pool to histone acetylation.  Furthermore, these 
data suggest that the increased lysine acetylation observed after alcohol exposure was due to alcohol 
ensued by shifts in redox potential, however, the contribution of deacetylase activity or inhibition may 
also have been a factor because of the fast rates of histone turnover (Figure 4.2C-D).  Previous work done 
by You et.al demonstrate that sirtuin 1 and histone 3 lysine 9 may work in tandem to prevent and slow 
the development of lipid accumulation in the liver in order to stall the onset of alcoholic liver disease 
[275].  These findings in combination with the new evidence presented here, suggest that during times of 
alcohol-induced stress, acetylation on histones may be site-selective in order to prevent liver injury by 
transcriptional regulation.  This hypothesis is could be further supported if the binge was repeated for a 
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longer period of time if hyperacetylation ensued the heavy-label incorporation should be identifiable in 
the majority of acetyl sites. 
The new data presented here now propose that alcohol can be incorporated, site-specifically onto 
known N-terminal histone acetylation sites important in chromatin remodeling (Figure 4.2 and 4.3).  
Furthermore, when two or more acetylation sites are available, incorporation of heavy-label occurs as a 
site-specific mixture (Figures. 4.4 and 4.5).  Site-specific incorporation of ethanol into histone protein 
acetylation advocates the need for specific transcriptional activation based on the type of liver injury the 
cells are experiencing.  For example, if an acute binge of alcohol is consumed and the alcohol can be 
metabolized and used as for transient acetylation and gene regulation, however during chronic exposure 
this mechanism will lead to hyperacetylation in order to prevent or promote long-term liver injury.  This 
hypothesis is consistent with our findings, in which label incorporation was found to have a fast turnover, 
signifying that the alcohol-induced modifications are transient and may be used as a mechanism by 
hepatocytes to alleviate stress and injury to the liver after alcohol exposure as deemed necessary by other 
signaling pathways.   
Recent advances in mass-spectrometry-based post-translational identification and quantitation 
have advanced the understanding of epigenetics and disease progression, such as ALD [272-274, 276].  
Histone 3K9Ac has been identified to upregulated during times of alcohol exposure and thought to play a 
protective role in the development of ALD [275, 277].  Interestingly, these new data show that 
incorporation and increased in site-specific acetylation are time-dependent.  Histone H3K14Ac was 
significantly increased within 4-hours of ethanol exposure and H3K9Ac was not observed to be 
significantly changed until after 24-hours when H3K14Ac was no longer upregulated (Figure 4.3A-B).  
Furthermore, overall total acetylation for the singly acetylated H3K9Ac and H3K14Ac peptide was found 
to be significant after 24-hours, these data suggest the need for site-specific quantitation (Figure 4.3A). 
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In order to assess site-specific label incorporation and overall acetylation of peptides through 
mass spectrometry, chromatographic separation of MS2 must be achieved (Figure 4.1F).  In addition, data 
analysis by XIC was limited when analyzing peptides such as H4 (K5-R17), which contained multiple 
acetylation sites on a peptide rich in glycine residues (Figures 4.6 and 4.7).  More comprehensive analysis 
using computer programs may offer some benefits over traditional methods of quantitation by XIC.  
Programs such as MaxQuant, extract intensities of the identified various proteoforms can be used to 
compare the modified and unmodified forms (Figures 4.6) [278].  Nevertheless, when relying on computer 
analysis, data must be validated and confirmed using the .raw data before assumptions can be made (Fig. 
6) [278].  One pitfall of computerized analysis is that it excludes peptides of low protein expression so 
mass spectrometer sensitivity must have high enough resolution in order for accurate quantitation [278].  
Furthermore, Histone elution in mass spectrometry often poses a problem with coelution of other 
histones or proteoforms [271, 274].  Coelution of simultaneous proteoforms or partially labeled peptides 
makes quantitation accuracy difficult when studying overall changes in alcohol-induced lysine acetylation.  
These data open the door for in vivo experimentation using a mass spectrometry SILAC approach.  These 
data have demonstrated that ethanol is metabolized and becomes a contributor to histone lysine 
acetylation via acetyl-CoA.  Further research using stable isotopes will help to identify novel targets and 
pathways directly impacted by alcohol consumption and the onset of alcoholic liver disease.      
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Chapter 5 
 
 
Conclusions and Future Directions 
 
Alcoholism and Alcohol Liver Disease a Review 
Alcoholism is a global issue that affects millions of people every year worldwide [1, 279].  Over 
3.3 million deaths are attributed to alcohol consumption every year and it is currently the 5th leading cause 
of premature death and disability [1].  The reason alcohol claims so many lives is because of its damaging 
effects on the entire body, affecting major organs such as the brain, heart, liver and immune system [1].  
Every day more than 6 people die from alcohol poisoning alone and currently, alcohol abuse has become 
the 2nd leading cause of preventable deaths, just under tobacco [1, 279].  In the United States (US) alone, 
over 80,000 people die every year from alcohol-related deaths and currently, 15 million people are 
struggling with an alcohol disorder [1, 279].  As a result, the US spends upwards of 250 billion dollars every 
year on alcohol-related treatments, of which three-quarters of the total cost originates from binge 
drinking.  Binge drinking has been on the rise especially in young adults ranging in ages from 18-34.  The 
National Institute on Alcohol Abuse and Alcoholism (NIAAA) define binge drinking as any pattern of 
drinking that raises the blood alcohol level to greater than 0.08mg/dL, which typically translates to 5 drinks 
in 2-hours for men and 4 for women [1, 2, 279].  Men are more likely than women to excessively drink 
alcohol, which increases their chances of alcohol-related injury [1, 279].  Close to 60% of men reported 
drinking in the last 30-days, of that 23% admitted to binge drinking at least 8 drinks in a sitting [279].  Only 
45% of women reported drinking alcohol in the last 30 days, and only 12% of those women admitted to 
binge drinking [1, 279].  Although women drink less than men they are more prone to liver injury for 
reasons still unknown.  
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Alcohol liver injury develops over 3 stages, steatosis, hepatitis, and cirrhosis, with no clear 
definition of where one stage ends and the next begins.  Both steatosis and hepatitis are reversible until 
fibroid tissue forms during cirrhosis when the irreversible fibroid tissue develop.  The first stage of ALD is 
steatosis and begins with the development of fatty liver.  Fatty liver development is the result of lipid 
peroxidation caused by the inhibition of PPAR α and AMPK activity [280].  The inhibition of AMPK results 
in SREBP1 activation of fatty acid synthesis [280].  Chronic drinking results in inhibition of PPARα and 
activation of SREBP1, which results in lipid accumulation and the development of fatty liver.  Without 
abstinence, steatosis will become hepatitis and liver injury progresses.  Eventually, long-term heavy 
alcohol consumption cause hepatocytes to become necrotic and fibroid tissue develops causing the 
irreversible steatosis.  Alcohol metabolism is an oxidative process that predominantly takes place in the 
liver.  The two enzymes in the liver responsible for the metabolism alcohol are alcohol dehydrogenase 
(ADH) and Cytochrome IIE1 (CYP2E1).  Both enzymes require the cofactors NAD+/NADH to catalyze the 
breakdown of ethanol into acetate.  The breakdown of alcohol induces shifts in redox potential and long-
term exposure can lead to mitochondria dysfunction and liver injury [4, 5, 48, 174, 221, 222].  The 
development of ALD has been well characterized, however many gaps in knowledge still remain. 
Overview of Major Findings 
Chapter 2 uses a chronic-binge mouse model of ALI to look for possible mechanisms responsible 
for gender differences commonly observed after chronic binging.  Following the 10-day chronic-binge, 
BAC levels were raised in both the male and female mice, where males showed approximately a 1.6 fold 
change in serum BAC.  Visual inspection of the H&E stained livers displayed no visible changes between 
the male and female mice receiving the high-fat control diet.  Both male and female mice receiving the 
ethanol diet displayed a clear indication of lipid accumulation in both genders when compared to their 
respective control-fed mice.  Although there were noticeable differences in both mouse genders, female 
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mice that had received ethanol exhibited more severe lipid accumulation when compared to their male 
pair-fed counterparts.  These data confirmed that the 10-day chronic-binge mouse model would be a good 
model to study gender differences in ALI.   
Proteomic analysis of whole cell liver lysate using Ingenuity Pathway Analysis (IPA) predicted 
women to upregulate genes and proteins more commonly associated with liver damage whereas males 
were predicted to upregulate genes and proteins commonly observed in liver injury.  Furthermore, 
Cytochrome P450 proteins, which are most known for their role in the metabolic breakdown of drugs 
used to treat diseases [281, 282], A wide range of CYP expression was observed between genders 
following the 10-day chronic-binge.  There are 18 families of CYP P450 proteins and families are grouped 
based on their primary function [281-283].  Interestingly the different families (2, 3, and 4) of cytochromes 
that were identified following the 10-day chronic binge in male and female mice tend to be involved in 
the metabolism of drugs, outside chemicals, and fatty acids [281, 282].  Hepatic cytochromes have been 
implicated in the development of liver disease because of a loss in their activity as liver injury increases. 
[282]  For example, hepatic CYP2E1 is well known for its role in oxidative alcohol metabolism, lipid 
peroxidation and the generation of reactive oxygen species, and was found upregulated in both genders 
following chronic-binge ethanol-diet [71, 75, 182, 221, 284-286].  Cytochromes belonging to the family’s 
1A, 2C19, and 3A activity have been shown to have increased sensitivity as the liver disease worsens [282].  
This may explain a loss of activity observed in the female mice since only expressed CYP3A44 and CYP3A16 
in the control-fed mice.  Males did not express those CYP3A44 and CYP3A16 in either the control or 
ethanol-fed mice, suggesting the use of different isoform to aid in metabolic clearance in the liver.  Also, 
CYP2A4, CYP2C70, CYP4V2, and CYP2F1 were only expressed in female mice after ethanol exposure, 
whereas male mice solely expressed CYP1A2 and CYP4F15.  Male mice did, however, exhibit a large 
increase in fold-change of CYP2A5, and CYP4A14 when compared to their female counterparts.  Although 
the role of Cyp2e1 has been studied extensively in the context of ALI [173, 174, 177, 182, 197-199], the 
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results from our preliminary studies are intriguing as the contribution of other CYP enzymes in ALI is largely 
unexplored.  In addition to CYP differential expression and lipid metabolism, proteomic analysis revealed 
greater activities of transcription factors associated with oxidative stress (Nrf2) affirming the previously 
established links between oxidative stress in ALI [6, 7, 134-138, 174, 177, 221, 222, 287, 288].  Results 
from this analysis have provided detailed information at the protein level for future mechanistic studies 
aimed to identify therapeutic targets with consideration of possible sex-specific strategies for prevention 
or treatment of alcoholic liver disease.  These differences may propose potential targets in gender-bias 
and liver injury.  One mechanism that may aid in cytochrome P450 development of gender influenced ALD 
is by their role in the formation of protein-aldehyde adducts and NADPH oxidase activity [288, 289]. 
Hepatocytes in the liver use pathways such as cellular respiration, CYP2E1, and NADPH oxidase, 
during ethanol metabolism which in turn promote the formation of ROS [4, 5, 7-9, 165, 209, 214, 215, 
287-289].  Cytochrome IIE1 is known for generating copious amount of superoxide (O2-) and hydrogen 
peroxide (H2O2) and creating mitochondrial dysfunction during ethanol metabolism [42, 71, 174, 177, 182, 
198, 221, 286].  In turn, the elevated hepatic oxidative stress levels will lead to an inflammatory response 
[7].  Nitric oxide (NO) is a key regulator of the inflammatory response and often plays a dual role in cellular 
protection and cell injury [290-293].  Nitric oxide is a free radical that is a generated by inducible nitric 
oxide synthase [291, 294].  Nitric oxide is important in maintaining cellular homeostasis through its 
signaling properties; while scavenging, it can react with excess superoxide generated from alcohol 
metabolism to form peroxynitrite (ONOO-), thus altering the pathways open to NO signaling [219, 295, 
296].  Both NO or O2- are considered to have weak oxidizing potential, however, once they combine to 
form ONOO- the newly formed radical has powerful oxidizing potential and can target a wide range of 
biological targets [94, 199, 219, 291-293, 295-298].  An interesting target of ONOO- in alcohol liver injury 
is tyrosine when ONOO- reacts with tyrosine to form nitrotyrosine [29, 94, 297]. 
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Tyrosine nitration is a post-translational modification that poses an interesting target in the 
pathogenesis of alcohol liver injury (ALI) because of its ability to alter protein function [29, 94, 299, 300].  
The ability of ONOO- to form nitrotyrosine in vivo has recently questioned due to the naturally low 
abundance of cellular ONOO- [300].  Alcohol-induced liver injury provides a conducive environment for 
nitrotyrosine formation because of increased nitrosative and oxidative stress incurred mitochondria 
dysfunction and inflammation [300-303].  Numerous efforts have been made to study this lowly expressed 
modification in vivo but have fallen short with traditional techniques of enrichment [300, 301].  These 
data now show a significant (p=.0001) increase in the amount of endogenous nitrotyrosine found in the 
mouse liver after 28-days of chronic ethanol exposure when compared to their control-fed counterparts.  
Furthermore, I was able to identify and validate 4 histone targets of nitration.  The 4 sites that were 
positively identified for tyrosine nitration were H3nY41, H1nY70, and H4nY51 and H4nY72.  These sites 
have all previously been demonstrated to have a role in epigenetic modulation when modified.  Histone 
3 tyrosine 41 can also be phosphorylated.  Upon H3Y41 phosphorylation the JAK2 kinase pathway is 
activated by excluding HP1α chromatin binding, which then allows for the activation oncogenes such as 
Imo2 [109, 235].  Histone 4 tyrosine’s 51 and 72 phosphorylation have also been implicated in DNA 
damage, chromatin restructures, histone turnover and transcriptional regulation [304].  Histone Y51 is 
recognized by the Abelson murine leukemia viral oncogene homolog 1 (ABL1), upon phosphorylation of 
H4Y51 ABL1 recognizes the signal as DNA damage, and recruits DNA repair machinery [304].  Histone 4 
tyrosine 72 phosphorylation also has a role in DNA damage and repair by signaling for epidermal growth 
factor receptor (EGFR) [305, 306].  Epidermal growth factor receptor is a receptor that aids in cell division 
and is often found upregulated in cancers due to the rapid proliferation during tumor growth and 
metastasis [305, 306].  The identification and validation of nitration on H1Y70 pose as an interesting 
epigenetic target.  Histone 1 is a linker protein which binds DNA around the nucleosome aiding in structure 
and chromatin remodeling, [307, 308].  Previous work in vitro has identified H1 to become nitrated as well 
 
120 
 
as be a target for dinitrase activity [114], and more recently histone H1 acetylation has recently been 
demonstrated to cross-talk with DNA methylation in order to promote gene silencing [309-311]. 
Molecular dynamics now predict that histone H3nY41 promotes a change in DNA conformation 
over the native unmodified H3Y41 by molecular dynamic simulations.  In order to further understand how 
H3nY41 affected the DNA, the phosphorus atoms of those nucleotides that are within 5 Å of H3 in the 
crystallographic conformation were tracked from both H3 proteins within the nucleosome and found to 
converge at t=200ns.  Also, when H3Y41 is nitrated, the DNA-P to H3Y41 distance increases on average by 
2 Å, which is the approximate distance of 2 hydrogen atoms.  The maximum DNA-P to H3Y41 distance 
observed in the wild-type system is <64 Å, while the H3nY41 system consistently assumes conformations 
where the DNA-P and H3Y41 distance is >67 Å.  Furthermore, the H3nY41 occasionally samples the 
conformational space of the wild-type system, yielding a lower average.  Although these distances seem 
relatively small they are large enough for the nitro group to draw in potassium ions, creating a water shell.  
In turn, as the positively charged ions move closer to the nitro group the water and phosphate move 
further away.  In order to further investigate how H3nY41 affects the DNA conformation, ChIP-sequencing 
was performed using an antibody synthesized against H3nY41.  ChiP-sequencing yielded 18 novel and 
potential sites within the genome that may interact with H3nY41.  Of these 18 sites, only 5 were located 
within the annotated portion of the genome.  Two of these sites, Ano2 and Dpp9, were used for validation 
by qPCR analysis and were found to not be significantly expressed when compared to the IgG negative 
control.  These data now show that chronic alcohol exposure increases levels of nitrotyrosine in the liver, 
with localization surrounding vascular regions as well as the nucleus.  The increased levels of nitrotyrosine 
in the nucleus following ethanol exposure were identified on numerous proteins important for 
transcriptional regulation, of those were 4 novel sites located on the N-terminal histone protein tail.  
These new data of histone nitration along with the molecular dynamic simulations suggest a possible role 
in transcriptional regulation and/or signaling mechanisms.  Previous data suggest that histone nitration is 
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reversible and found to increase in diseased or injured environments [106, 114].  Further understanding 
of the mechanisms involved in nitration regulation and disease progression will provide new epigenetic 
therapeutic targets.  Furthermore, understanding the relationship between tyrosine nitration and 
phosphorylation will provide an understanding of cellular signaling in disease causation and progression 
not only in ALI but many other diseases, which rely heavily on phosphorylation signaling pathways, such 
as cancer.   
In parallel to histone tyrosine nitration, protein and histone acetylation has previously been 
demonstrated to become upregulated following alcohol exposure [87, 88, 163].  Chapter 4 looks at the 
effects of acute alcohol exposure on hepatic histone acetylation using stable isotope labeling and mass 
spectrometry.  These experiments are the first to use heavy-labeled ethanol to metabolically trace ethanol 
to histone acetylation through its metabolite acetyl-CoA.  Significant incorporation of the 13C2 heavy-label 
was observed on histone 3 lysine 14 after 4 h (p=0.004) and still at 24 h (p=0.002) following alcohol 
exposure.  Incorporation was also found to be significant on both of the singly acetylated peptides 
containing H3K9/K14 and H3K18/23 after 24 hours (p=0.002, and p=0.02 respectively).  Although 
incorporation was not found to be significant on the doubly acetylated peptides containing H3K9/K14 and 
H3K18/K23, data does show that the 13C2 heavy-label is incorporated site-specifically as a mixture.  Histone 
H4 also showed to incorporate the 13C2 heavy-label at all 4 H4 lysine residues (K5, K8, K12, and K16), 
although quantitation had to be completed using computational extraction of intensities because of 
incorporation rates and histone turnover.  Data also showed that overall acetylation significantly 
increased during the 24 h post ethanol gavage in both the H3K9/K14 peptide (p= and also the H3K18/K23 
(p= peptide.  However, the H3K9 acetylation site was found not to have any significant contribution to 
overall acetylation, whereas the H3K14Ac peptide did (p=0.02).  These data now propose a link between 
ethanol metabolism, acetyl-CoA, and histone acetylation.  By ethanol seemingly targeting the N-terminal 
region on histone tails, it can be inferred that the changes in acetylation may play a role in chromatin 
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remodeling and transcriptional regulation.  This notion is further supported that when there are 2 or more 
acetylation sites, incorporation occurred as a mixture between sites.  Site-specificity of label incorporation 
provided by ethanol through acetate into acetyl-CoA to histone protein acetylation proposes a specific 
and transient response for transcriptional regulation based on the immediate reaction to acute ethanol 
exposure.  These findings, in combination with the new evidence presented here, suggest that during 
times of alcohol-induced stress, epigenetic changes to histones could regulate a selective transcriptional 
response related to ethanol response and liver injury. 
Future Directions 
 These studies use different models of alcohol exposure to close the gap in knowledge in the 
development of alcohol-induced liver injury (ALI).  The 10-day chronic-binge ethanol diet was used to 
study gender differences in the development of ALI.  Although the 10-day ethanol diet is easy to perform 
and has been shown to induce elevated levels of ALT and steatosis, it does not encompass chronic or acute 
drinking.  Women have been shown to develop more severe liver injury and faster when compared to 
males that consume the same or more quantities of alcohol [165, 167, 179, 312].  One approach that may 
help to capture the difference in short and long-term markers of liver injury in males and females might 
include varying the lengths of alcohol consumption.  By assessing both short and long-term changes 
induced by alcohol in males and females, will provide a more rounded approach to understanding 
pathways and proteins that influence gender bias in ALI.  Such approaches may include whole proteome 
studies using mass spectrometry, which will provide a global analysis of liver proteins responsible for the 
alcohol-induced liver injury.  Programs such as Ingenuity Pathway Analysis (IPA) can help to identify which 
genes, pathways, and proteins can be targeted for further analysis.   
 Another future direction will be to isolate Cytochrome P450 proteins that were identified to be 
differentially expressed in males and females following alcohol consumption.  The Cyp450 family of 
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enzymes is important in the metabolism of drugs, alcohol, cholesterol, steroids, and lipids [78, 211, 282, 
289, 313].  Interestingly, these enzymes are involved in lipid metabolism where sex-specific CYP activity 
could be related to the enhanced lipid accumulation phenotype observed in female mice after chronic-
binge ethanol feeding.  Cyp2j5 is important in the metabolism of arachidonic acid to various 
epoxyeicosatrienoic acids where metabolites from this pathway could have a role in protection against 
cellular oxidative stress.  Using methods of gene editing such as Cre recombinant or Crisper/Cas systems 
to knock out expression of highly upregulated CYPP450 proteins such as Cyp2j5 may offer insight into how 
these proteins alter ALI between genders.   
 Analysis of gender-specific epigenetic marks following long-term alcohol consumption would also 
provide an interesting look at transcriptional regulation during the development of alcohol liver disease.  
It would be interesting to look at nitrotyrosine and acetylation differences in male and female mice 
following both acute and long-term alcohol exposure.  In order to assess targets within the genome that 
are modulated by N-terminal histone acetylation during the development of ALI, ChIP-sequencing could 
be used to identify novel targets and then compared to known targets in wild-type and other diseases.  
The same histone acetylation sites that were identified using the 13C2 experiment (H3K9, K14, K18, and 
K23, and also H4K5, K8, K12, and K16) have ChIP-sequencing grade antibodies commercially available.  
These residues are important in transcriptional activation, however, their role in gene regulation after 
ethanol exposure has not yet been investigated.   
 Histone tyrosine nitration may also be further investigated using ChIP-seq.  The H3nY41 antibody 
can be further optimized using different concentrations of cells and antibody. The remaining 3 sites 
identified in the preliminary study should also be validated using qPCR.  The analysis can include both the 
wild-type and ethanol-treated mice and can be expanded to include both male and female mice.  Another 
technical approach in developing the H3nY41 ChIP analysis would be the further enrichment of nitrated 
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proteins prior to sequencing.  A stable protocol for enrichment of nitrotyrosine has been yet to be 
established.  Histone or protein may be the best way to enrich for the identification of nitrotyrosine site 
due to the low amounts of the modification observed in vivo.  Another method to enhance the 
understanding of alcohol-induced nitrotyrosine formation would be to target the nitric oxide producer 
inducible nitric oxide synthase (iNOS).  Creating a mouse model that overexpresses iNOS can be used to 
theoretically generate more nitrotyrosine formation.  In order to assess the role of nitrotyrosine in the 
development of ALI, when more NO is synthesized it can readily combine with increasing amounts of ROS 
within the liver.  Long-term upregulation of nitrotyrosine can be assessed in terms of liver damage by 
using markers for ALT, AST, triglycerides, and cholesterol.  Livers can also be used for histology to for a 
visual inspection of nitrotyrosine and lipid accumulation.  On the other hand, a mouse model deficient in 
iNOS can be used to which pathways and proteins are down-regulated following long-term alcohol 
exposure. 
 Next, the use of stable isotope labeling in vivo can be of great use in quantitative epigenetic 
studies.  Recently, stable isotope labeled mouse chow has become commercially available.  The cost of 
conducting experiments using stable isotopes is considerably high for both in vitro and in vivo but provides 
a way for researchers to quantify changes in protein expression using mass spectrometry.  By using a 
stable isotope labeled mouse chow in conjunction with another method of alcohol administration, 
changes in ALI can be quantified long-term using mass spectrometry.  Using labeled mouse chow also 
opens the door for heritability studies in the predisposition to ALI or alcohol fetal syndrome.  Labeled 
chow can be fed in conjunction with long-term alcohol binges to identify epigenetic marks in offspring 
contributed by the female, male, or both.  This type of study can be used to assess different epigenetic 
marks including methylation, acetylation, and phosphorylation.  Furthermore, generational studies can 
be conducted due to the fast breeding rate of mice. 
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Lastly, one obstacle that needs further optimization in order to use a labeling approach for 
epigenetic studies, both short and long-term, is the use of computational analysis in quantitating multiple 
sites of label incorporation on proteins and histones.  Multiple epigenetic marks that were identified to 
incorporate heavy label in the 13C2 experiment were difficult to quantify due to the fast rate of histone 
turnover as well as the rate of label incorporation.  The addition of more time points and the use of 
multiple labels will provide a kinetic approach to quantifying the rate of incorporation in regards to the 
rate of incorporation to turnover.  Because the liver can only metabolize ethanol based on the availability 
of proteins necessary for metabolism, such as alcohol dehydrogenase and the cofactor NAD+, 
incorporation rates over long-term alcohol studies may show different trends. 
Conclusions 
 These studies provide novel results into how different rates of alcohol consumption affect the 
liver and the pathogenesis of ALI.  These data now show that male and female mice express different 
proteins and pathways important in the onset and development of ALI.  Furthermore, the Cyp P450 family 
of proteins, which have a large role in lipid accumulation and liver toxicity are differentially expressed 
between genders.  These data also show that during the time of alcohol metabolism protein nitration is 
upregulated within the liver.  This discovery prompted the evaluation of histone tyrosine nitration.  
Interestingly, histone tyrosine nitration was identified to be on multiple histones in the N-terminal region.  
These sites are known for the role in transcriptional regulation and prompted further analysis by 
molecular dynamics simulations and ChIP-sequencing.  Molecular dynamic simulations predict the 
nitrotyrosine on H3Y41 caused the DNA to prefer a conformational change.  This change may allow for 
transcription of genes important in the alleviation of ROS/RNS, inflammation, and lipid accumulation.  On 
the other hand, the dysregulation of transcription may also lead to more severe liver injury, which raises 
the need for further investigation.  This thought is further supported by the increased acetylation 
 
126 
 
observed on histone H3 following acute alcohol exposure.  Lable incorporation was observed to occur in 
as soon as 4 hours following alcohol exposure.  This demonstrates a link between ethanol and histone 
acetylation through the metabolites acetate and acetyl-CoA.  In conclusion here, I now show both a direct 
and indirect repercussion of alcohol abuse.  Ethanol can be directly linked via metabolism to histone 
acetylation and indirectly linked to histone tyrosine nitration as a result if increased ROS and 
inflammation.  
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